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The objective of this study was to determine the metabolic, stress, hematology, 
organ weights, histology and cardiac anatomical features of beef heifers supplemented 
with zilpaterol hydrochloride (ZH) when exposed to a corticotropin-releasing hormone 
(CRH) and arginine vasopressin (VP) challenge. Crossbred heifers (n = 20; 556 ± 7 kg 
BW) were randomized into two treatment groups: 1) Control (CON):  no ZH, and 2) 
Zilpaterol (ZIL): supplemented with ZH at 8.33 mg / kg (DM basis).  The ZIL group was 
supplemented ZH for 20 d, with a 3-d withdrawal period.  On d 24, heifers received an 
intravenous bolus of CRH (0.3 µg / kg BW) and VP (1.0 µg / kg BW).  Blood samples 
were collected at 30- and 60-min intervals for serum, and 60-min intervals for plasma and 
whole blood, from -2 to 8 h relative to the challenge.  Heifers were harvested to collect 
organ weights and histology samples on d 25, 26, and 27.  There was a treatment (P < 
0.001) effect for vaginal temperature (VT), with ZIL having a 0.1
o
C decrease in VT.  A 
treatment x time effect (P = 0.002) was observed for non-esterified fatty acid such that 
concentrations were increased in CON heifers at 4, 6, 7, 7.5, and 8 hrs.  There was a 
treatment effect for cortisol (P < 0.01) and epinephrine (P = 0.003) with ZIL having 
 
 
 
 
decreased concentrations. Glucose concentrations within the longissimus muscle were 
greater (P = 0.03) in CON heifers.  Lactate concentrations and glycolytic potential within 
the biceps femoris were greater in CON heifers (P = 0.05).  A treatment effect (P ≤ 0.02) 
was observed for calcium and potassium, with ZIL heifers having decreased 
concentrations.  Zilpaterol heifers had increased concentrations of creatinine (P = 0.02).  
A treatment x time interaction (P = 0.02) was observed for phosphorus.  Raw liver 
weights tended (P = 0.08) to be less in ZIL heifers.  These data suggest some variations 
between treatments in terms of response to ZH supplementation and challenge; however, 
in the environmental conditions of this study, the data suggests that the supplementation 
of ZH does not negatively alter the status of homeostasis in cattle.
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Chapter I 
 
Introduction 
The United States feedlot industry operates with small profit margins yearly but is 
able to increase profit potential by marketing more pounds of product.  Therefore, 
repartitioning agents are beneficial in beef production to increase pounds of marketable 
product and improve growth efficiencies.  The first reported repartitioning beta-
adrenergic agonist in livestock species was clenbuterol (Ricks et al., 1984).  To date, two 
β-AA are approved to be fed to cattle in the United States.  Increases in ADG  have been 
observed (Montgomery et al., 2009a) with slight decreases in DMI with β-AA 
supplementation resulting in increased feed efficiency (Mersmann, 2002) and an increase 
in gain to feed ratio (Avendaño-Reyes et al., 2006). –adrenergic receptor agonists are 
associated with an increase in lean tissue deposition in carcass components (HCW 
increase 13 and 11 kg in steers and heifers, respectively,(Montgomery et al., 2009a) and a 
decrease in adipose tissue (Mersmann, 2002; Mersmann, 1998). 
Although the first approved β-AA has been on the market for over 25 years, little 
is actually known about how β-AA interact with endogenous stress hormones during a 
stress response.  Anecdotal claims have implemented zilpaterol hydrochloride (ZH) as a 
potential cause of lame, stiff moving cattle at abattoirs.  Furthermore, an epidemiological 
risk of increased mortality associated with ZH supplementation during the late feeding 
period has been reported; however, no cause of the mortality was reported (Loneragan et 
al., 2014).  Therefore, the following literature review evaluates the overall status of 
homeostasis of animals’ supplemented β-AA. 
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CHAPTER II 
LITERATURE REVIEW 
 
History of beta-adrenergic agonist 
 The cost of livestock products directly depends on the efficiency of production; 
which is categorized into three segments: female production, reproduction, and growth of 
the young (Dickerson, 1970).  An issue that affects the production and efficiency of 
growth of livestock is the ratio of adipose tissue to lean muscle mass (Ricks et al., 1984).  
Two metabolic modifier technologies have been utilized in the cattle industry to increase 
the accretion of lean muscle mass.  These metabolic modifiers are anabolic steroids and 
-adrenergic agonists (β-AA; (Schmidt and Olson, 2007).  This literature review will 
focus on the history, mode of action, and production effects of β-AA with an emphasis on 
changes to blood metabolites, stress response, and organ effects of β-AA. 
 The use of β-AA as a growth promotion tool in livestock has been investigated for 
over 50 years.  Beta adrenergic agonists are phenethanolamines with a similar structure to 
the naturally occurring catecholamines (dopamine, norepinephrine, and epinephrine). 
Catecholamines and β-AA elicit a response by binding to  adrenergic receptors (β-AR; 
(Scramlin et al., 2010).  Phenethanolamine adrenergic agents share common structural 
components; however, not all phenethanolamines elicit β-AA activity. In fact, some 
phenethanolamine compounds actually elicit and β adrenergic antagonist effects 
(Smith, 1998).  Furthermore, phenethanolamines are further divided into subcategories 
depending on activation of different α and β receptor families (Smith, 1998).  These 
adrenergic receptors were first described  in 1948 when two distinct classes of receptors 
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where distinguished and classified as  and adrenotropic receptors (Ahlquist, 1948).  
Ahlquist, (1948) suggested that receptors were associated with excitatory functions 
such as vasoconstriction and uterine contractions, while receptors were associated with 
inhibitory functions such as vasodilation and inhibition of uterine and bronchial muscle 
contraction.  Ahlquist’s suggestion were approximately 47 years after Takamine and 
Aldrich isolated adrenalin from adrenal glands in 1901 (Dakin, 1905).  However, the idea 
of potential receptors mediating the response of a stimulus was first introduced by 
Lewandowsky in 1899 and Langley in 1901 when suprarenal extract was able to elicit a 
response after the removal of the superior cervical ganglion (Langley, 1905).  These 
results led to the conclusion that adrenal gland extracts acted directly on the tissue of 
interest and not nerve endings (Langley, 1905).  These discoveries allowed for the 
development of pharmaceuticals that are able to elicit a response through β - adrenergic 
receptors. 
adrenergic agonist 
 In livestock, two β-AA have received approval by the United States Food and 
Drug Administration, ractopamine hydrochloride and zilpaterol hydrochloride.  
Ractopamine hydrochloride received approval for the use in swine to increase rate of 
weight gain, improve feed efficiency, and increase carcass leanness in 1999 (NADA, 
1999).  In 2003, ractopamine hydrochloride was approved for use in beef cattle fed in 
confinement the last 28 - 42 d on feed to increase rate of weight gain, improve feed 
efficiency, and increase carcass leanness (NADA, 2003).  In 2006, zilpaterol 
hydrochloride was approved to be fed to cattle in confinement during the last 20 – 40 d 
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on feed to increase rate of weight gain, improve feed efficiency and increase carcass 
leanness (NADA, 2006).  Lastly, ractopamine hydrochloride was approved in 2009 to be 
fed to turkeys for the last 7 – 14 d before harvest in hen turkeys and the last 14 d before 
harvest in tom turkeys to increase rate of weight gain and improve feed efficiency 
(NADA, 2009).  To date, ractopamine hydrochloride is approved for use in swine, cattle 
and turkey production in the United States.  Zilpaterol hydrochloride is only approved for 
use in confined cattle finishing in the United States. 
Mode of action 
 The binding of either a natural or synthetic ligand to a β-AR results in the 
activation of the receptor and is required to initiate a cellular response (Mersmann, 1998).   
- adrenergic receptors are G stimulatory protein coupled receptors that initiate a signal 
response of cascading events when bound to naturally occurring catecholamines or β-AA 
(Mersmann, 1998; Scramlin et al., 2010).  - adrenergic receptors are located on the 
plasma membrane of most mammalian cells and are physiologically stimulated by natural 
catecholamines (Mersmann, 1998).  When β-AAs are orally ingested, binding and 
activation to β-ARs can increase protein accretion while decreasing lipogenesis 
(Mersmann, 1998).  After oral ingestion and absorption, peak plasma concentrations are 
observed in approximately 1 to 3 h in humans (Morgan, 1990) with a similar response 
observed in livestock (Smith, 1998   - adrenergic agonist are virtually insoluble in non-
polar solvents and are not generally considered lipophilic (Smith, 1998). 
 Upon absorption, β-AA are transported through the body to different cells via the 
circulation system.  At the designated cell, β-AA bind to β-AR to form an agonist-
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receptor complex which stimulates the G stimulatory protein (Mersmann, 1998).  
Activation of the -subunit of the G protein couple seven-transmembrane receptor results 
in the production of the enzyme adenylyl cyclase (Mersmann, 1998).  Adenylyl cyclase 
produces cyclic adenosine monophosphate (cAMP) which is a major intracellular 
signaling compound.  To elicit a response, cAMP binds the regulatory subunit of protein 
kinase A which results in the release of the catalytic subunit of protein kinase A (Liggett 
and Raymond, 1993; Mersmann, 1998).  The catalytic subunit phosphorylates 
intracellular proteins which activates the targeted protein.  Protein kinase A also 
phosphorylates the cAMP response element binding protein (CREB; (Mersmann, 1998).  
Once phosphorylated, CREB can bind to a cAMP response element located in the 
regulatory portion of a specific gene which enables transcription of that particular gene 
(Mersmann, 1998).  With the phosphorylation of CREB, transcriptional activity of the 
gene increases allowing β-AA to elicit a response in gene transcription of mammalian 
cells (Mersmann, 1998).  The use of caffeine, theophylline, nicotine, and epinephrine in a 
pig model displayed an increase in cAMP resulting in an increase in muscle mass 
(Cunningham, 1965).  This discovery led to the utilization of β-AA as potential growth 
promotion technology in livestock production. 
 β – adrenergic agonist do not elicit similar responses across all species.  These 
effects tend to be less pronounced in broilers when compared to sheep and cattle; swine 
displaying an intermediate response (Mersmann, 1998).  One potential explanation to the 
observed results could be due to genetic selection for maximum growth potential in a 
vertically integrated system such as the poultry industry (Mersmann, 1998).  However, 
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another potential explanation of the species difference could potentially be explained by 
different quantities and subtypes of β-AR.   
Cattle performance 
 The magnitude of the response observed in cattle administered a β-AA varies 
depending on which β-AA is utilized.  Furthermore, the age, gender, breed, plane of 
nutrition, and duration of β-AA administration can affect the results observed in cattle 
(Bell et al., 1998b; Lean et al., 2014; Mersmann, 1998).  The utilization of ZH at the end 
of the feeding period resulted in a 15 kg increase in hot carcass weight (HCW) with 
increased dressing percentages and decreased USDA yield grade consistently (Hilscher et 
al., 2015; Lean et al., 2014; Vasconcelos et al., 2008).  There was no observed difference 
in final live BW when control cattle were compared with ZH supplementation for 20, 30, 
and 40 d of feeding.  However, HCW was increased approximately 17 kg in ZH 
treatments when compared to with the control cattle (Vasconcelos et al., 2008).  
Furthermore, there was no observed increase in final live BW or ADG for cattle fed ZH 
for 20 d when compared with control steers (Hilscher et al., 2015).  In contrast, an 
approximate 9 kg increase in final BW and 14 kg increase in HCW was reported for 
steers supplemented with ZH, when compared with control steers (Elam et al., 2009). 
 Zilpaterol hydrochloride has been reported to increase ADG and G:F when 
supplemented to cattle.  Steers supplemented with ZH for 20 d resulted in an increase of 
0.47 kg / d and 0.056 kg / kg for ADG and G:F, respectively, with a tendency for 
decreased DMI (Montgomery et al., 2009a).  Furthermore, steers supplemented with ZH 
for 21 d resulted in an increase of 0.8 kg / d and 0.016 kg / kg for ADG and G:F 
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respectively; however, no decrease in DMI was observed over the duration of the feeding 
period (Hales et al., 2014).  No difference were observed for DMI or ADG in steers 
supplemented with ZH for 20 d when compared with control steers; however, there was 
an increase observed for G:F over the duration of the feeding period for steers 
supplemented with ZH when compared with the negative control (Hilscher et al., 2015).  
Lastly, there was no reported difference in DMI for steers fed ZH for 30 d (Baxa et al., 
2010).  However, a meta-analysis of studies evaluating the effect of supplementing cattle 
with ZH revealed an increase of 8 kg in live BW with a 0.12 kg / d reduction in DMI and 
an increase of 0.15 kg / d in ADG (Lean et al., 2014).  Overall, decreases in DMI and 
increases in ADG and final live BW have been variable across studies evaluating the 
effects of supplementing cattle with ZH regardless of duration. 
  In steers supplemented with ZH for 20, 30, or 40 d, a 14 kg increase was 
observed for HCW when compared with control steers, and an approximate 2 kg increase 
in HCW between all ZH treatments (Elam et al., 2009).  A 13 kg increase in HCW with a 
1.3 percent increase in dressing percentage with a 0.38 unit decrease in USDA yield 
grade and a 7.2 cm
2
 increase in loin muscle area was reported for steers supplemented 
with ZH for 20 d (Montgomery et al., 2009a).  Furthermore, steers supplemented with ZH 
for 30 days resulted in an average 8.8 cm
2
 increase in loin muscle area and an average of 
0.70 unit decrease in USDA yield grade (Hilton et al., 2009).  Hilscher et al. (2015) 
reported similar results; 13 kg increase in HCW and a 7.3 cm
2 
increase in loin muscle 
area, and a 0.67 unit decrease in USDA yield grade when ZH was fed for 20 d.  Overall, 
ZH has been reported to increase loin muscle area and decrease USDA yield grade in 
cattle regardless of feeding duration. 
8 
 
 
 
Effects on body temperature 
 Maintaining body temperature requires internal thermoregulatory mechanism of 
the animal and a resistance of energy exchange from the environment (Finch, 1986).  The 
feeding of ZH has been reported to decrease rumen temperature when compared with 
control steers (Boyd et al., 2015).  As reported by Boyd et al (2015) the decreased body 
temperature may be attributed to increased respiration rates, allowing ZH supplemented 
steers the ability to dissipate excess body heat.  Another biological response typically 
observed following stimulation of the β-AR is vasodilation of interior tissues (e.g., 
skeletal muscle, heart, lungs, liver, and gastrointestinal tract; (Dawes et al., 1997).  An 
increase in vasodilation could potentially allow dissipation of heat from the body surface 
at a faster rate.  However, it would be expected to see a decline in vasodilation with 
continued treatment of β-AA due to a down-regulation of the β-AR (Smith et al., 1994).  
Understanding blood flow changes as a result of β-AA supplementation, and particularly 
ZH, would help explain differences observed in body temperature, and also nutrient 
delivery and blood cell population changes. 
 
Blood metabolites and beta-adrenergic agonist 
Glucose: Glucose is a sugar molecule that is the primary source of energy for life 
processes of mammalian cells.  Historically, glucose has not been considered a prominent 
metabolic intermediate in the rumen due to irrelevant concentrations (Owens et al., 
1998).  However, in engorgement studies, rumen glucose concentrations have exceeded 
160 mg / dL which exceeds normal blood reference ranges for cattle (Horn et al., 1979).  
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Reported reference ranges for blood glucose concentrations in cattle are 45-75 mg / dL 
(Kaneko et al., 2008).   
In rainbow trout supplemented RH at 5, 10, 20, and 40 ppm for 12 wks, serum 
glucose concentrations were increased (Vandenberg et al., 1998).  Furthermore, rainbow 
trout supplemented RH at 40 ppm for 8 wk had increased glucose concentrations when 
compared to controls (Vandenberg et al., 1998).  Acute stimulation of β-AR increases the 
release of glucose from the liver and muscles (Mersmann et al., 1987).  However, this 
initial increase in glucose concentration is thought to diminish over time due to decreased 
tissue sensitivity and return to concentrations observed in control calves following acute 
β-AA ingestion (Zimmerli and Blum, 1990).  Steers fed clenbuterol (β2-AA) over a 9 d 
period had increased plasma glucose concentrations on d 1 of supplementation.  
However, on d 9 of clenbuterol supplementation, plasma glucose concentrations were not 
different when compared to control steers (Eisemann et al., 1988a). 
 In steers supplemented with ZH for 23 d, whole blood glucose decreased over 
time compared with control steers (Van Bibber-Krueger et al., 2015   - adrenergic 
receptors were determined to be located on spleen and lung tissue samples (Hasegawa 
and Townley, 1983).  Van Bibber-Krueger et al. (2015) hypothesized that β-AA could 
potentially activate β-AR located on the spleen to increase secretion of red blood cells 
which could potentially increase cells available to metabolize glucose.  Steers 
supplemented with cimaterol (β2-AA), at a rate of 0, 10, or 500 mg / d for 98 d had no 
effect on plasma glucose concentrations (Ricks et al., 1984).  Similar results of no change 
in plasma glucose concentrations were observed in steers supplemented with cimaterol at 
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rates of 0, 33, 49.5, 0r 66 mg / d (Quirke et al., 1988).  Furthermore, no difference was 
observed in blood glucose concentrations of lambs fed cimaterol at 0 or 10 mg / kg for 7 
or 12 wks (Beermann et al., 1987).  Lastly, no difference was observed in serum glucose 
concentrations of feedlot lambs supplemented with either RH or ZH at 0.35, 0.70, or 1.05 
mg / kg of BW / d; or 0.10, 0.20, or 0.30 mg / kg of BW / d, respectively, when compared 
to control lambs (López-Carlos et al., 2010). 
Insulin: Insulin is a peptide hormone secreted by β cells in the islets of 
Langerhans located in the pancreas.  Insulin inhibits the release of glucagon and 
stimulates the uptake of glucose into muscle and adipose tissue (Reece et al., 2015).  
Three-week treatment of growing lambs with cimaterol resulted in a 50% decrease in 
insulin concentrations (O'Connor et al., 1991).  It has been hypothesized that the 
repartitioning effects of phenethanolamines could be partially due to opposing effects of 
insulin sensitivity in adipose tissue compared to muscle tissue (Anderson et al., 1991).  In 
rats and pigs supplemented RH, reduced insulin sensitivity in adipocytes has been 
observed (Hausman et al., 1989; Liu and Mills, 1990).  In rats chronically treated with 
adrenaline, an increase in insulin sensitivity was observed in the soleus muscle 
(Budohoski et al., 1987).  Cattle supplemented with RH at 80 mg / kg of feed had no 
change in insulin secretion or uptake when compared with controls utilizing the 
hyperinsulinemic, euglycemic clamp approach to conduct measurement (Eisemann and 
Bristol, 1998).  Lastly, in postpartum beef cows supplemented with ZH at 0.15 mg / kg of 
BW for 33 d had decreased insulin concentrations starting on d 14 of supplementation 
when compared with controls (Guzman et al., 2012).  The conflicting reports in the 
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literature on β-AA effects on insulin concentrations could potentially be due to the 
activation of different subclasses of β-AR and diets fed during these research trials. 
Blood urea nitrogen: Blood urea nitrogen (BUN) is a measurement of urea 
concentrations produced by the urea cycle as a waste product of protein breakdown and is 
utilized as a measurement of renal function (Kaneko et al., 2008).  Blood urea nitrogen 
concentrations can increase in healthy animals due to increased dietary protein (White et 
al., 1984).  In cattle, reported reference ranges for BUN are 20-30 mg / dL (Kaneko et al., 
2008).  Steers supplemented with clenbuterol at 500 mg / d for 98 days had decreased 
BUN concentrations at harvest when compared with control cattle that did not receive 
clenbuterol.  Furthermore, steers supplemented with clenbuterol at 10 mg / dL for 98 d 
tended to have decreased BUN concentrations when compared with controls (Ricks et al., 
1984).  Decreased BUN concentrations are associated with an increase in nitrogen 
retention (Davis et al., 1970; Preston, 1968).  Van Bibber-Krueger et al. (2015) reported 
decreased plasma urea concentrations in steers supplemented with ZH at 8.33 mg / kg of 
the diet for 23 d; suggesting decreased protein catabolism in skeletal muscle.  A decrease 
in BUN concentrations would be expected in cattle administered β-AA due to increased 
nitrogen retention associated with the increased deposition of muscle mass (increased 
HCW (Hilscher et al., 2015; Montgomery et al., 2009b). 
Non-esterified fatty acid: Non-esterified fatty acids (NEFAs) are fatty acids 
released from stored triacylglycerols in adipose tissue through actions of hormone-
sensitive lipase (Reece et al., 2015).  Once released, NEFAs are transported by albumin 
to target tissues where oxidation takes place releasing energy (Reece et al., 2015).  A 
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common effect of β-AA supplementation is decreased adipose tisssue which could 
possibly be due to increased fat mobilization, decreased lipogenesis, or a combination of 
both of these biological activities (Yang and McElligott, 1989).  In an attempt to estimate 
lipolysis, plasma NEFA concentrations can be utilized due to the strong correlation 
between lipolysis and NEFA turnover (Beermann et al., 1987).  Beermann et al. (1987) 
attributed a 60% increase in circulating NEFA concentrations in lambs to fasting for 1 d 
before sampling instead of cimaterol supplementation.  In steers administered cimaterol 
at rates of 0, 33, 49.5, or 66 mg / d, a quadratic increase was observed for NEFA 
concentrations with steers receiving 33 mg / d having the least NEFA concentrations and 
steers receiving 66 mg / d having the greatest NEFA concentrations between treatments 
(Quirke et al., 1988).  Steers supplemented with cimaterol at 0.09 mg / kg of BW for 13 d 
had an increase in NEFA concentrations on d 1 and 13 when compared to steers not 
receiving cimaterol (Chikhou et al., 1991a).  Chikhou et al. (1991) attributed increased 
NEFA concentrations of steers receiving cimaterol to increased lipolysis and reduced free 
fatty acid uptake.  In a closed arterial infusion trial utilizing steers, cimaterol 
administration increased plasma NEFA concentrations at 6 h following initial infusion 
(Byrem et al., 1996).  In a following closed arterial infusion trial, cimaterol 
administration increased plasma NEFA concentrations of steers at 6 h of infusion; 
however, at 24 h of infusion, NEFA concentrations had returned to concentrations 
observed during basal sampling (Byrem et al., 1998).  In steers supplemented with ZH for 
23 d, no difference in NEFA concentrations were observed when compared with control 
steers (Van Bibber-Krueger et al., 2015). 
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- hydroxybutyrate: Metabolism of NEFAs in the liver produces -
hydroxybutyrate which is a ketone body that can be increased during times of negative 
energy balance (Ospina et al., 2010).  In cattle, the average range for - hydroxybutyrate 
are reported as 0.41 ± 0.03 mmol / liter (Kaneko et al., 2008).  No difference was 
observed for - hydroxybutyrate in steers supplemented with 8 mg / d of clenbuterol in a 
balanced, single reversal trial (Eisemann et al., 1988a).  In steers suplemented with ZH 
for 23 d, no difference was observed in - hydroxybutyrate concentrations when 
compared with control steers (Van Bibber-Krueger et al., 2015).  It appears cattle 
supplemented β-AA are capable of metabolizing - hydroxybutyrate sufficiently which 
prevents a detectable increase in circulating concentrations (Van Bibber-Krueger et al., 
2015). 
Creatinine: Reported reference values for serum creatinine in cattle are 1.0-2.0 
mg / dL (Kaneko et al., 2008).  During normal muscle metabolism, creatine is broken 
down into creatinine which has been utilized as an indicator of muscle mass in serum 
(Russell and Roussel, 2007).  Furthermore, serum creatinine is positively correlated with 
carcass weight, dressing percentage, and proportion of lean meat (Istasse et al., 1990).  
Cimaterol supplementation  , increased plasma creatinine concentrations in Friesian 
steers during long term supplementation (Chikhou et al., 1993; Signorile et al., 1995).  
Furthermore, increased creatinine concentrations have been observed in sheep and cattle 
during heat stress (Koubkova et al., 2002; Srikandakumar et al., 2003).  Peripheral 
vasodilation increases during heat stress, reducing blood flow to organs in an attempt to 
dissipate more heat (Srikandakumar et al., 2003).  This decrease in blood flow during 
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vasodilation could potentially decrease renal filtration of creatinine resulting in increased 
circulating concentrations of creatinine (Scharf et al., 2010).  Since β-AA act as 
vasodilators, an increase in creatinine concentrations could potentially be due to 
decreased renal blood flow and increases in total muscle mass in animals supplemented 
with β-AA. 
Creatine kinase: Creatine kinase is a key enzyme for cellular energetics as a 
catalyst for the reversible reaction of creatine to phosphocreatine (Wallimann et al., 
1992).  Reported normal reference ranges for creatine kinase in cattle are 4.8-12.1 U / L 
(Kaneko et al., 2008).  During FDA approval, creatine kinase concentrations were 
reported to be increased in cattle fed ZH during approval trials (NADA, 2006).  No 
increase in creatine kinase activity was observed in steers under normal feedlot 
conditions supplemented with ZH or RH when compared with a control group.  However, 
creatine kinase concentrations were increased above normal reference ranges in two 
downer steers euthanized at a commercial abattoir that were reportedly fed ZH (Thomson 
et al., 2015).  Creatine kinase has been reported to increase when steers are transported 
due to an increase in muscle cell membrane permeability due to increased muscle activity  
(Warriss et al., 1995).  Furthermore, increased creatine kinase concentrations were 
observed in steers on d 14 and 21 of ZH supplementation (Fuller, 2014).  Increased 
creatine kinase concentrations were also observed in swine supplemented with RH 
(Athayde et al., 2013).  In three horses supplemented with ZH at 0.17 mg / kg of BW, 
increased creatine kinase concentrations were observed after 1 d of supplementation 
(Wagner et al., 2008).  The authors attributed this increase in creatine kinase to the 
15 
 
 
 
experimental design in which the horses consumed the entire dose of ZH at one time; 
thus potentially causing muscle damage (Wagner et al., 2008). 
Lactate and lactate dehydrogenase: Cells with increased glucose demand produce 
lactate during glucose utilization.  Pyruvate is produced when glucose is broken down 
during glycolysis.  Pyruvate concentrations increases intracellular absorbing two protons 
allowing the enzymatic production of lactate (Reece et al., 2015).  Thomson et al. (2015) 
and Van Bibber-Krueger et al. (2015) reported no difference in lactate concentrations of 
steers supplemented with ZH.  Van Bibber-Krueger et al. (2015) observed a numerical 
decrease in plasma lactate concentrations as d on ZH increased.  The inclusion of P-5369 
and Q-2636 β-AA within milk replacer increased lactate concentrations in calves (Blum 
and Flueckiger, 1988).  Eisemann et al. (1988) observed increased lactate concentrations 
with the inclusion of clenbuterol in steer diets.  Furthermore, arterial cimaterol infusion 
increased lactate concentrations in a dose-dependent manner (Byrem et al., 1996).  The 
reported increases in lactate concentrations suggest that cattle supplemented with β-AA 
have an increase in peripheral glycolysis (Eisemann et al., 1988a) in anaerobic 
conditions. 
The glycolytic enzyme lactate dehydrogenase (LDH) catalyzes the conversion of 
lactate to pyruvic acid (Doornenbal et al., 1988).  The reported reference range for LDH 
in cattle is 692 – 1445 U / liter (Kaneko et al., 2008).  When ZH was administered to 
horses at a rate of 0.17 mg / kg of BW, an increase in LDH was observed (Wagner et al., 
2008).  In cattle, the effects of supplementation with β-AA on LDH concentrations have 
not been reported in controlled studies. 
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 Serum protein profiles: There are two major proteins (i.e., albumin and globulin) 
that contribute to the total serum proteins concentrations evaluated during a serum 
chemistry profile test (Russell and Roussel, 2007). Albumin and other globulin fractions 
are indicators of protein status (Evans and Duncan, 2003).  Albumin is primarily 
responsible for the sequestering of H2O into the circulatory system during oncotic 
pressure and is synthesized in the liver (Russell and Roussel, 2007).  Immunoglobulins 
synthesized in lymphoid cells make up a majority of the total globulins located in 
circulation, with other globulins being synthesized in the liver (Russell and Roussel, 
2007).  The reported reference concentrations for albumin and globulin in cattle are 30.3-
35.5 and 32.9 ± 1.3 g / L, respectively (Kaneko et al., 2008).  An increase in albumin 
and/or globulin results in a condition known as hyperproteinemia.  Dehydration is the 
major known cause of an increase in albumin resulting in hyperalbuminemia (Russell and 
Roussel, 2007).  Cases of hyperproteinemia without dehydration are usually caused by 
increased globulin concentrations.  One common cause of hyperglobulinemia is chronic 
inflammatory diseases and hepatic disease (Russell and Roussel, 2007).  Lopez-Carlos et 
al. (2010) reported that ZH supplementation at either 0.10, 0.20, or 0.30 mg / kg of BW/d 
for the last 42 d of feeding had no impact on serum total protein (López-Carlos et al., 
2010).  Furthermore, the feeding of clenbuterol to Hereford steers did not impact serum 
total protein or albumin (Ricks et al., 1984). 
Minerals 
 The mineral calcium is vital for vertebrate animals to maintain homeostasis and 
functions in muscle contraction, blood coagulation, enzyme activity, hormone secretion, 
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and is a major component of bone structure (Capen and Rosol, 1993).  The two primary 
functions of calcium in the body are to maintain bone structure and serve as a messenger 
or regulatory ion in the body (Ebashi, 1985).  Ninety-nine percent of calcium in the body 
is located in the inorganic matrix of bone and hydroxyapatite with the remaining 1% of 
calcium being located in plasma membranes, endoplasmic reticulum of cells, and 
extracellular fluids (Kaneko et al., 2008).  Calcium is absorbed from the diet with the 
majority of absorption taking place in the duodenum (McDowell, 2003).  Ricks et al. 
(1984) reported no difference in blood calcium concentrations at harvest of steers 
receiving 0, 10, or 500 mg / hd / d supplemented with clenbuterol for 98 d.  
Supplementation of ZH for 20 d resulted in a decrease in calcium concentrations in steers 
and heifers when compared with cattle not receiving ZH.  Furthermore, a greater 
reduction of calcium concentrations was observed in steers receiving ZH supplementation 
when compared with heifers receiving ZH supplementation (Burson, 2014).  However, in 
steers receiving 90 mg / hd / d of ZH, there was no difference in calcium
+
 concentration 
when compared with control steers (Fuller, 2014). 
 In the mammalian body, 90% of phosphorus is located in the mineralized matrix 
of bone in the body as hydroxyapatite.  The remaining 10% of phosphorus  is located in 
soft tissues and serves as a major intracellular anion (Dennis, 1996).  Approximately 60 – 
70% percent of dietary phosphorus  is absorbed by active transport coupled to H
+ 
ion in 
ruminants and by passive diffusion (Shirazi-Beechey et al., 1996).  In ruminants, 
phosphorus  adsorption primarily takes place in the forestomachs (Care, 1994).  
Furthermore, salivary secretions supply endogenous phosphorus  to the gastrointestinal 
tract in ruminants (Shirazi-Beechey et al., 1996).  Ricks et al. (1984) reported no 
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difference in phosphorus concentrations at harvest in steers receiving 0, 10, or 500 mg / 
hd / d of clenbuterol for 98 d.  In steers supplemented with 90 mg / hd / d of ZH, there 
was no difference in phosphorus concentrations when compared with steers that received 
no β-AA (Fuller, 2014). 
 The major cation maintaining osmotic pressure and water content of extracellular 
fluid is sodium (Reece et al., 2015).  Sodium functions to maintain acid-base balance and 
is crucial in the transmission of nervous impulses by determining electrical potential of 
nerve tissues.  The major cation maintaining osmotic pressure and water content of 
intracellular fluid is potassium (Reece et al., 2015).  Potassium is present in extracellular 
fluid but is highly regulated due to major effects on organs that could become life 
threatening (Russell and Roussel, 2007).  Lastly, chloride is the major anion of 
extracellular fluid that is a component of bodily secretions such as sweat, saliva, and 
gastric secretions (Russell and Roussel, 2007).  Normally, sodium and chloride 
concentrations are parallel due to simultaneous reabsorption in the kidneys.  Together, 
these three minerals are classified as electrolytes which can be utilized with the inclusion 
measurement of carbon dioxide or bicarbonate to calculate the anion gap (Russell and 
Roussel, 2007).  The anion gap is the calculated difference of the major cations (sodium 
and potassium) and the major anions (chloride and bicarbonate) that is utilized to 
determine acid-base disorders.  Bicarbonate is a buffer that neutralizes H
+
 that is 
produced during metabolism (Kaneko et al., 2008). 
 Due to a significant amount of mineral storage in bone, serum circulating 
concentrations of minerals may be an unreliable measurement on total body mineral 
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status of an animal.  However, in steers and heifers, supplementation of ZH resulted in an 
increase in blood potassium concentrations when compared with steers and heifers that 
received no β-AA (Burson, 2014).  Furthermore, Fuller (2014) reported an increase in 
potassium and chloride in steers receiving either 300 mg / d of RH or 90 mg / d of ZH 
when compared with steers receiving no β-AA.  Ramirez et al. (1992) reported a decrease 
in bicarbonate concentrations of Holstein cows reared at sea level when compared with 
Holstein cows reared at 3,000 m.  Cows reared in high altitude are exposed to ambient 
hypoxia resulting in the development of decreased bicarbonate concentrations to 
compensate abnormal acid-base concentrations (Ramirez et al., 1992).  Clenbuterol has 
been reported to increase blood flow and oxygen uptake in the hind-quarters of cattle 
during early supplementation (Eisemann and Huntington, 1987).  Due to an increase in 
oxygen uptake observed in β-AA supplemented cattle, greater bicarbonate concentrations 
could suggest an increase in oxygen availability with β-AA supplementation. 
Liver enzymes 
 Alkaline phosphatase (ALP) catalyzes the cleavage of inorganic phosphate from 
phosphate esters with production of ALP originating in the liver of mature animals 
(Doornenbal et al., 1988).  Furthermore, in normal animals, serum ALP originates from 
liver and bone tissue (Rogers, 1976).  The reference values for ALP in the cow are 78 – 
132 U / L (Kaneko et al., 2008).  Alkaline phosphatase concentrations will increase with 
acute or chronic liver disease; however, cholestasis conditions result in significant ALP 
concentration increases (Kaneko et al., 2008).  Ricks et al. (1984) reported no difference 
in ALP in Hereford steers supplemented with clenbuterol.  In dogs with increased 
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corticosteroid concentrations, ALP concentrations are increased due to the formation of a 
more heat stable isoenzyme of ALP (Teske et al., 1986).   
Aspartate transaminase (AST) is an enzyme that catalyzes the transfer of an α-
amino group from an amino acid to an α-keto acid (Doornenbal et al., 1988).  The most 
important tissues for AST production are liver and muscle (Russell and Roussel, 2007).  
During acute or chronic liver injury, serum AST concentrations may increase; however, 
AST activity can also be elevated in kidney, pancreas, and erythrocytes which can 
increase circulating concentrations if cells are damage (Kaneko et al., 2008).  An increase 
in AST concentrations was observed in Friesian calves administered cimaterol (Chikhou 
et al., 1993).  Ricks et al. (1984) also reported an increase in AST concentrations in steers 
supplemented with clenbuterol at 10 and 500 mg / hd / d for 98 d when compared to 
steers not receiving clenbuterol.  Furthermore, AST concentrations were increased above 
normal reference ranges in two downer steers euthanized at a commercial abattoir that 
were reportedly fed ZH (Thomson et al., 2015). 
Gamma glutamyltransferase (GGT) is a membrane bound enzyme that catalyzes 
the transfer of gamma glutamyl groups from gamma glutamylpeptides to other peptides 
or amino acids with a normal reference range in cattle of 6.1 – 17.4 U / L (Kaneko et al., 
2008).  In ruminants, GGT is considered to be a more appropriate indication of liver 
disease than ALP (Russell and Roussel, 2007).  Serum GGT predominately originates 
from cellular membranes of the bile and liver and is indicative of liver disease (Russell 
and Roussel, 2007).  In canines, glucocorticoids have been associated with an increase in 
GGT concentrations (Shull and Hornbuckle, 1979).   
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Sorbitol dehydrogenase (SDH) can be utilized as a specific indicator of acute liver 
damage in ruminants due to a dramatic increase in serum concentrations followed by a 
drastic decrease in activity after liver damage (Russell and Roussel, 2007).    Reported 
SDH reference ranges for the cow are 4.3 – 15.3 U / L (Kaneko et al., 2008).  Feed 
restriction in llamas resulted in an increase in hepatic lipidosis which resulted in elevated 
SDH concentrations (Tornquist et al., 2001). 
Complete blood cell count (CBC)  
A complete blood cell count (CBC) is a hematology test that evaluates the 
leukocytes and other constituents of blood with the primary function of screening for 
hemic system abnormalities due to disease or determining hematologic disorders 
(Stockham and Scott, 2013).  Red blood cells (RBCs) or erythrocytes are evaluated in a 
CBC to determine size and abnormalities.  Erythropoietin production in the kidneys 
results in the production of RBCs in bone marrow (Jones and Allison, 2007).  The 
function of RBCs is gas exchange which takes place when RBCs are in the heme 
structure allowing for the transportation of oxygen and carbon dioxide (Jones and 
Allison, 2007).  Hematocrit or packed cell volume (PCV) in conjugation with total 
plasma protein can be utilized to evaluate changes in fluid and electrolyte balance.  A 
change in hematocrit values results from a plasma volume alteration if no change in total 
protein is assumed (Kaneko et al., 2008).  In steers and heifers, ZH supplementation for 
20 days did not affect hematocrit concentrations when compared with control cattle not 
receiving ZH (Burson, 2014).  The effects of clenbuterol supplementation and treadmill 
exercise were evaluated utilizing male Simmental calves with an average BW of 88 ± 4 
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kg over a 6 wk period.  Calves were supplemented 10 µg of clenbuterol / kg of BW daily 
except on treadmill exercise days which were d 0, 1, and 14 relative to clenbuterol 
supplementation (Bruckmaier and Blum, 1992).  On treadmill exercise days, calves were 
supplemented 25 µg of clenbuterol / kg of BW.  Pack cell volume increased from 
baseline concentrations during exercise; however, PCV values did not differ between 
clenbuterol and control calves except on exercise d 14 when clenbuterol steers had 
increased PCV during exercise when compared with control calves (Bruckmaier and 
Blum, 1992).  However, PCV values returned to observed pre-exercise baseline values 
following exercise regime in both clenbuterol and control calves (Bruckmaier and Blum, 
1992).  The increase in PCV were suggested to be caused by a decrease in blood water 
content and the increase of RBC release from the spleen (Bruckmaier and Blum, 1992). 
 Hemoglobin is a heme-containing protein transported in RBCs and accounts for 
95 percent of the total protein located in RBCs (Kaneko et al., 2008).  The transportation 
of hemoglobin inside RBCs allows for a longer half-life which would only be a few hours 
if not bound inside RBCs.  The overall function of hemoglobin is the transportation of 
oxygen and carbon dioxide in the body (Kaneko et al., 2008).  Bruckmaier and Blum 
(1992) observed an increase in hemoglobin in both calves supplemented 10 µg of 
clenbuterol / kg of BW daily and control calves during treadmill exercise with no 
clenbuterol effect on hemoglobin concentrations. 
 Blood platelets are cellular particles with growth regulatory factors produced by 
megakaryocytes (Kaneko et al., 2008).  The approximate life span of a platelet is 10 days 
with new platelet production taking place daily (Kaushansky, 2005).  Platelets are a key 
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component of hemostasis, thrombosis, and also produce proteins, lipids, carbohydrates, 
and nucleotides (Kaneko et al., 2008).  In a horse supplemented with ZH at 0.17 mg / kg 
of BW for 1 d and approximately 0.02 mg / kg of BW on d 2 and last day of 
supplementation, platelet concentrations were increased above normal reference ranges 8 
and 14 days following ZH supplementation (Wagner et al., 2008).  No conclusion was 
drawn on why platelets were increased approximately 6 and 12 d following ZH 
supplementation. 
  Lastly, leukocytes or white blood cells (WBC) are measured as part of a CBC and 
are divided into granulocytes and mononuclear cells.  Granulocytes consist of 
neutrophils, eosinophils, and basophils while mononuclear cells consist of lymphocytes 
and monocytes (Jones and Allison, 2007).  Neutrophils, eosinophils, basophils, and 
monocytes are produced and mature in bone marrow while lymphocytes that originate 
from bone marrow stem cells mature and proliferate in lymph tissue (Jones and Allison, 
2007).  Within 2 h of a foreign object or bacterial  insult, neutrophils migrate to the site of 
damage in an attempt to neutralize the threat through phagocytosis (Morris and Large, 
1990).  In one horse supplemented with ZH, damaged neutrophils were observed; 
however, two other horses supplemented with ZH did not have damaged neutrophils 
(Wagner et al., 2008).  Clenbuterol had no effect on total WBC counts when 
supplemented to rats; however, clenbuterol treatment did increase neutrophils and 
monocytes (Shirato et al., 2007).  Monocytes in circulation are able to phagocytose 
infectious organisms or cellular debris and become macrophages (Jones and Allison, 
2007).  In steers supplemented with ZH and RH, neutrophils increased on d 1 and 3 
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during ZH supplementation and on d 7 of RH supplementation when compared to control 
steers not supplemented a β-AA (Fuller, 2014). 
 The function of eosinophils is to initiate an immune response when exposed to 
parasites, allergens, or other inflammatory reagents by releasing cytotoxic proteins (Jones 
and Allison, 2007).  Eosinophil concentrations can fluctuate in cattle, but may be 
increased during inflammation or during a stress response (Jones and Allison, 2007).  
Basophils are usually in small concentrations in ruminants and respond to allergic and 
inflammatory processes by releasing inflammatory mediators such as histamine (Jones 
and Allison, 2007).  Two classes of lymphocytes exist which are B cells that produce 
antibodies and T cells which function in the regulation of the immune response and 
cytotoxic immunity (Jones and Allison, 2007).  In rats supplemented with clenbuterol, 
eosinophil and lymphocyte concentrations decreased when compared with rats that did 
not receive clenbuterol (Shirato et al., 2007).   In pigs, supplementation of clenbuterol 
resulted in an increase in apoptosis of T cells (Blanco et al., 2003).  This cell death of T 
cells was attributed to decreased thymus cell size which could potentially result in a 
decrease in interleukin-6 concentrations during β-AA supplementation (Blanco et al., 
2003).  In lambs supplemented the β-AA L-646, 969, no difference in WBCs, 
lymphocytes, or neutrophils were observed between treatments.  An increase in 
lymphocyte proliferation was observed in lambs supplemented with L-646, 969 when 
compared with the control treatment; however, no difference in overall immune function 
was observed between treatment groups (Li et al., 2000). 
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Organ and tissue affects 
In human patients with failing hearts, β2-AR have been reported to increase 
allowing for increased stimulation by β2-AA when utilized (Bristow et al., 1986).  
Therefore, the effects of ZH supplementation on heart weight and anatomy would be 
beneficial when evaluating bovine hearts during supplementation.  No difference was 
observed in combined heart and lung weights of beef steers fed ZH for 20 d (Holland et 
al., 2010).  However, the feeding of clenbuterol in normal mice decreased heart weights 
by 8% when compared with control mice (Sharma et al., 1997).  Furthermore, a tendency 
for a decrease in heart weights of Holstein steers supplemented with ZH for 20 d was 
reported with no difference in lung weights between ZH and control steers (May et al., 
2014).  Also, May et al. (2014) reported a decrease in kidney and liver mass of ZH 
supplemented steers when compared with control steers.  The feeding of salbutamol (β2-
AA) to pigs has been reported to decrease kidney and liver weights when compared with 
control pigs (Hansen et al., 1994).  The decrease in renal and liver mass could be a result 
of decreased gut fill.  The repartitioning of energy to skeletal muscle growth and a 
decrease in feed intake resulting in less gut fill could explain the decrease in renal and 
liver mass of ZH supplemented cattle (Montgomery et al., 2009b).  The comparing of 
organ weight ratios to BW can result in misleading interpretation of data due to 
differences in animal adipose and muscle tissues (Joseph, 1908), as well as the previously 
reported effect of ZH on HCW (Montgomery et al., 2009a; Montgomery et al., 2009b).  
Reported percentages for bovine heart weight ratios to BW are 0.26, 0.52, and 0.38 for 
steers, bulls, and females respectively (Joseph, 1908). 
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 Glycolytic potential (GP) is a measurement of glucose, lactate, glycogen, and 
glucose-6-phosphotase that is present in muscle that ultimately can be converted to lactic 
acid.  This index can be used as a measurement of the capacity for postmortem glycolysis 
in muscle resulting in a decrease of muscle pH in the conversion of muscle to meat 
(Monin and Sellier, 1985).  Glycolytic potential has been evaluated as a potential 
measurement of meat quality in beef and pork (Hamilton et al., 2003; Wulf et al., 2002).  
In cattle, GP has been reported to have a curvilinear response with ultimate longissimus 
muscle (LM) pH after harvest.  Muscle samples with a GP less than 100 µmol / g are 
associated with a greater postmortem pH that results in decreased lactate production and 
can cause dark, firm, and dry beef (Wulf et al., 2002).  In previous ZH studies, Hilton et 
al. (2009) reported ZH supplementation increased beef color resulting in a brighter cherry 
red beef color during a 5 d shelf-life study.  Furthermore, Montgomery et al. (2009a) 
reported ZH supplementation increased LM cherry red color and resulted in a decrease of 
dark colored LM when compared with control carcasses.  The increase in bright cherry 
red color was attributed to an increase in myoglobin content that resulted in a favorable 
improvement in muscle color (Montgomery et al., 2009a).  In the rat model, it has been 
reported that the activity of protein kinases on glycogen synthase in skeletal muscle 
predominantly take place in the liver (Imazu et al., 1984).  If blood glucose 
concentrations are decreased, glucagon would be released from the α-cells of the 
pancreas to raise blood glucose concentrations (Navarro et al., 1999). 
 
 
27 
 
 
 
Stress 
 Stress is a term that has been utilized in the literature to explain a condition 
resulting in a forfeiture of homeostasis of a biological system.  Distress is described as an 
event caused by some form of stressor resulting in a biological response due to a threat to 
homeostasis.  However, not all stress is detrimental to the homeostasis and could 
potentially benefit the biological system through preparation and thus may be classified 
as eustress (Moberg and Mench, 2000).  Cattle are exposed to multiple stressors 
throughout the production phases.  In feedlot cattle, this stress can be experienced on the 
first day of arrival at the feedlot.  Although aspects of production are managed in an 
attempt to prevent stress, no production system can be maintained stress free.  Initial 
stressors faced by cattle entering a feedlot system will more than likely be immunological 
and metabolic stress due to exposure to a new environment and diets.  However, as cattle 
progress through the feeding period, stress can continue due to events such as extreme 
weather fluctuations and/or transportation to the abattoir.  Evolution of animals has 
allowed for the development of mechanisms to cope with stressful stimuli, but if the 
stimuli becomes too overwhelming, the animal must elicit a stress response to combat the 
stressor (Salak-Johnson and McGlone, 2007). 
Hypothalamic–pituitary–adrenal axis    
 During times of stress, the hypothalamic–pituitary–adrenal (HPA) axis is 
activated in an attempt to return the body to homeostasis which is a concept first 
introduced in 1929 (Cannon, 1929).  In an attempt to combat the stressful stimuli, one of 
the body’s main defense systems will be to activate the hypothalamus (Aron et al., 2007).  
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The hypothalamus allows for the connection of the neurological and endocrine systems of 
the body especially relating to stressful situations (Reece, 2004).  Composed of twelve 
different nuclei, these nuclei areas allow neuron control of endocrine factors that affect 
endocrine body function (Reece, 2004).  During stress, the main function of the 
hypothalamus is the secretion of corticotropin-releasing hormone (CRH) after stimulation 
from the higher brain center.  During stress, a catecholamine release acts on axons 
connected to the paraventricular nucleus by binding adrenergic receptors which causes a 
secretion of CRH into the portal circulation from the hypothalamus (Hadley and Levine, 
2007).  Corticotropin-releasing hormone acts on the pituitary gland, specifically the 
anterior pituitary which accounts for two-thirds of the pituitary gland, to secrete 
hormones including adrenocorticotrophic hormone (ACTH; (Ehlert et al., 2001).  
Adrenocorticotrophic hormone is secreted from basophilic corticotropic cells of the 
anterior pituitary to act on the adrenal glands (Reece, 2004). 
 The adrenal glands are located on the cephalic poles of the kidneys and are 
divided into two layers which include the adrenal cortex and medulla (Reece, 2004).  The 
adrenal cortex is further divided into three zones that include the zona glomerulosa, zona 
fasciculate, and zona reticularis.  The zona glomerulosa secretes mineralocorticoids and 
the zona fasciculate secretes glucocorticoids.  Lastly, the zona reticularis produces sex 
hormones that originate from the adrenal cortex (Hadley and Levine, 2007).  During 
stress, the zona fasciculate is activated by the binding of ACTH to produce 
glucocorticoids which include cortisol and corticosterone.  Upon binding, ACTH 
activates the receptor which works through G protein stimulation.  This activation 
stimulates adenyl cyclase which forms cAMP that activates protein kinase A.  This kinase 
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phosphorylates cholesterol ester hydrolase forming free cholesterol (Reece, 2004).  In the 
mitochondria, free cholesterol is converted to pregnenolone; however, the mitochondria 
does not obtain the enzyme to convert pregnenolone to cortisol or corticosterone.  For 
this conversation, pregnenolone is transported to the smooth endoplasmic reticulum 
where cortisol and corticosterone is hydroxylated to form 11-deoxycortisol and 11-
deoxycorticosterone.  After formation, 11-deoxycortisol and 11-deoxycorticosterone are 
transported back to the mitochondria where 11-hydroxylation forms cortisol and 
corticosterone respectively (Reece, 2004).  In cattle, the adrenal cortex secretes cortisol at 
greater concentrations than corticosterone; furthermore, cortisol is released in a diurnal 
pattern with highest concentrations being released during early morning (Reece, 2004).  
Control of the HPA axis resulting in the secretion of cortisol is under the negative 
feedback of cortisol.  As cortisol concentrations increase, cortisol down regulates CRH 
and ACTH release as an inhibitory blocker (Reece, 2004). 
Sympathetic nervous system  
The sympathetic nervous system (SNS) is associated with active conditions and 
prepares the body for a “fight or flight” response that will be activated during times of 
stress (Hadley and Levine, 2007).  The SNS is composed of two types of neurons which 
include preganglionic neurons and postganglionic neurons.  Preganglionic neurons are 
located within the thoracic and lumbar regions in the spinal cord whereas the 
postganglionic neurons are composed of long axons that transmit signals to different 
tissue areas of the body (Reece, 2004).  Furthermore, chromaffin cells are sympathetic 
ganglia located in the adrenal medulla which secrete catecholamines and are part of the 
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SNS (Reece, 2004).  Catecholamines are neurotransmitters that are synthesized from 
tyrosine absorbed from the diet or cleaved from phenylalanine.  Once transported into 
cells, tyrosine hydroxylase forms 3,4-dihydroxyphenylalanine from tyrosine.  Next, 
aromatic L-amino acid decarboxylase transforms 3,4dihydroxyphenylalanine into 
dopamine.  Dopamine is the precursor for norepinephrine in the presence of dopamine β-
hydroxylase, and norepinephrine is converted to epinephrine if cortisol and 
phenylethanolamine N-methyltransferase are available during synthesis (Reece, 2004). 
Exogenous hypothalamic–pituitary–adrenal activation 
 The evaluation of a stress response can be one of the more challenging biological 
responses to measure due to the fact that in some cases the actual collection of the 
samples can result in a stress response.  Due to this, activation of the HPA axis can be 
accomplished by administration of exogenous hormones to elicit an acute stress response.  
To test the sensitivity of the HPA axis, corticotropin-releasing hormone, arginine 
vasopressin, and ACTH have been utilized as repeatable methods to induce similar 
responses observed during acute stressors.  With utilization of exogenous hormones, 
constant concentrations can be administered to multiple animals allowing for true 
evaluation of applied treatment effects on the HPA activation.  It was observed that 
ACTH administration would elicit a cortisol response with increasing doses of ACTH 
resulting in a greater response (Lay et al., 1996).  However, overall plasma peak cortisol 
concentrations did not differ regardless of initial ACTH dose.  Corticotropin-releasing 
hormone and arginine vasopressin are capable of eliciting similar cortisol responses when 
administered individually.  However, a tandem dose of CRH and arginine vasopressin 
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results in a more sustained cortisol response (Carroll et al., 2007).  These exogenously 
administered hormones allow for activation of the HPA axis by eliciting similar stress 
responses observed during normal production phases.  Therefore, the utilization of this 
method is an appropriate and reliable option to test the sensitivity of the HPA axis in 
regards to a specific treatment. 
-adrenergic agonist and stress   
 -adrenergic agonist upon binding β-AR increase the production of cAMP 
(Mersmann, 1998).  This increase in cAMP can result in the availability of nutrients to be 
utilized by multiple systems.  Furthermore, increased circulating concentrations of 
catecholamines in stress-susceptible pigs produced pale, soft, exudative (PSE) pork due 
to increased lactate in muscles (Warriss et al., 1990).  Furthermore, pigs supplemented 
with RH were reported to have increased circulating concentrations of catecholamines 
(Marchant-Forde et al., 2003).  Similar findings were observed for cortisol concentrations 
in lambs and cattle supplemented with β-AA (Bryant et al., 2010; Li et al., 2000).  An 
increase in cortisol concentrations would be expected if β-AA increased stress.  In pigs 
supplemented with RH, no increase in cortisol concentrations were observed (Athayde et 
al., 2013).  In horses, supplementation of ZH for 2 d resulted in increased lactate 
dehydrogenase, creatine kinase, and aspartate transferase, which was interpreted as an 
indicator of muscle damage (Wagner et al., 2008).  Overall, limited studies have 
evaluated the stress response of livestock species supplemented with β-AA; however, in 
the available control studies, β-AA do not appear to significantly alter the ability of 
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animals to elicit an appropriate stress response in species that are approved to be 
supplemented with β-AA. 
Conclusion 
Due to animal wellbeing concerns related to the supplemented with ZH to cattle, 
the ZH was voluntarily removed from the market in August, 2013.  However, at the time 
of removal, no scientific data were available to support or refute animal welfare concerns 
regarding ZH supplementation.  It was suggested that cattle supplemented with ZH could 
potentially have an altered stress response when faced with stressful stimuli during 
production practices such as transportation to the abattoir.  At the time, no studies had 
evaluated the stress response of any livestock species supplemented a β-AA in a 
controlled setting which would provide crucial baseline concentrations of metabolites 
affected only by β-AA supplementation.  Therefore, the objective of the following study 
was to evaluate the stress response of beef feedlot heifers supplemented with ZH for a 20 
d period followed by a 3 d withdrawal period.  To scientifically evaluate the stress 
response, a CRH and arginine vasopressin endocrine challenge was utilized allowing for 
a controlled stressful stimulus to be administered across all treatments equally.  This 
allowed for the evaluation of the capability of cattle to elicit a stress response after β-AA 
supplementation.  Furthermore, this approach allowed for the opportunity to measure the 
overall metabolic status and blood chemistry analysis of cattle supplemented a β-AA 
during a controlled stress challenge. 
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CHAPTER III 
THE METABOLIC, STRESS AXIS AND HEMATOLOGY RESPONSE OF 
ZILPATEROL HYDROCHLORIDE SUPPLEMENTED BEEF HEIFERS WHEN 
EXPOSED TO A DUAL CORTICOTROPIN-RELEASING HORMONE AND 
VASOPRESSIN CHALLENGE 
A manuscript accepted to The Journal of Animal Science 
Abstract 
The objective of this study was to determine the metabolic, stress, and 
hematology response of beef heifers supplemented with zilpaterol hydrochloride (ZH) 
when exposed to an endocrine stress challenge. Heifers (n = 20; 556 ± 7 kg BW) were 
randomized into two treatment groups: 1) Control (CON):  no ZH supplementation, and 
2) Zilpaterol (ZIL): supplemented with ZH at 8.33 mg / kg (DM basis). The ZIL group 
were supplemented ZH for 20 d, with a 3-d withdrawal period. On d 24, heifers received 
an i.v. bolus of corticotropin-releasing hormone (CRH; 0.3 µg / kg BW) and arginine 
vasopressin (VP; 1.0 µg / kg BW) to activate the stress axis. Blood samples were 
collected at 30-min intervals for serum, and 60-min intervals for plasma and whole blood, 
from -2 to 8 h relative to the challenge at 0 h (1000 h). Samples were analyzed for 
glucose, insulin, NEFA, blood urea nitrogen (BUN), cortisol, epinephrine, 
norepinephrine, and complete blood cell counts. Following the challenge, cattle were 
harvested over a 3-d period. Liver, longissimus muscle (LM), and Biceps femoris (BF) 
samples were collected and analyzed for glucose, lactate, and glycolytic potential (GP). 
There was a treatment (P < 0.001) effect for vaginal temperature (VT), with ZIL having a 
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0.1
o
C decrease in VT when compared with CON. A treatment x time effect (P = 0.002) 
was observed for NEFA. A treatment effect was observed for BUN; ZIL had decreased 
BUN concentrations compared with CON (P < 0.001) prior to the challenge; however, no 
treatment x time effect was observed. There was also a treatment effect for cortisol (P < 
0.01) and epinephrine (P = 0.003); ZIL had decreased cortisol and epinephrine during the 
CRH/VP challenge, when compared with CON. There was a time effect for total white 
blood cells, lymphocytes, and monocytes; each variable increased (P < 0.01) 2 h post-
challenge. Additionally, neutrophil counts decreased (P < 0.01) in response to CRH/VP 
challenge in both treatment groups. Glucose concentrations within the LM were greater 
(P = 0.03) in CON when compared with ZIL. Lactate concentrations and GP within the 
BF were greater in CON (P = 0.05) when compared with ZIL. These data suggest there 
are some variations observed between treatments in terms of response to the CRH/VP 
challenge; however, in the environmental conditions of this trial, none of the variations 
observed suggests that the supplementation of ZH detrimentally alters the ability of cattle 
to effectively respond to stressful stimuli. 
Introduction 
Zilpaterol hydrochloride (ZH, Zilmax, Merck Animal Health, NJ,) is a β – 
adrenergic receptor agonist (β-AA) that is approved for the use in feedlot cattle in the 
United States (Schmidt and Olson, 2007). In 2013, sporadic reports of of lame and slow 
moving cattle arriving at the at abattoirs was attributed to ZH supplementation (Thomson 
et al., 2015).  Zilpaterol hydrochloride is a β2AA that functions as a ligand of the β2 G 
protein coupled receptors (seven transmembrane domain receptor; Mersmann, 1998). 
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Ligand binding to the β2 – adrenergic receptor activates adenylate cyclase, thus initiating 
the synthesis of cyclic adenosine monophosphate (cAMP) resulting in regulation of the 
activity of protein kinase A (Mersmann, 1998). 
It is speculated that the binding of ZH to the β2 – adrenergic receptor causes a 
shift in cell signaling that up-regulates genes associated with protein accretion, and 
down-regulates genes associated with protein degradation and lipogenesis (Mersmann, 
1998). Feeding of β-AA down-regulates these receptors, resulting in an uncoupling and a 
reduction in β-adrenergic receptors available in the plasma membrane of cells (Mills, 
2002). Chronic feeding of ractopamine to swine resulted in up to a fifty percent decrease 
in β-adrenergic receptors in adipose tissue (Smith et al., 1994), thus suggesting a 
potential interaction between the feeding of β-AA and regulation of the stress axis. 
Glucocorticoids are regulators of metabolism, including glucose metabolism, and 
have been documented for many years (Long et al., 1940). Changes in blood metabolites 
would be expected during the stress response due to energy mobilization that can lead to 
depletion of energy stores such as liver glycogen (Gupta et al., 2005; Moberg and Mench, 
2000). This study was designed to determine the effect of β-AA supplementation on the 
metabolic, stress, and hematology response to a dual corticotropin-releasing hormone and 
arginine vasopressin challenge in finished heifers. 
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MATERIALS AND METHODS 
Experimental design 
All experimental procedures were in compliance with the Guide for the Care and Use of 
Agricultural Animals in Research and Teaching and approved by the Institutional Animal 
Care and Use Committee at the University of Nebraska (IACUC #902). 
Twenty ovariectomized English-influenced crossbred heifers (initial BW = 556 ± 
7 kg BW) from the University of Nebraska Agricultural Research and Development 
Center feedlot were utilized for this study.  Prior to initiation of the study, heifers were 
acclimated for a 3-wk period.  During acclimation, heifers were haltered and acclimated 
to being restrained in a tie stall environment and to human contact.  At the end of the 3-
wk acclimation period, heifers were assigned randomly to one of two treatments: 1) 
Control (CON; n = 10): fed a finishing diet without ZH (Table 1.); and 2) zilpaterol 
hydrochloride (ZIL; n = 10): fed the same diet supplemented with ZH at 8.33 mg / kg 
BW on a DM basis.  For delivery of ZH, five percent of the high-moisture corn in the diet 
was replaced with 4.9853% fine ground corn and ZH at 0.0147% calculated to supply ZH 
at 8.33 mg / kg on a DM basis. Five percent of the CON diet was replaced with fine 
ground corn to ensure similarity between the two diets.  All supplements were 
individually mixed into individual heifer’s daily allotment prior to feeding.  Heifers were 
fed once daily at 0800 for 20 d followed by a 3-d withdrawal period of ZH.  During the 3-
d period, the five percent high-moisture corn was returned to both the CON and ZIL diets 
to replace the five percent ground corn supplement.  The trial was designed to follow 
common industry feeding practices of feeding ZIL for a 20-d period followed by a 3-d 
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mandatory withdrawal before heifers were eligible to be shipped to an abattoir.  The 
transportation of cattle results in activation of the HPA axis (Falkenberg et al., 2013); 
furthermore, the use of the CRH/VP stress model has resulted in a similar endocrine 
response (Carroll et al., 2007) when compared with an actual relocation event.  Therefore 
the CRH/VP challenge on d 24 was utilized as a controlled endocrine stressor to produce 
a similar endocrine response that would be similar to shipping heifers to the abattoir. 
Eight days prior to the start of ZH supplementation, heifers were relocated to the 
University of Nebraska - Lincoln Agricultural Research and Development Center 
Nutrition Dairy Barn during the month of December 2013.  The Nutrition Barn is a 40-
stall barn equipped with individual bunks, automatic waters, and dairy mattresses.  Prior 
to heifers being placed into the barn, tie stalls (first ten stalls in a row on opposite sides of 
an alleyway in the barn) were assigned randomly to treatment, but blocked by treatment 
group (two heifers per block) so that no CON shared water with the ZIL.  Heifers were 
maintained in individual tie stalls (1.34 m wide by 1.84 m long) for the duration of the 
trial.  Pine shavings were added on top of the dairy mattress and replaced when needed.  
On d -3 (prior to ZH supplementation, which occurred on d 1), heifers were fitted with 
indwelling vaginal temperature (VT) monitoring devices (Burdick et al., 2012) that 
recorded VT at 5-min intervals throughout the duration of the study.  On d 20 (last d of 
ZH supplementation), heifers were removed from tie stalls to obtain a BW (for CRH and 
VP dose calculations) and fitted with indwelling jugular catheters and then returned to 
their respective tie stalls.  For the jugular cannulation procedure, heifers were restrained 
in a working chute.  A small (2 to 3 cm) incision was made in the skin to more easily 
access the jugular vein.  Indwelling jugular catheters, consisting of 30.48 cm of sterile 
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Tygon tubing (AAQ04133; US Plastics, Lima, OH; 1.27 mm i.d. and 2.286 mm o.d.), 
were inserted into the jugular vein using a 14-gauge by 5.08-cm thin-walled stainless 
steel biomedical needle (o.d. = 3 mm).  The catheter was stabilized using tag cement and 
a 2.08-cm wide porous surgical tape around the incision site.  Heifer’s entire neck reason 
was wrapped with vet wrap (Vetrap; 3 M Animal Care Products, St. Paul, MN) to ensure 
stability of the catheterization site.  The remaining tubing not inserted into the heifer 
served as the extension portion of the cannula for collection of blood samples (Burdick 
Sanchez et al., 2013).  Environmental temperature and relative humidity data were 
collected inside the Nutrition Barn utilizing four HOBO U23 Pro v2 temperature/relative 
humidity data logger (U23-001, Onset, Bourne, MA).  Data from all four probes was 
averaged and compiled to provide an overall environmental temperature and relative 
humidity.  On d 24, the average environmental temperature was 13 ̊C ± 1.2 ̊C and an 
average relative humidity of 52% ± 3.1%.  On d 24, the average temperature-humidity 
index was 24.8 ± 1.6 within the barn.  Prior to d 24, two heifers were removed from the 
trial.  One heifer was removed from the trial due to development of a sore underneath the 
halter and the other heifer was removed due to failure of the jugular catheter on d 13 and 
21 respectively; therefore, there were ten heifers in the CON group and eight heifers in 
the ZIL group. 
On d 24 at 0600 h, all residual feed was removed from bunks and daily allotment 
of feed was not provided until 1900 h (completion of the stress challenge).  Starting at 
0800 (-2 h) and continuing until 1800 h (8 h), blood samples were collected from each 
heifer. At 1000 h (immediately following collection of blood sample), each heifer 
received an i.v. bolus of bovine CRH (0.3 µg / kg BW) and arginine VP (1.0 µg / kg 
51 
 
 
 
BW); (Carroll et al., 2007).  Following collection of the last blood sample (1800 h), 
catheters were removed and daily allotment of feed was delivered.  A total of three blood 
samples were collected relative to administration of CRH and VP challenge (1000h).  In 
30-min intervals during the trial (0800 – 1600 h), one 9 mL blood sample was collected 
into Sarstedt tubes containing no additive (Sarstedt, Inc., Newton, NC) for isolation of 
serum for a total of 17 samples.  Serum blood samples were allowed to clot for 30 min at 
room temperature and were then centrifuged at 1,500 x g for 20 min at 4
o
C.  Isolated 
serum was stored at – 80oC until analyzed for glucose, insulin, NEFA, blood urea 
nitrogen (BUN), and cortisol concentrations.  In 60-min intervals during the trial (0800 – 
1800 h), one 9 mL blood sample was collected in Vacutainers containing EDTA (Fisher 
Scientific, Pittsburg, PA) for isolation of plasma.  Plasma blood samples were centrifuged 
immediately after collection at 1,500 x g for 20 min at 4
o
C.  Isolated plasma was flash 
frozen in liquid nitrogen and stored at  -80
o
C until analyzed for epinephrine and 
norepinephrine concentrations (Burdick et al., 2009).  Also in 60-min intervals during the 
trial (0800 – 1800 h), a 3 mL blood sample was collected into Vacutainers containing 
EDTA (Fisher Scientific, Pittsburg, PA) to determine complete blood cell (CBC) counts 
using a ProCyte Dx Hematology Analyzer (IDEXX Laboratories, Westbrook, ME).   
On d 25, 26, and 27, heifers were harvested at the Loeffel Meat Laboratory 
located at the University of Nebraska – Lincoln.  Heifers were assigned randomly to one 
of the three harvest days, and within days, harvest order was alternated based on 
treatment resulting in extended withdrawal times for heifers harvested on different days 
(4, 5, and 6 d post ZIL supplementation).  After evisceration, samples were obtained from 
liver, Longissimus muscle (LM) directly above the 13
th
 rib, and Biceps femoris (BF) from 
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the outer center of the muscle.  Within 45 mins of stunning, tissue samples were collected 
and flash frozen in liquid nitrogen, and stored at -80
o
C until analyzed for glycolytic 
potential, glucose, and lactate concentrations. 
Serum analysis 
Serum glucose concentrations were determined in duplicate samples by 
modification of the enzymatic Autokit Glucose (Wako Diagnostics, Richmond, VA) to fit 
a 96-well format.  Briefly, 300 µL of prepared working solution was added to 2 µL of 
serum or prepared standards in a 96-well plate.  Plates were incubated at 37
o
C for 5 min 
and then read using a plate reader at 505 nm.  Concentration of glucose was determined 
by comparing unknown samples to a standard curve of known glucose concentrations.  
The minimum detectable concentration was 3.8 mg / dL and the intra- and inter-assay 
coefficients of variation were 7.0% and 9.5%, respectively.  Data are presented as the 
concentration in mg / dL. 
Serum insulin concentrations were determined in duplicate samples by a bovine-
specific insulin ELISA according to the manufacturer’s instructions (Cat # 80-INSBO-
E01; Alpco Diagnostics, Salem, NH).  The minimum detectable concentration was 0.1 
ng/mL and the intra- and inter-assay coefficients of variation were 11.8% and 17.9%, 
respectively.  Data are presented as the concentration in ng / mL. 
Serum concentrations of NEFA were determined in duplicate samples by 
modification of the enzymatic HR Series NEFA-HR (2) assay (Wako Diagnostics, 
Richmond, VA) to fit a 96-well format.  Briefly, 200 µL of the prepared Color Reagent A 
were added to 5 µL of serum or prepared standards in a 96-well plate.  Plates were 
incubated at 37
o
C for 5 min and absorbance was read using a spectrophotometer at 505 
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nm.  Next, 100 µL of prepared Color Reagent B was added to all wells on the 96-well 
plate.  Plates were incubated for an additional 5 min and read for a second time using a 
plate reader at 505 nm.  Concentrations of NEFA were determined by comparing 
unknown samples to a standard curve of known NEFA concentrations.  The minimum 
detectable concentration was 0.0014 mmol / L and the intra- and inter-assay coefficients 
of variation were 7.1% and 6.3%, respectively.  Data are presented as the concentration in 
mmol / L. 
Serum concentrations of BUN were determined in duplicate samples by a 
colorimetric assay according to the manufacturer’s directions (K024-H1; Arbor Assays, 
Ann Arbor, MI) by comparison of unknowns to standard curves generated with known 
concentrations of urea nitrogen.  The minimum detectable BUN concentration was 0.065 
mg / dL and the intra- and inter-coefficients of variation were 3.5% and 8.3%, 
respectively.  Data are presented as the concentration in mg / dL. 
Serum cortisol concentrations were determined in duplicate samples by enzyme 
immunoassay according to the manufacturer’s instructions (Arbor Assays, Ann Arbor, 
MI).  Serum concentrations of cortisol were determined by comparison to a standard 
curve of known cortisol concentrations.  The minimum detectable concentration was 45.4 
pg / mL and intra- and inter-assay coefficients of variation were 18.6% and 16.0%, 
respectively.  Data are presented as the concentration in ng / mL. 
Epinephrine and Norepinephrine Analysis 
Plasma concentrations of epinephrine and norepinephrine were determined in 
duplicate samples by enzyme immunoassay according to the manufacturer’s directions 
(17-BCTHU-E02.1; Alpco Diagnostics, Salem, NH) by comparison of unknowns to 
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standard curves generated with known concentrations of epinephrine or norepinephrine 
(Burdick et al., 2009).  The minimum detectable concentrations were 10 pg / mL and 50 
pg / mL for epinephrine and norepinephrine, respectively.  The intra- and interassay 
coefficients of variation were ≤ 17.3% and ≤ 22.3%.  Data are presented as the 
concentration in pg / mL. 
Tissue analysis 
 Glycolytic potential values were calculated by the formula:  [Glycolytic potential 
= 2 ([glycogen] + [glucose] + [glucose-6-phosphate]) + (lactate)] (Monin and Sellier, 
1985).  Duplicate samples of LM, BF, and liver samples were homogenized in 0.6 N 
perchloric acid, and glycogen was digested with amyloglucosidase and 20 µL of 5.4 N 
KOH.  Glucose assays were performed with a coupled enzymatic assay kit (hexokinase 
and glucose-6-phosphate dehydrogenase, Sigma-Aldrich, St. Louis, MO).  Lactate 
content was measured using an enzyme assay including lactate dehydrogenase (Souza et 
al., 2011).  
Statistical analysis 
Data were analyzed using the MIXED procedure of SAS specific for repeated 
measures (SAS Inst. Inc., Cary, NC).  Treatment, time, and the treatment by time 
interaction were included as fixed effects, with heifer within treatment included as the 
experimental unit.  If treatment or the treatment by time interaction were significant, data 
were further analyzed separately in two different time periods: Baseline, time period prior 
to administration of CRH and VP (-2 to 0 h); and Challenge, time period following 
administration of CRH and VP (0 to 8 h).  Due to differences in baseline, VT data were 
analyzed as the change in VT relative to baseline (-2 to -0 h) values, with average 
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baseline VT values included as a covariate.  All heifers were challenged at the same time, 
following collection of the 0 h sample at 1000 h. The authors measured vaginal 
temperature for several days prior to the challenge; however, for baseline we focused on 
the 2 hours prior to coincide with the baseline sample collection which began 2 hours 
prior to the challenge.  Additionally, average baseline values were included as a covariate 
in the analysis of the change in vaginal temperature.  Tissue samples were analyzed with 
treatment included as a fixed effect and heifer within treatment included as the 
experimental unit.  When main effects were significant, specific treatment comparisons 
were made using the PDIFF option in SAS, with P < 0.05 considered significant and 0.05 
< P < 0.10 considered a tendency.  All data are presented as the LSM ± SEM. 
RESULTS 
Vaginal Temperature 
There were treatment (P < 0.001) and time (P < 0.01) effects, but not a treatment 
x time interaction (P = 0.96), for VT.  Specifically, VT was decreased (P < 0.001) in ZIL 
compared with CON heifers, and varied over time.  Due to the treatment effect, with ZIL 
heifers entering the challenge with decreased VT, the VT data were further analyzed as 
the change from baseline values (average of values from -2 to 0 h; 0800 to 1000 h), with 
average baseline values included as a covariate in the analysis.  The change in VT 
relative to baseline values was affected by treatment (P < 0.001) and time (P = 0.02), but 
there was no treatment x time interaction (P = 0.99; Fig. 1).  Heifers in the CON group 
had an overall positive change (increase; P < 0.001) in VT (0.068 ± 0.005
o
C) while ZIL 
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heifers had an overall negative (decrease) change in VT in response to CRH/VP 
challenge (-0.050 ± 0.005
o
C). 
Serum Metabolites  
There was no treatment effect (P = 0.62) or treatment x time interaction (P = 0.97) 
for serum glucose concentrations.  There was a time effect (P < 0.001) for glucose 
concentrations.  Regardless of the treatment, glucose concentrations increased (P < 
0.001) within 0.5 h of administering the CRH/VP challenge and remained increased until 
2 h post-challenge (Figure 2).  There was also no treatment effect (P = 0.82) or treatment 
x time interaction (P = 0.70) for serum concentrations of insulin.  A time effect (P < 
0.001) was also observed for serum insulin concentrations. Regardless of treatment, 
insulin concentrations increased (P < 0.001) within 0.5 h of administering CRH/VP 
challenge and remained increased until 2 h post-challenge (Figure 3). 
 There was a treatment x time interaction (P < 0.001) for serum NEFA 
concentrations.  Prior to challenge, there were no difference (P = 0.27) in serum NEFA 
concentrations between CON and ZIL heifers.  Concentrations of NEFA were greater in 
CON heifers, compared with ZIL heifers at 4 h (P = 0.04), at 6 h (P = 0.02) and from 7 to 
8 h (P < 0.01) following the CRH/VP challenge (Figure 4).     
Serum BUN concentrations were affected by treatment (P < 0.001) and time (P < 
0.001; Figure 5) but there was no treatment x time interaction (P = 1.00).  In terms of 
treatment effect, concentrations of BUN were greater (P < 0.001) in CON heifers when 
compared with ZIL heifers (14.0 ± 0.2 mg / dL vs. 11.9 ± 0.2 mg / dL, respectively).  
This difference in BUN was observed prior to the CRH/VP challenge; baseline 
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concentrations (-2 to 0 h) were greater (P < 0.001) in CON heifers compared with ZIL 
heifers (13.5 ± 0.3 mg / dL vs. 11.5 ± 0.4 mg / dL, respectively). 
Serum cortisol concentrations were affected by treatment (P = 0.002) and time (P 
< 0.001), but there was no treatment x time interaction (P = 0.09).  Overall, cortisol 
concentrations were greater (P = 0.002) in CON (26.0 ± 0.7 ng / mL) compared with ZIL 
heifers (23.2 ± 0.07 ng / mL) during the CRH/VP challenge.  Specifically, prior to the 
CRH/VP challenge, baseline (- 2 to 0 h) concentrations of cortisol were similar between 
the two treatment groups; (P = 0.17; Figure 6).  Following administration of the CRH/VP 
challenge cortisol concentrations increased (P < 0.001; 0.5 h compared with 0 h) within 
0.5 h of the challenge (regardless of treatment) and did not return to near baseline 
concentrations until 5.5 h (P = 0.21; 5.5 h compared with 0 h) after the challenge.  While 
the treatment x time interaction was not significant, there was a tendency (P = 0.09) for 
cortisol concentrations for ZIL heifers to be decreased from 0.5 h to 2 h, when compared 
with CON heifers. 
Epinephrine and Norepinephrine Concentrations 
 Plasma epinephrine concentrations were affected by treatment (P = 0.003) and 
time (P < 0.001), but there was no treatment x time interaction (P = 0.29; Figure 7). Due 
to the treatment effect, data were further analyzed within baseline and challenge periods.  
Prior to the CRH/VP challenge, CON heifers had greater (P = 0.005; 33.5 ± 3.0 pg / mL) 
baseline epinephrine concentrations (-2 to 0 h), when compared with ZIL heifers (20.4 ± 
3.0 pg / mL; Fig 7).  Following the challenge, there was a treatment (P = 0.03) and time 
(P = 0.002) effect for epinephrine concentrations but no treatment x time interaction (P = 
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0.18). Post CRH/VP challenge, CON heifers had greater (16.7 ± 1.0 pg / mL) epinephrine 
concentrations, when compared with ZIL heifers (13.4 ± 1.0 pg / mL; Figure 3 B).   
There was only a time effect (P < 0.001) for plasma norepinephrine 
concentrations (treatment: P = 0.94; treatment x time: P = 0.44; Figure 8). 
Norepinephrine concentrations decreased (P < 0.001) 1 h following administration of 
CRH/VP. Concentrations remained decreased for the duration of the study (P < 0.001, 8 
h compared with 0 h; Figure 8) for CON and ZIL heifers. 
Complete Blood Cell Counts 
 There were no main effect differences in total red blood cells (P = 0.82), 
hemoglobin (P = 0.14), or platelets (P = 0.70; Table 2) between CON and ZIL heifers. 
There was a tendency (P ≥ 0.06) for both total red blood cells and hemoglobin to change 
over time regardless of treatment.  There was a time difference (P < 0.001) for platelets 
with platelet concentrations increasing relative to the CRH/VP challenge in both CON 
and ZIL heifers.  There was a treatment x time interaction (P = 0.03) for hematocrit.  
Therefore, hematocrit concentrations were further analyzed as baseline and post-
challenge.  There was a tendency (P = 0.06) for a treatment effect and a difference (P = 
0.05) over time during the baseline period between treatments for hematocrit.  Therefore, 
change from baseline was calculated and analyzed as a percent change between 
treatments.  There was no difference for treatment (P = 0.85; Table 2) or treatment x time 
(P = 0.80) for percent change in hematocrit.  However, there was a time difference (P = 
0.04) for percent change in hematocrit such that hematocrit concentrations decreased 
following administration of CRH/VP. 
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Total white blood cells (Figure 9), lymphocytes (Figure 10), and neutrophils 
(Figure 11) were not affected by treatment (P ≥ 0.41) or a treatment x time interaction (P 
≥ 0.60); however, these variables were affected by time (P < 0.001).  White blood cells 
and lymphocytes increased (P < 0.001) 2 h following administration of CRH/VP, and 
remained increased for the duration of the study (P < 0.001, 8 h compared with 0 h). In 
contrast, neutrophils decreased (P < 0.001) 3 h following administration of CRH/VP, and 
remained decreased for the duration of the study (P < 0.001, 8 h compared with 0 h).  
There was a treatment x time (P = 0.04) interaction for monocytes (Figure 12).  However, 
no time points were different between treatment groups during the trial.  The treatment x 
time interaction can primarily be contributed to a greater fluctuation of monocyte 
concentrations within the CON heifers.  There was a treatment effect (P =0.04) for 
eosinophils; eosinophils were greater for CON (0.13 10
3 
/ µL; Table 2), when compared 
with ZIL heifers (0.007 10
3 
/ µL). There was a treatment x time (P = 0.04) interaction for 
basophil concentrations.  At 8 h post CRH/VP challenge, basophil concentrations were 
greater for ZIL heifers when compared with CON heifers (0.002 vs. 0, 10
3 
/ µL; 
respectively; Figure 13) during the CRH/VP challenge. 
Tissue samples 
There were no differences (P = 0.49) in concentrations of glucose or lactate, and 
no difference in glycolytic potential for the liver samples between the CON and ZIL 
heifers (Table 3).  Glucose concentrations within the LM were greater (P = 0.03) in CON 
heifers (47.95 ± 12.01 µg / mol) compared with ZIL heifers (35.84 ± 10.74 µg / mol; 
Figure 5).  Supplementation of ZH did not affect lactate concentrations (P = 0.39) or total 
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glycolytic potential (P = 0.11) for LM samples (Table 3).  Glucose concentrations in the 
BF tissue samples were not affected (P = 0.22) by ZH supplementation (Table 3).  
Lactate concentrations in BF tissue samples were greater (P = 0.05) in CON (71.75 ± 
6.90 µg / mol) heifers when compared with ZIL heifers (64.47 ± 7.79 µg / mol; Table 3).  
Furthermore, there was a treatment effect for glycolytic potential in BF samples (P = 
0.05; Table 3) with CON heifers having greater concentrations (140.47 ± 23.60 µg / mol) 
compared with ZH-supplemented heifers (120.05 ± 17.55 µg / mol).  
DISCUSSION 
 Data from the current study would indicate that that activation of the 
hypothalamic-pituitary-adrenal (HPA) axis will increase both stress and metabolic 
variables.  Activation of the HPA axis is a cascading response, regulated by the 
magnitude of the stressor (Tsigos and Chrousos, 2002).  An acute response may result in 
brief down-regulation of systems not necessary for survival, such as digestion and 
reproduction, and stimulate catabolism of energy stores and body tissues to be used for 
energy (Sapolsky et al., 2000).  While there are data to suggest the initiation of a stress 
response during relocation events (Falkenberg et al., 2013), there are few or no data 
available to describe how this event is altered due to supplementation of β-AAs.    
Studies in cattle using other β-AAs (i.e., clenbuterol) have observed differences in 
glucose, lipid, and protein metabolism (Eisemann et al., 1988b); yet these metabolites 
were measured early in the supplementation process rather than following withdrawal as 
in the current study.  When glucose and insulin were measured on d 13 of cimaterol 
supplementation in steers, there were no differences in glucose or insulin concentrations 
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compared with control steers (Chikhou et al., 1991b).  Additionally, results from a study 
in finishing steers revealed decreased glucose concentrations after 21 d of 
supplementation with ZH (Van Bibber et al., 2010).  The observed difference in glucose 
concentrations reported by Van Bibber et al. (2010) differs from the current study where 
no treatment differences in circulating concentrations of glucose were observed in 
response to ZH supplementation in cattle.  The differences observed between the study by 
Van Bibber et al. (2010) and the current study could be due to sample frequency and the 
collection of samples following a 3 d withdrawal in the current study, which the previous 
studies did not include.  In the current study, samples were obtained through indwelling 
jugular catheters in 30-min increments whereas in the Van Bibber et al. (2010) study, 
blood samples were only collected once daily by processing cattle through a processing 
facility.  Furthermore, the current study was conducted within an indoor environment 
where less maintenance energy requirements would be expected (Hoffman and Self, 
1970).  Comparison of different compounds and species should be conducted with great 
caution do to the diversity of β-adrenergic receptors and receptor tissue distribution 
differences in livestock species (Mersmann, 2002). 
There is limited reported data regarding the effect of β-AA on body temperature 
in any species including cattle.  The feeding of ZH has been reported to decrease ruminal 
temperature when compared with control steers not fed ZH (Boyd et al., 2015).  As 
reported by Boyd et al (2015) the decreased body temperature may be attributed to 
increased respiration rates, allowing ZH supplemented steers the ability to dissipate 
excess body heat.  In this study, authors attributed decreased body temperature to 
increased respiration rates body heat, which has been published by others (Boyd et al., 
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2015).  Another biological response typically observed following stimulation of the β-
adrenergic receptors is vasodilation of interior tissues (e.g. skeletal muscle, heart, lungs, 
liver, and gastrointestinal tract; (Dawes et al., 1997).  An increase in vasodilation would 
support the observed decrease in body temperature, as this would allow dissipation of 
heat from the body surface at a faster rate compared with CON heifers.  However, it 
would be expected to see a decline in vasodilation with continued treatment of β-AA due 
to a possible down-regulation of the β-adrenergic receptors (Smith et al., 1994).  
Understanding blood flow changes as a result of β-agonists supplementation, and 
particularly ZH, would help justify differences observed, in body temperature and also 
nutrient delivery and blood cell population changes.  In the current study, VT supports 
decreased body temperature with ZH feeding that could potentially benefit the animal 
during stress allowing the animal to dissipate excess body heat. 
Following administration of the CRH/VP challenge, an increase in VT was 
observed in both treatments within 25 min.  While VT remained increased in CON 
heifers, a return to baseline and sub-baseline values was observed in ZIL heifers.  The 
temporal VT response to the CRH/VP challenge in the current study has similarities to 
the response observed in weaned Brahman calves challenged with CRH, in that study the 
authors reported fluctuations in rectal temperature in the 8-h period following CRH 
administration (Hulbert et al., 2013). 
The adrenergic receptors are the receptors that catecholamines (i.e., epinephrine 
and norepinephrine) bind to initiate a response and are distributed throughout the body. 
There are two major types of adrenergic receptors, the α- and β-adrenergic receptors, both 
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of which have several subtypes and are all membrane-bound receptors (Mersmann, 
1998). While β-adrenergic receptors are located on most mammalian cells, the β2-
adrenergic receptors are the primary receptors located in both adipose and skeletal muscle 
(Mersmann, 1998). Specifically, ZH is considered a β2-adrenergic receptor agonist 
(Hilton et al., 2009).  Initial feeding of β-AAs has been reported to increase NEFA 
concentrations (Mersmann, 1998). During the initial stages of feeding, β-AAs exhibit 
more lipolytic effects, a biological effect that may be eventually down-regulated during 
extended feedings and as fat content decreases.  In a prior study, concentrations of NEFA 
measured weekly during ZH supplementation in finishing steers reported no difference in 
NEFA concentrations (Van Bibber et al., 2010), thus supporting data from the current 
study as baseline NEFA concentrations did not differ between treatments groups. 
The decrease in NEFA concentrations in response to the CRH/VP challenge in the 
ZH-supplemented heifers is not surprising considering the increase in lean tissue growth, 
and the decrease in lipogenesis that has been observed in β-AA fed cattle (Sillence, 
2004).  Feeding of β-AAs leads to decreased lipid deposition, and thus decreased NEFA 
concentrations when stimulated by a catabolic agent such as cortisol.  Studies reported in 
the literature have demonstrated that β-AAs have anti-lipogenic effects (Dunshea, 1993; 
Sillence, 2004), data that also supports the results in the current study.   
The major growth promoting effects of β-AAs are primarily observed in skeletal 
muscle (Sillence, 2004), which results in the catabolism of protein from other tissues to 
be used to build muscle, although only critical when provided inadequate nutrition 
(Sillence, 2004).  Furthermore, β-AA activate β-receptors in muscle and adipose tissue 
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resulting in decreased lipogenesis, and increased lipolysis and protein accretion 
(Mersmann, 1998).  Therefore, the decreased BUN concentrations in ZH-supplemented 
heifers is likely due to increased anabolism of protein in skeletal muscle and decreased 
catabolism of protein in other tissues as these heifers were provided adequate nutrition to 
support additional lean tissue accretion during the study  (Bell et al., 1998a).  The 
decrease in BUN observed in the current study is supported by work with other β-AAs in 
which the authors observed similar decreases in BUN concentrations in cattle 
supplemented with cimaterol (Chikhou et al., 1991b).  The increase in BUN 
concentrations post-CRH/VP in both treatment groups is in concert with the increased 
concentrations of NEFA observed post-challenge, and suggests a greater energy demand 
during this period than was supplied by glucose alone.  Decreased BUN concentrations in 
ZH-supplemented cattle observed in the current study is supported by work in finishing 
steers in which the authors reported decreased BUN concentrations after 20 d and 21 d of 
ZH supplementation, (Parr et al., 2010; Van Bibber et al., 2010). 
Baseline cortisol concentrations were not different between treatments in the 
current study.  This is in agreement with a study utilizing a cimaterol treatment in steers, 
where no difference in cortisol concentrations were observed 1 and 13 d following 
initiation of oral dosing (Chikhou et al., 1991b).  The temporal pattern associated with an 
acute increase in circulating concentrations of cortisol followed by a subsequent decline 
in the current study is similar to that observed in Brahman calves in response to a CRH 
challenge (Hulbert et al., 2013), albeit the magnitude of the cortisol response was greater 
in the current study.  Control heifers produced a greater cortisol response to the CRH/VP 
challenge compared with ZIL heifers, thus suggesting a possible down-regulation of 
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aspects associated with HPA axis regulation.  As mentioned above, there is cross-talk 
between the sympathomedullary system and the HPA axis.  Thus, the observed cortisol 
response suggests that supplementation of ZH not only influenced the sympathomedulary 
system, but may have down-regulated portions of the HPA axis either directly or through 
actions on the sympathomedullary system.   
Differences observed in epinephrine concentrations but not norepinephrine 
concentrations would theoretically be expected when feeding ZH.  Naturally-occurring 
physiological β-adrenergic agonists consist of norepinephrine, a neurotransmitter, and 
epinephrine, an adrenal medullary hormone (Mersmann, 1998).  Both epinephrine and 
norepinephrine are capable of binding to the α1-, α2-, β1 and β2-adrenergic receptors 
(Robinson et al., 1989); however,  β2-adrengeric receptors have a greater affinity for 
epinephrine compared with norepinephrine.  Therefore, the lack of down-regulation of 
the norepinephrine response may be due to the difference in receptor affinity.  With ZH 
being classified as a β2-adrenergic receptor agonist it should not affect the regulation of 
norepinephrine via actions on the α1-, α2-, and β1-adrengeric receptors.  Adenylate 
cyclase in the erythrocytes of frogs has been used to demonstrate a loss of β-adrenergic 
receptor binding sites in response to catecholamine induced sensitivity.  When injected 
with norepinephrine or isoproterenol (β1-adrenergic receptor agonist), cyclic adenosine 
monophosphate generated from frog erythrocyte membranes decreased compared with 
controls (Mukherjee et al., 1975).  The authors concluded that the decrease in 
catecholamine responsiveness was due to a reduction in β-adrenergic receptors, or a 
conformational change resulting in inactive receptors (Mukherjee et al., 1975).  In the 
current study, decreased concentrations of epinephrine in ZIL heifers would further 
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support a down-regulation of the sympathomedulary axis via action on the β2-adrengeric 
receptors as discussed above. 
Few studies have determined the effect of CRH or a combined CRH/VP challenge 
on immune cell populations, particularly in cattle; however, increased glucocorticoids 
results in an increase of neutrophils (Burton et al., 2005).  Immune cell populations are 
sensitive to CRH, as well as the intermediate stress hormone, adrenocorticotropic 
hormone (ACTH), and cortisol.  Hulbert et al. (2013) observed a decrease in total 
leukocytes at 1 h following a CRH challenge in Brahman calves.  This is in contrast to 
the current study, in which an increase in total WBCs was observed 2 h following 
CRH/VP administration regardless of treatment.  Many factors may contribute to these 
opposing observations, including age of the cattle, breed of the cattle, and/or the 
combination of a CRH challenge with VP given simultaneously versus a solitary CRH 
challenge.  While there are limited studies utilizing CRH, the CRH/VP challenge in this 
study was utilized to mimic an acute stressor.  In mice exposed to acute restraint stress, 
an increase in natural killer (NK) cells, a subset of lymphocytes, was observed (Bauer et 
al., 2001).  Furthermore, the use of cyanoketone, an androstanol, in restraint-stressed rats 
resulted in less cortisol production during the time of stress (Dhabhar et al., 1996).  The 
blocking of cortisol production with cyanoketone also significantly reduced the stress-
induced decrease in leukocytes that has been reported in rats under acute stress (Dhabhar 
et al., 1996).   
The decrease in circulating neutrophils following CRH/VP challenge is indicative 
of movement of neutrophils out of the blood and into the tissues in preparation for 
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immune activation (e.g. wounding).  In contrast, the increase in circulating total WBC 
and lymphocytes suggests a mobilization of these cells (Dhabhar et al., 2012).  This 
redistribution of immune cells suggests an activation of the immune response, as several 
factors, including chemoattractants, cell adhesion molecules, and cytokines are needed 
for this process to occur (Bauer et al., 2001).  Changes in expression of cell adhesion 
molecules, stimulated by stress hormones, may be responsible for the changes observed 
in immune cell populations not only in response to CRH/VP challenge, but in response to 
ZH supplementation. 
Glycolytic potential (GP) is a measurement of glucose, lactate, glycogen, and 
glucose-6-phosphotase that is present in muscle that ultimately can be converted to lactic 
acid.  This index can be used as a measurement of the capacity for postmortem glycolysis 
in muscle resulting in a decrease of muscle pH in the conversion of muscle to meat 
(Monin and Sellier, 1985).  Glycolytic potential has been evaluated as a potential 
measurement of meat quality in beef and pork (Hamilton et al., 2003; Wulf et al., 2002).  
In cattle, GP has been reported to have a curvilinear response with ultimate LM pH after 
harvest.  Muscle samples with a GP less than 100 µmol / g are associated with a greater 
postmortem pH that results in decreased lactate production and can cause dark, firm, and 
dry beef (Wulf et al., 2002).  In the current study, GP in the LM was not different in CON 
and ZH-supplemented heifers.  In the BF, ZH-supplemented heifers did have a decreased 
GP; however, this was associated with less available lactate resulting in a decreased 
calculated GP and was greater than the 100 µmol / g threshold that has been suggested 
for optimal pH postmortem.  In previous ZH studies, Hilton et al. (2009) reported ZH 
supplementation increased beef color resulting in a brighter cherry red favorable beef 
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color during a 5 d shelf-life study.  Furthermore, (Montgomery et al., 2009a) reported ZH 
supplementation increased LM cherry red color and resulted in a decrease of dark colored 
LM when compared with control carcasses.  The increase in bright cherry red color was 
attributed to an increase in myoglobin content that resulted in a favorable improvement in 
muscle color (Montgomery et al., 2009a).  In liver samples, there was no difference in 
glucose, lactate, or GP observed in CON and ZH-supplemented heifers.  In the rat model, 
it has been reported protein kinases activity on glycogen synthase in skeletal muscle 
predominantly take place in the liver (Imazu et al., 1984).  Furthermore, the lack of 
differences in glucose and GP between treatment groups of liver samples would further 
support the fact that no differences in serum glucose were observed in the current study.  
If blood glucose concentrations decreased, glucagon would be released from the α-cells 
of the pancreas to raise blood glucose concentrations (Navarro et al., 1999).  These data 
suggest that ZH-supplemented heifers do not have decreased available energy stores in 
muscle or liver samples that could cause muscle fatigue from lack of an energy source. 
Also, these data demonstrate that a simulated stress induced by administration of 
CRH/VP in beef cattle elicits shifts in immune cell populations and metabolic variables; 
and stress hormones, metabolic variables, and immune cell responses are altered in beef 
heifers supplemented with ZH when cattle are exposed to a simulated stress challenge.  
However, within the environment of this study, supplementation of ZH did not appear to 
hinder finishing heifer’s ability to mount a stress, immune, or metabolic response during 
a neurohomone-induced stimulated stress challenge.    
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Table 1.  Composition of finishing diets fed to control (CON) and zilpaterol (ZIL) heifers 
as a percent of DM basis during a corticotropin-releasing hormone (CRH; 0.3 µg / kg 
BW) and vasopressin (VP; 1.0 µg / kg BW) challenge in finishing heifers. 
  Treatment 
Item  Control ZIL
1 
Ingredient (%)    
High Moisture Corn  51.00 51.00 
Sweet Bran®  40.00 40.00 
Wheat Straw    5.00   5.00 
Fine Ground Corn        1.8710       1.8710 
Limestone        1.6400       1.6400 
Salt        0.3000       0.3000 
Tallow        0.1000       0.1000 
Beef Trace Mineral        0.0500       0.0500 
Rumensin-90        0.0150       0.0150 
Vitamin A-D-E        0.0165       0.0165 
Tylan-40        0.0075       0.0075 
Supplement
1 
   
   Fine Ground Corn  5.0       4.9853 
   Zilpaterol Hydrochloride       -       0.0147 
1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal 
2
The control supplement contained fine ground corn only. Zilpaterol hydrochloride (ZH) 
supplement contained (DM basis) 0.0147% Zilmax® (Merck Animal Health) Type A 
medicated article and 4.9853% fine ground corn and supplied zilpaterol hydrochloride 
(ZH) supplementation (8.33 mg / kg on a DM basis).  Supplement was fed for 20 d.   
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Table 2. Changes in blood variables in response to CRH/VP challenge in heifers 
supplemented with zilpaterol hydrochloride (ZH, 8.33 mg / kg on a DM basis). 
 Treatment   
Variable Control    ZIL SEM P-value 
Red blood cells, 10
5 
/ µL     6.24     6.31   0.20   0.82 
Hemoglobin, g / dL   10.7   11.2   0.25   0.14 
Hematocrit change, %    -0.87    -0.79   0.30   0.85 
Platelets, 10
3 
/ µL 313.66 300.92 23.9   0.70 
Eosinophils, 10
3 
/ µL     0.13     0.07   0.02   0.04 
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1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal 
2 
Glycolytic Potential 
3
 Longissimus muscle 
4
Biceps Femoris 
  
Table 3.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a DM basis) 
on tissue samples following 20 d ZH supplementation, 3 d withdrawal period, and a 
corticotropin-releasing hormone and vasopressin challenge administered on d 24. 
Item CON ZIL
1 
SEM P-value 
Liver     
   Glucose 152.75 146.46   6.70 0.51 
   Lactate   11.54   11.11   0.85 0.71 
   GP
2 
317.03 304.02 13.38 0.49 
LM
3 
    
   Glucose   47.95   35.84   3.81 0.03 
   Lactate   63.83   68.91   4.18 0.39 
   GP
2 
159.73 140.60   8.17 0.11 
BF
 4 
    
   Glucose   34.36   27.79   3.77 0.22 
   Lactate   71.75   64.47   2.44 0.05 
   GP
2 
140.47 120.05   6.99 0.05 
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Fig. 1  Vaginal temperature of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / kg on a 
DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet for 23 d 
and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / kg BW) 
and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at time 0. 
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Fig. 2  Serum glucose response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / kg 
on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet for 
23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / kg 
BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0 h.  Control represents heifers that were not fed ZH while ZIL represents 
heifers fed ZH for 20 d followed by a 3 d withdrawal. 
 
 
  
0
50
100
150
200
250
300
-2
.0
-1
.5
-1
.0
-0
.5
0
.0
0
.5
1
.0
1
.5
2
.0
2
.5
3
.0
3
.5
4
.0
4
.5
5
.0
5
.5
6
.0
6
.5
7
.0
7
.5
8
.0
G
lu
co
se
, 
m
g
 /
 d
L
 
Time (h) relative to CRH/VP challenge 
Control
ZH Treatment          P = 0.62  
Time          P < 0.001 
Treatment x Time  P = 0.97   
IL 
78 
 
 
 
Fig. 3  Serum insulin response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / kg 
on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet for 
23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / kg 
BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0 h. Control represents heifers that were not fed ZH while ZIL represents 
heifers fed ZH for 20 d followed by a 3 d withdrawal. 
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Fig. 4  Serum non-esterified fatty acid (NEFA) response of heifers fed zilpaterol 
hydrochloride (ZH; 8.33 mg / kg on a DM basis) for 20 d followed by a 3 d 
withdrawal, or fed the control diet for 23 d and then subjected to a corticotropin-
releasing hormone (CRH; 0.3 µg / kg BW) and vasopressin (VP; 1.0 µg / kg BW) 
challenge administered on d 24 at time 0 h. Control represents heifers that were 
not fed ZH while ZIL represents heifers fed ZH for 20 d followed by a 3 d 
withdrawal.  * represents individual time points that are different (P ≤ 0.05) 
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Fig. 5  Serum blood urea nitrogen (BUN) response of heifers fed zilpaterol hydrochloride 
(ZH; 8.33 mg / kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed 
the control diet for 23 d and then subjected to a corticotropin-releasing hormone 
(CRH; 0.3 µg / kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge 
administered on d 24 at time 0 h. Control represents heifers that were not fed ZH 
while ZIL represents heifers fed ZH for 20 d followed by a 3 d withdrawal. 
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Fig. 6  Serum cortisol response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / kg 
on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet for 
23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / kg 
BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0.   
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Fig. 7  Plasma epinephrine response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg 
/ kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet 
for 23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / 
kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0. 
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Fig. 8 Plasma norepinephrine response of heifers fed zilpaterol hydrochloride (ZH; 8.33 
mg / kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control 
diet for 23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 
µg / kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 
24 at time 0. 
  Time (h) relative to CRH/VP challenge 
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Fig. 9  Total white blood cell (WBC) count response of heifers fed zilpaterol 
hydrochloride (ZH; 8.33 mg / kg on a DM basis) for 20 d followed by a 3 d 
withdrawal, or fed the control diet for 23 d and then subjected to a corticotropin-
releasing hormone (CRH; 0.3 µg / kg BW) and vasopressin (VP; 1.0 µg / kg BW) 
challenge administered on d 24 at time 0. 
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Fig. 10  Lymphocyte count response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg 
/ kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet 
for 23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / 
kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0. 
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Fig. 11  Neutrophil count response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / 
kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet 
for 23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / 
kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0. 
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Fig. 12  Monocyte count response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / 
kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet 
for 23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / 
kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0. 
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Fig. 13  Basophil count response of heifers fed zilpaterol hydrochloride (ZH; 8.33 mg / 
kg on a DM basis) for 20 d followed by a 3 d withdrawal, or fed the control diet 
for 23 d and then subjected to a corticotropin-releasing hormone (CRH; 0.3 µg / 
kg BW) and vasopressin (VP; 1.0 µg / kg BW) challenge administered on d 24 at 
time 0.  * represents individual time points that are different (P ≤ 0.05).  
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CHAPTER IV 
BLOOD CHEMISTRY AND SELECT ORGAN WEIGHT, HISTOLOGY, AND 
CARDIAC MORPHOLOGY OF BEEF HEIFERS SUPPLEMENTED WITH 
ZILPATEROL HYDROCHLORIDE AND EXPOSED TO A DUAL 
CORTICOTROPIN-RELEASING HORMONE AND VASOPRESSIN STRESS 
CHALLENGE 
Abstract 
The objective of this study was to: 1) determine if administration of a 
corticotropin-releasing hormone (CRH) and vasopressin (VP) challenge following 20 d 
ZH supplementation altered the blood chemistry profile in cattle and 2) determine if 
supplementation of Zilpaterol Hydrochloride (ZH) altered select organ weights, histology 
and cardiac anatomical features at harvest.  Crossbred heifers (n = 20; 556 ± 7 kg BW) 
were randomized into two treatment groups: 1) Control (CON): no ZH, and 2) Zilpaterol 
(ZIL):  ZH at 8.33 mg / kg (DM basis) for 20 d. On d 20 of supplementation, heifers were 
fitted with indwelling jugular catheters. On d 24, starting at 0800h and continuing until 
1600h, blood samples were collected at 60-min intervals. At 1000h, heifers received an 
i.v. bolus of CRH (0.3 µg / kg BW) and VP (1.0 µg / kg BW) to activate the stress axis. 
Serum from blood samples was separated and stored at -80
o
C until analyzed for a large 
animal chemistry panel. Following the CRH/VP challenge, heifers were harvested on d 
25, 26, and 27 (5, 6, and 7 d post ZH supplementation); BW, HCW, select organ weights, 
histology, and total heart necropsy were performed. A treatment effect (P ≤ 0.02) was 
observed for Ca and K, ZIL heifers had decreased concentrations during the CRH/VP 
challenge and increased concentrations of creatinine (P = 0.02) during the CRH/VP 
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challenge, when compared to control heifers. A treatment x time interaction (P = 0.02) 
was observed for P; concentrations were similar between treatments from -2h to 6h post-
challenge, while CON heifers had decreased P at 7 h post-challenge. Control heifers had 
greater (P ≤ 0.05) concentrations of alkaline phosphatase and sorbitol dehydrogenase, 
when compared with ZIL heifers. Liver (P = 0.06) and kidney (P = 0.08) weights as a 
percent of BW tended (P = < 0.08) to be reduced in ZIL heifers. Gross liver weights 
tended (P = 0.08) to be less in ZIL heifers. Other organ (heart, lung, adrenals) to BW 
ratios remained similar (P ≥ 0.41). These data suggest that there are some variations 
observed between treatments in terms of response to ZH supplementation and the 
CRH/VP challenge; however, in the environmental conditions of this study, limited 
variation in blood metabolic responses and organ weights suggests that the 
supplementation of ZH did not detrimentally alter the physiology of cattle. 
Keywords: β-agonist, cattle, heart, pathology, serum profile   
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INTRODUCTION 
adrenergic agonist can be defined as a phenylethanolamine similar to the 
natural adrenergic neurotransmitters epinephrine and norepinephrine (Smith, 1998). The 
binding of β-adrenergic agonists (β-AA) to β-adrenergic receptors (β-AR) forms a 
complex which activates the Gstimulatory (Gs) protein. The activation of the Gs protein’s α-
subunit activates the enzyme adenylyl cyclase which produces cyclic adenosine 
monophosphate (cAMP), an intracellular signaling molecule that binds the regulatory 
subunit of protein kinase A. This binding releases the catalytic subunit allowing for the 
phosphorylation of intracellular proteins (Mersmann, 1998).   
Zilpaterol hydrochloride (ZH) is a β2 – adrenergic receptor agonist (β2-AA) that is 
approved for the use in feedlot cattle in Mexico, South Africa, and the United States 
(Schmidt and Olson, 2007). Increases in ADG have been observed (Montgomery et al., 
2009a) with slight decreases in DMI with ZH supplementation resulting in increased feed 
efficiency (Mersmann, 2002) and an increase in gain to feed ratio (Avendaño-Reyes et 
al., 2006). Zilpaterol hydrochloride is associated with an increase in lean tissue 
deposition in carcass components (addition of 13 and 11 kg in HCW for steers and 
heifers, respectively; (Montgomery et al., 2009a) and a decrease in adipose tissue 
(Mersmann, 2002; Mersmann, 1998).  
Recently, the supplementation of ZH was implicated as a possible cause of 
reported lameness at harvest (Thomson et al., 2015). A recent report demonstrated an 
epidemiologic risk of mortality associated with ZH supplementation during the late 
feeding period, but did not investigate the cause of the mortality (Loneragan et al., 2014). 
92 
 
 
 
Furthermore, limited controlled studies have investigated the impact of ZH 
supplementation on organ morphology (May et al., 2014). Therefore, the objective of this 
trial was to evaluate the impact of ZH supplementation on blood chemistry 
concentrations and internal organ weight and morphology of feedlot heifers at harvest. 
MATERIALS AND METHODS 
Experimental design 
All experimental procedures were in compliance with the Guide for the Care and 
Use of Agricultural Animals in Research and Teaching and approved by the Institutional 
Animal Care and Use Committee at the University of Nebraska (IACUC #902). 
Twenty ovariectomized English-influenced crossbred heifers (n = 20; 556 ± 7 kg 
BW) from the University of Nebraska Agricultural Research and Development Center 
feedlot were selected for this study.  Prior to initiation of the study, heifers were 
acclimated for a 3 wk period.  During acclimation, heifers were haltered and acclimated 
to being restrained in a tie stall environment and to human contact.  At the end of the 3 
wk acclimation period, heifers were randomly assigned to one of two treatments: 1) 
Control (CON; n = 10), fed a finishing diet without ZH (Table 1.); and 2) zilpaterol (ZIL; 
n = 10), fed the same finishing diet supplemented with ZH (Zilmax
®
; Merck Animal 
Health) at a rate of 8.33 mg / kg BW on a DM basis.  For delivery of ZH, five percent of 
the high-moisture corn in the diet was replaced with 4.9853% fine ground corn and ZH at 
0.0147% calculated to supply ZH at 8.33 mg / kg on a DM basis. Five percent of the 
CON diet was replaced with fine ground corn to ensure nutritional similarity between the 
two diets.  All supplements were individually mixed into individual heifer’s daily 
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allotment prior to feeding.  Heifers were fed once daily at 0800 for 20 d followed by a 3 d 
withdrawal period of ZH.  During the 3 d period, the five percent high-moisture corn was 
returned to both the CON and ZIL diets to replace the five percent ground corn 
supplement.   
Eight d prior to the start of ZH supplementation, heifers were relocated to the 
University of Nebraska - Lincoln Agricultural Research and Development Center 
Nutrition Dairy Barn during the month of Dec 2013.  The Nutrition Barn is a 40-stall 
barn equipped with individual bunks, automatic waters, and dairy mattresses.  Prior to 
heifers being placed into tie stalls, stalls were randomly assigned to treatment, but 
blocked by treatment group (two heifers per block) so that no CON heifers shared water 
with a ZIL heifer. Heifers were maintained in individual tie stalls (1.34 m wide by 1.84 m 
long) for the duration of the trial.  Pine shavings were added on top of the dairy mattress 
and replaced when needed.  On d 20 (last d of ZH supplementation), heifers were 
removed from tie stalls to obtain a BW (for corticotropin-releasing hormone (CRH) and 
vasopressin (VP) dose calculations) and fitted with indwelling jugular catheters and then 
returned to tie stalls.  For the jugular cannulation procedure, heifers were restrained in a 
working chute and the neck area was prepped utilizing betadine scrub and ethanol wipes.  
A small (2–3 cm) incision was made in the skin to more easily access the jugular vein.  
Indwelling jugular catheters, consisting of 30.48 cm of sterile Tygon
®
 tubing 
(AAQ04133; US Plastics, Lima, OH, USA; 1.27 mm i.d. and 2.286 mm o.d.), were 
inserted into the jugular vein using a 11-gauge by 8.3-cm thin-walled stainless steel 
biomedical needle (o.d. = 3 mm).  The catheter was stabilized using tag cement and a 
2.08-cm wide porous surgical tape around the incision site.  Heifer’s entire neck region 
94 
 
 
 
was wrapped with vet wrap (Vetrap™; 3 M Animal Care Products, St. Paul, MN, USA) 
to ensure stability of the catheterization site.  The remaining tubing served as the 
extension portion of the cannula for collection of blood samples (Sanchez et al., 2013).  
Environmental temperature and relative humidity data were collected inside the Nutrition 
Barn utilizing four HOBO U23 Pro v2 temperature/relative humidity data logger (U23-
001, Onset, Bourne, MA, USA).  Data from all four probes was averaged and compiled to 
provide an overall environmental temperature and relative humidity.  On d 24, the 
average environmental temperature was 13 ̊C±1.2 ̊C and an average relative humidity of 
52%±3.1%.  On d 24, the average temperature-humidity index was 24.8±1.6 within the 
barn.  Prior to d 24, two heifers were removed from the trial.  One heifer was removed 
from the trial due to development of a sore underneath the halter and the other heifer was 
removed due to failure of the jugular catheter on d 21 respectively; therefore, there were 
ten heifers in the CON group and eight heifers in the ZIL group.   
The transportation of cattle results in activation of the hypothalamic-pituitary-
adrenal (HPA) axis (Falkenberg et al., 2013); furthermore, the use of the CRH/VP stress 
model has resulted in a similar endocrine response (Carroll et al., 2007) when compared 
with an actual relocation event.  Therefore a CRH/VP challenge on d 24 was utilized as a 
controlled endocrine stressor to produce a similar endocrine response that would be 
similar to shipping heifers to the abattoir. On d 24 at 0600 h, all feed residual was 
removed from bunks and heifers were not provided daily allotment of feed until 1700 h 
(completion of the stress challenge).  Starting at 0800 h and continuing until 1600 h, 18 
mL of blood were collected in Sarstedt tubes containing no additive (Sarstedt, Inc., 
Newton, NC USA) from each heifer in 60-min intervals.  Blood samples were allowed to 
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clot for 30 min at room temperature and then centrifuged at 1500 g for 20 min at 4
o
C.  
Isolated serum was stored at -80
o
C until analyzed for a large animal chemistry profile, -
hydroxybutyrate, lactate, and lactate dehydrogenase.  At 1000 h (immediately following 
collection of blood sample), each heifer received an i.v. bolus of bovine CRH (0.3 µg / kg 
BW) and arginine VP (1.0 µg / kg BW; (Carroll et al., 2007).  Following collection of the 
last blood sample at 1600 h, catheters were removed and the daily allotment of feed was 
delivered.  
On d 25, 26, and 27, heifers were transported to the University of Nebraska – 
Lincoln Loeffel Meat Laboratory and harvested under USDA Inspection.  Heifers were 
randomly assigned to one of the three harvest d with an equal number of CON and ZIL 
harvested on each day.  Individuals collecting organ weights/measurements and 
conducting histologic examinations were blinded to treatment. At time of evisceration, 
organ weights were collected.  Following weighing of organs, tissue samples of each 
organ, the pulmonary artery, and the longissimus were collected, placed into 10% neutral 
buffered formalin and stored until processed routinely for hematoxylin and eosin staining.  
All tissue slides were evaluated by a certified American College of Veterinary 
Pathologist that was blinded to treatment. 
Serum analysis 
Serum samples were shipped overnight to Kansas State Veterinary Diagnostic 
Laboratory (Manhattan, KS 66506) the laboratory on dry ice.  At the diagnostic 
laboratory, a large animal chemistry profile was performed on serum samples utilizing a 
Roche Cobas C501 chemistry analyzer for serum samples.  Serum concentrations of total 
protein (mg/dL), albumin (g/dL), globulin (g/dL), total calcium (mg/dL), phosphorus 
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(mg/dL), potassium (mmol/L), sodium (mmol/L), sodium potassium ratio, chloride 
(mmol/L), bicarbonate (mmol/L), anion gap (mmol/L), creatinine (mg/dL), creatine 
kinase (CK, U/L), aspartate transaminase (AST, U/L), alkaline phosphatase (ALP, U/L 
glutamyltransferase (GT, U/L), and sorbitol dehydrogenase (SDH, U/L) were 
measured. 
Serum -hydroxybutyrate (HB) concentrations were determined in duplicate 
samples by utilizing a HB assay kit (MAK041; Sigma-Aldrich, St. Louis, MO, USA) in 
a 96-well format.  Plates were incubated at 37
o
C for 30 min and then read using a plate 
reader at 450 nm.  Concentration of HB was determined by comparing unknown 
samples to a standard curve of known HB concentrations.  Data are presented as the 
concentration in ng / µL. 
Serum lactate concentrations were determined in duplicate samples by utilizing a 
lactate assay kit (MAK064; Sigma-Aldrich, St. Louis, MO, USA) in a 96-well format.  
Plates were incubated at 37
o
C for 30 min and then read using a plate reader at 570 nm.  
Concentration of lactate was determined by comparing unknown samples to a standard 
curve of known lactate concentrations.  Data are presented as the concentration in ng/µL. 
Serum lactate dehydrogenase (LDH) concentrations were determined in duplicate 
samples by utilizing a LDH activity assay kit (MAK066; Sigma-Aldrich, St. Louis, MO, 
USA) in a 96-well format.  Plates were incubated at 37
o
C for 2 min and then an initial 
absorbance was measured using a plate reader at 450 nm.  After the initial reading, 
subsequent absorbance was measured every 5 min at 450 nm until the most active 
unknown sample value was greater than the highest standard.  The final measurement 
utilized in calculating the enzyme activity was the penultimate reading or the value 
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before the most active sample is near or exceeds the end of the linear range of the 
standard curve.  Concentration of LDH was determined by comparing unknown samples 
to a standard curve of known LDH concentrations.  Data are presented as the 
concentration in milliunits/mL. 
Statistical analysis 
A completely randomized design was utilized in the current study.  Data were 
analyzed using the MIXED procedure of SAS specific for repeated measures (SAS Inst. 
Inc., Cary, NC USA).  For serum blood metabolites, treatment, time, and the treatment by 
time interaction were included as fixed effects, with heifer within treatment included as 
the experimental unit.  Organ weights were analyzed with treatment included as a fixed 
effect and heifer within treatment included as the experimental unit.  When main effects 
were significant, specific treatment comparisons were made using the PDIFF option in 
SAS, with P < 0.05 considered significant and 0.05 < P < 0.10 considered a tendency.  
All data are presented as the LSM ± SEM. 
RESULTS 
 A time (P < 0.001) affect and treatment x time interaction (P = 0.001) was 
observed between CON and ZIL heifers (not treatment affect; P < 0.58).  When 
individual time points between treatments were evaluated, no time points were different; 
serum total protein concentrations were 7.60±0.11 g/dL and 7.51±0.11 g/dL for CON and 
ZIL heifers, respectively (Table 2).  There was a treatment (P = 0.02) and time (P < 
0.001) effect for serum albumin but no treatment x time interaction (P = 0.60).  Serum 
albumin concentrations were 3.64±0.05 g/dL and 3.47±0.05 g dL for CON and ZIL 
98 
 
 
 
heifers, respectively (Table 2). A time (P < 0.001) effect and a treatment x time (P = 
0.001) interaction was observed for serum globulin concentrations between CON and ZIL 
heifers; but no treatment affect (P < 0.61).  When individual time points were evaluated, 
no time points were different between treatment groups, and serum globulin 
concentrations were 3.95±0.14 g/dL and 4.04±0.14 g/dL for CON and ZIL heifers, 
respectively (Table 2). 
 Serum calcium concentrations were affected by treatment (P = 0.001) and time (P 
< 0.001); there was no treatment x time interaction (P = 0.34; Table 2).  Overall, serum 
calcium concentrations were greater in CON heifers (9.75±0.07 mg/dL) compared with 
ZIL heifers (9.49±0.07 mg/dL).  For serum phosphorus concentrations, there was no 
treatment (P < 0.60) affect, but a time (P < 0.001) affect and treatment x time (P = 0.02) 
interaction was observed.  When individual time points were evaluated, no time points 
were different between treatment groups.  Serum phosphorus concentrations were 
5.67±0.19 mg/dL compared with 5.80±0.19 mg/dL for CON and ZIL heifers, 
respectively.  A treatment (P = 0.02) and time (P < 0.001) effect were observed for serum 
potassium; but no treatment x time interaction (P < 0.13).  Serum potassium 
concentrations were 3.90±0.02 mmol/L compared with 3.82±0.02 mmol/L for CON and 
ZIL heifers, respectively.  Serum sodium concentrations were not affected by treatment 
(P = 0.95) or treatment x time (P = 0.53) interaction.  However, there was a time (P < 
0.001) effect for serum sodium concentrations.  Serum sodium/potassium ratio was 
affected by treatment (P = 0.03) and time (P < 0.001).  Furthermore, there was a 
tendency (P = 0.06) for a treatment x time interaction for serum sodium-potassium ratio.  
Serum sodium-potassium ratio were 35.6±0.25 compared with 36.4±0.25 for CON vs. 
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ZIL heifers, respectively.  There was no treatment (P = 0.19), time (P = 0.37), or 
treatment x time (P = 0.26) interaction for serum chloride concentrations.  Serum 
chloride concentrations were 98.8±0.77 and 97.4±0.77 for CON and ZIL heifers 
respectively.  There was a time (P < 0.001) effect and a tendency (P = 0.06) for a 
treatment difference for serum bicarbonate, but no treatment x time (P = 0.88) 
interaction.  Serum bicarbonate concentrations were 25.7±0.43 mmol/L and 26.9±0.43 
mmol/L for CON and ZIL heifers, respectively.  There was a treatment (P = 0.03) and 
time effect (P < 0.001), but no treatment x time (P = 0.66) interaction for serum anion 
gap.  Serum anion gap was 18.7±0.30 and 17.8±0.30 for CON and ZIL heifers 
respectively. 
 Serum creatinine concentrations were affected by treatment (P = 0.003) and time 
(P = 0.02), but there was only a tendency (P = 0.06) for a treatment x time interaction. 
Overall, creatinine concentrations were less (P = 0.003) in CON heifers (1.13±0.06 
mg/dL), when compared with ZIL heifers (1.40±0.06 mg/dL).  Creatine kinase 
concentrations were not affect by treatment (P = 0.17), time (P = 0.55), nor was there a 
treatment x time (P = 0.40).  Serum creatine kinase concentrations were 131.8±49 U/L 
compared with 227.1±49 U / L for CON and ZIL heifers, respectively. 
 Serum HB concentrations were not affected by treatment (P = 0.11) or treatment 
x time (P = 0.83), but there was a time (P < 0.001) effect.  There was a time effect (P = 
0.001) and a tendency (P = 0.09) for a treatment effect, but no treatment x time (P = 
0.72) interaction for serum lactate concentrations.  Overall, serum lactate concentrations 
were 22.95±1.02 ng/µL and 20.52±1.02 ng/µL for CON and ZIL heifers, respectively.  
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There was no treatment (P = 0.39) or treatment x time (P = 0.41) interaction for serum 
LDH but there was a time (P < 0.001) effect. 
Liver Enzymes 
 There was a treatment (P = 0.05) and time (P < 0.001) effect, but no treatment x 
time interaction (P = 0.88) for serum ALP concentrations.  Overall, serum concentrations 
of ALP were 111.6±8.02 U/L for CON heifers and 88.5±8.02 U/L for ZIL heifers.  There 
was no treatment (P = 0.22) or treatment x time (P = 1.0) interaction, but there was a time 
(P < 0.001) effect for serum AST.  There was no treatment (P = 0.28) effect for serum 
GT.  However, there was a tendency (P = 0.08) for a treatment x time interaction.  
Overall, serum GT concentrations were 48.66±6.41 U/L and 39.00±6.41 U/L for CON 
vs. ZIL heifers, respectively.  There was a treatment (P = 0.05) and time (P < 0.001) 
effect, but no treatment x time (P = 0.64) interaction for serum SDH.  Overall, SDH 
concentrations were 64.34±6.86 U/L for ZIL heifers, when compared with 45.04±6.86 
U/L for CON heifers. 
Initial BW, final live weight, HCW, and dressing percentage are reported in Table 
3.  There was no difference in initial live BW (P = 0.79), final live BW (P = 0.90), or 
HCW (P = 0.17) between CON and ZIL heifers (Table 3).  There was a difference (P 
<0.001) in dressing percent with ZIL heifers having a greater dressing perent, when 
compared to CON heifers (65.8±0.5 vs. 62.3±0.5%; Table 3).  In terms of select organ 
weights, there was no effect of treatment; weights for the heart (P = 0.36), lungs (P = 
0.30), total kidneys (P = 0.11), left kidney (P = 0.31), and left adrenal gland (P = 0.79) 
were similar (Table 4).  There was a tendency (P = 0.08) for liver weights to be greater in 
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CON heifers (7.7±0.10 kg) when compared with ZIL heifers (6.9±0.10 kg; Table 4).  
Also, there was a tendency (P = 0.10) for right adrenal gland weights to be greater in 
CON heifers (14.3±0.69 g) than in ZIL heifers (12.7±0.69 g; Table 4).  There was a 
treatment difference (P = 0.03) for right kidney weights; right kidney weights were 
greater in CON heifers (595.3±28.9 g) compared with ZIL heifers (504.8±28.9 g; Table 
4).  As a percentage of BW, there was no treatment effect on heart (P = 0.45), lung (P = 
0.41), and total adrenal gland (P = 0.42) weights (Table 5).  However, as a percentage of 
BW, there was a tendency (P = 0.06) for CON heifers to have greater liver and total 
kidney (P = 0.08) weights than ZIL heifers.  Liver and kidney weights as a percentage of 
final BW were 0.65±0.05 vs 0.61±0.05 for liver and 0.0021±0.001 vs 0.0018±0.001 for 
kidney comparing CON vs ZIL, respectively (Table 5). 
 Between CON and ZIL heifers, no treatment differences were observed between 
CON and ZIL heifers for aortic valve to left atrial ventricular valve diameter ratio (P = 
0.64), aortic valve to pulmonary valve diameter ratio (P = 0.16), aortic valve 
circumference (P = 0.98), or the aortic valve / right ventricular valve diameter ratio (P = 
0.96; Table 6).  Also, there were no differences for inter-ventricular septum thickness (P 
= 0.30), left atrial ventricular valve circumference (P = 0.64), left atrial ventricular valve / 
right atrial ventricular valve diameter ratio (P = 0.64), left ventricle free wall thickness (P 
= 0.97), or for the left ventricle + interventricular septum / right ventricle weight ratio (P 
= 0.14) between treatment groups (Table 6).  There was a tendency (P = 0.07) for left 
ventricle + interventricular septum / total heart weight ratio to be less in CON (0.58 ± 
0.05),when compared with ZIL heifers (0.61 ± 0.05; Table 6).  There was no difference in 
left ventricle free wall thickness / right ventricle free wall thickness ratio (P = 0.13), left 
102 
 
 
 
ventricle thickness / septal thickness ratio (P = 0.36), or left ventricle + septum weight (P 
= 0.97; Table 6).  In addition, there was no difference in pulmonary valve / left atrial 
ventricular valve ratio (P = 0.47), pulmonary valve / right atrial ventricular valve ratio (P 
= 0.30), or pulmonary valve circumference (P = 0.11; Table 6).  There was no difference 
(P = 0.94) for right atrial ventricular valve circumference.  There was a tendency (P = 
0.09) for right ventricle free wall thickness to be thicker in CON (2.11 ± 0.05 cm), when 
compared to ZIL heifers (1.99 ± 0.05 cm; Table 6).  There was no difference (P = 0.33) 
in right ventricle free wall weight between treatment groups.  There was a difference (P = 
0.04) in right ventricle free wall / inter-ventricular septal thickness ratio with CON 
having a greater ratio when compared with ZIL (0.51 ± 0.02 vs 0.47 ± 0.02, respectively; 
Table 6).  However, there was no difference (P = 0.72) for right ventricle / total heart 
weight ratio between treatments (Table 6).  Furthermore, there was no difference (P = 
0.85) in left ventricle + inter-ventricular septum as a percent of BW or right ventricle (P 
= 0.30) as a percent of BW (Table 7). Gross lesions of hepatitis were seen in two CON 
heifers and gross nephritis was seen in one ZIL heifer; catheter infection observed during 
the trial). Histologic evaluation of lungs demonstrated a very mild regional eosinophilic 
interstitial pneumonia in one CON heifer.  Pulmonary artery changes were adventitial and 
consisted of periarterial fibrosis and subacute inflammation and were noted in two CON 
and one ZIL heifer. Livers had mild periportal hepatitis in 6/10 CON and 7/9 ZIL heifers. 
The two CON heifers with gross hepatitis had histologic fibrosis in addition to mild 
lymphocytic infiltrates. The hepatic lesions were typical mild periportal infiltrates and 
rare isolated small lymphocytic foci. Renal lesions were mild focal chronic interestital 
nephritis consisting of very small, sparse, scattered, interstitial aggregates of lymphocytes 
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and plasma cells (6 CON and 6 ZIL heifers).  A single foci of lymphocytes was seen in 
the adrenal medulla of one CON heifer. Skeletal muscle and cardiac muscle was 
histologically normal in all heifers.   
 
DISCUSSION 
 To our knowledge, the evaluation of complete blood chemistry profiles of cattle 
supplemented with ZH for a 20 d period in a controlled environment has not been 
reported.  However, similar measurements have been reported in feedlot lambs 
supplemented with ZH (correct?).  Lopez-Carlos et al. (2010) reported that ZH 
supplementation at either 0.10, 0.20, or 0.30 mg/kg of BW/d for the last 42 d of feeding 
had no impact on serum total protein (don’t need this citation at the end of the sentence 
since you start with it) (López-Carlos et al., 2010).  Serum total protein concentrations 
account for albumin and other globulin fractions and are indicators of overall serum 
protein status (Evans and Duncan, 2003).  Neither supplementation of ZH or ractopamine 
hydrochloride had an impact on overall serum protein status in feedlot lambs (López-
Carlos et al., 2010).  Furthermore, the feeding of clenbuterol to Hereford steers did not 
impact serum total protein (Ricks et al., 1984).  In the current study, ZH supplementation 
decreased serum total protein in heifers; however, the decrease was minimal (based upon  
reported normal references for cattle).  Furthermore, a decrease in total protein would be 
anticipated due to a decrease of albumin in ZIL supplemented heifers. 
 Blood pH affects blood calcium concentrations, with an increase in pH resulting 
in an increase in calcium concentrations (Russell and Roussel, 2007).  Furthermore, 
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decreases in albumin can result in decreased calcium concentrations (Russell and 
Roussel, 2007).  In the current study, serum calcium concentrations were decreased in 
ZIL heifers which also had decreased albumin concentrations.  Ricks et al., (1984), 
reported no difference in blood calcium or phosphorus concentrations of Hereford steers 
supplemented clenbuterol in samples collected immediately prior to harvest.  Due to 
approximately 99% of mineral storage in bone, serum circulating concentrations of 
minerals may be an unreliable measurement on total body mineral status of an animal 
(Russell and Roussel, 2007).  Potassium is the major intracellular cation which is 
extensively regulated due to organ interactions (Russell and Roussel, 2007).  In the 
current study, potassium concentrations were decreased in ZIL heifers when compared 
with CON.  The decrease in serum potassium concentrations in ZIL heifers could 
possibly be explained due to an increase in lean muscle deposition observed during the 
utilization of ZH (Vasconcelos et al., 2008).  Muscle has been reported to contain 
2.43±0.9 mg/g of potassium (Mariam et al., 2004).  Serum sodium concentrations 
correlated to total body sodium due to the fact that sodium is a major extracellular cation 
which is the main contributor to osmotic force and is confined to extracellular fluid 
(Russell and Roussel, 2007).  No differences for serum sodium would be expected in the 
current study as all heifers had ab libitum access to water.  The treatment difference 
observed for Na:K ratio with ZIL heifers having greater concentrations when compared 
with CON heifers would be expected due to the observed differences between treatment 
groups for potassium.   
Chloride is the major anion in extracellular fluid and usually resembles sodium 
concentrations due to the reabsorption of sodium and chloride together in the kidneys 
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(Russell and Roussel, 2007).  In the current study, serum chloride concentrations were 
not affected by treatment which would be anticipated when compared with serum sodium 
concentrations.  The reference range for bicarbonate in cattle is 17 – 29 mmol/L (Kaneko 
et al., 2008).  In the current study, both CON and ZIL heifers had bicarbonate 
concentrations within the reported reference range.  However, bicarbonate tended to be 
decreased in CON heifers.  Ramirez et al. (1992) reported a decrease in bicarbonate 
concentrations of Holstein cows reared at sea level when compared with Holstein cows 
reared at 3,000 m.  Cows reared in high altitude are exposed to ambient hypoxia resulting 
in the development of decreased bicarbonate concentrations to compensate abnormal 
acid-base concentrations (Ramirez et al., 1992).  Clenbuterol a β2-AA has been reported 
to increase blood flow and oxygen uptake in the hind-quarters of cattle during early 
supplementation (Eisemann and Huntington, 1987).  Due to an increase in oxygen uptake 
observed in β2-AA supplemented cattle, greater bicarbonate concentrations observed in 
ZIL heifers may suggest an increase in oxygen availability with ZH supplementation.   
The reported reference range for anion gap for cattle  is 13.9 – 20.2 mmol/L 
(Kaneko et al., 2008).  Alterations in the anion gap are commonly utilized to determine 
acid/base disorders; an increase in lactate or HB concentrations (Gabow et al., 1980).  In 
the current study, HB concentrations were within the normal reference range for anion 
gap for CON and ZIL heifers.  However, CON heifers had a greater anion gap which 
could possibly be explained due to a tendency for CON heifers to have greater serum 
lactate.  Creatinine concentrations were greater in ZIL heifers but were within the normal 
reported reference range; 1.2 – 1.9 mg/dL (Kaneko et al., 2008); however, CON heifers 
had decreased creatinine concentrations when compared with normal reported reference 
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ranges.  The increase in creatinine would be expected due to a 19 kg increase in HCW for 
ZIL heifers, when compared with CON heifers.  During normal muscle metabolism, 
creatine is broken down into creatinine which can be utilized as an indicator of muscle 
mass in the serum (Russell and Roussel, 2007).  Furthermore, serum creatinine is 
positively correlated with HCW, dressing percentage, and proportion of lean meat in a 
carcass (Istasse et al., 1990).  Cimaterol, a β2-AA (Signorile et al., 1995), increased 
plasma creatinine concentrations in Friesian steers during long term supplementation 
(Chikhou et al., 1993).  Creatine kinase is a key enzyme for cellular energetics 
(Wallimann et al., 1992).  In the current study, there was no difference in creatine kinase 
between CON and ZIL heifers.  Thomson et al., 2015 reported no increase in creatine 
kinase activity in steers under normal feedlot conditions supplemented ZH or 
ractopamine hydrochloride when compared with a control group.  Creatine kinase has 
been reported to increase when steers are transported (Warriss et al., 1995). 
-hydroxybutyrate  is a ketone body produced during the metabolism of NEFA in 
the liver and can indicate a negative energy balance (Ospina et al., 2010).  No difference 
was observed between treatment groups for HB in the current study.  This lack of a 
difference is similar to those reported in steers supplemented clenbuterol (Eisemann et 
al., 1988a).  Furthermore, there was also no difference observed for HB concentrations 
for steers supplemented ZH for a 23 d duration (Van Bibber-Krueger et al., 2015).  Van 
Bibber-Krueger et al. (2015) suggested that ZH supplementation in cattle did not alter the 
metabolization rate of HB.  During anaerobic conditions, lactate is formed by the 
oxidation of NADH by pyruvate, thus allowing glycolysis to continue (Reece et al., 
2015).  In the current study, there was a tendency for lactate to be decreased in ZIL 
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supplemented heifers.  Thomson et al. (2015) and Van Bibber-Krueger et al. (2015) 
reported no difference in lactate concentrations of steers supplemented ZH.  Differences 
observed between these studies could be explained by frequency of sampling, as the 
current study evaluated lactate concentrations during a 10 h CRH/VP challenge following 
a 3 d ZH withdrawal.  Van Bibber-Krueger et al. (2015) observed a suggested association 
for decreased plasma lactate concentrations as d on ZH increased; however, no samples 
were obtained during the 3 d ZH withdrawal period.  These results are in confliction with 
those reported from previous β-AA supplementation.  The inclusion of P-5369 and Q-
2636 in milk replacer increased lactate concentrations in calves (Blum and Flueckiger, 
1988).  Eisemann et al. (1988) observed increased lactate concentrations when 
clenbuterol was supplemented to steers.  Furthermore, arterial cimaterol infusion 
increased lactate concentrations as cimaterol infusion rates increased (Byrem et al., 
1996).  Observed differences between the current study and previous studies could be 
again, related to the time at which serum samples were collected.  In the current study 
heifers had been withdrawn from ZH supplementation for 3 d, while in the 
abovementioned studies, serums samples were collected during the supplementation 
period.  The glycolytic enzyme LDH catalyzes the conversion of lactate to pyruvic acid 
(Doornenbal et al., 1988).  The reference range for LDH in the cow is 692 – 1445 U/L 
(Kaneko et al., 2008).  In the current study, there was no difference in LDH 
concentrations between CON and ZIL heifers.  When ZH was administered to horses, an 
increase in LDH was observed (Wagner et al., 2008).  Differences observed in these 
studies can possibly be explained by species differences as ZH is not approved for 
utilization in the horse (and can be fatal). 
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In the current study, serum concentrations for alkaline phosphatase (ALP), 
aspartate transaminase glutamyltransferase, and sorbitol dehydrogenase were 
determined.  Alkaline phosphatase catalyzes the cleavage of Pi from phosphate esters 
with production of aspartate transaminase originating in the liver of mature animals 
(Doornenbal et al., 1988).  The reference values for aspartate transaminase in the cow are 
78 – 132 U/L (Kaneko et al., 2008).  Ricks et al. (1984) reported no difference in 
aspartate transaminase in Hereford steers supplemented clenbuterol.  In the current study, 
aspartate transaminase concentrations were decreased in ZIL heifers when compared with 
CON.  A possible hypothesis for the decrease in aspartate transaminase concentrations 
could be the related to the decrease in liver weight observed in the current study.  It has 
been reported that in dogs with increased corticosteroid concentrations, aspartate 
transaminase concentrations are increased due to the formation of a more heat-stable 
isoenzyme of aspartate transaminase (Teske et al., 1986).  Previous work from our lab 
observed a decrease in cortisol in ZIL supplemented heifers which could explain the 
increase in aspartate transaminase observed in CON heifers.  Aspartate transaminase is an 
enzyme that catalyzes the transfer of an α-amino group from an amino acid to an α-keto 
acid (Doornenbal et al., 1988).  In the current study, no difference was observed in 
aspartate transaminase concentrations.  An increase in aspartate transaminase 
concentrations was observed in Friesian calves administered cimaterol (Chikhou et al., 
1993).  However, Chikhou et al. (1993) did not observe a difference in liver weights in 
cimaterol treated calves, possibly explaining the differences between these studies.  
glutamyltransferase is a membrane bound enzyme that catalyzes the transfer  
glutamyl groups from glutamylpeptides to other peptides or amino acids with a 
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normal reference range of 6.1 – 17.4 U/L (Kaneko et al., 2008).  In the current study, 
there was no difference in glutamyltransferase between treatment groups; however, 
both treatment groups were above normal reference ranges.  A potential cause of 
increased glutamyltransferase in the current study could be associated with the 
CRH/VP challenge administered.  In canines, glucocorticoids have been associated with 
an increase in glutamyltransferase concentrations (Shull and Hornbuckle, 1979).  
Lastly, sorbitol dehydrogenase concentrations were increased in CON heifers in the 
current study; however, both treatment groups had elevated sorbitol dehydrogenase 
concentrations compared with reference ranges for the cow which are 4.3 – 15.3 U/L 
(Kaneko et al., 2008).  Feed restriction in llamas resulted in an increase in hepatic 
lipidosis which resulted in elevated sorbitol dehydrogenase concentrations (Tornquist et 
al., 2001).  Therefore, the increase in sorbitol dehydrogenase in the current study could 
potentially be a result of increased lipolysis during the CRH/VP challenge allowing 
heifers to mount a stress challenge.  
Experiments that have evaluated and reported the effects of β-AA on major 
organs of feedlot cattle are limited.  In the current study, there was no difference in final 
BW or HCW potentially due to the number of animals on study; however, there was a 
numerical difference in HCW with ZIL supplemented heifers having a 19 kg increase 
when compared with CON heifers.  Montgomery et al. (2009a) reported an 11 kg 
increase in HCW with a 20 d supplementation of ZH in heifers.  In the current study, 
there was a positive increase in dressing percentage observed when ZH was 
supplemented.  Montgomery et al. (2009b) reported a dressing percentage increase of 1.2 
percentage units with the feeding of ZH.  The current study was not designed to evaluate 
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the carcass effects of ZH but a more in-depth analysis of organ parameters with the 
supplementation of ZH.  The increase in dressing percentage of ZIL heifers would 
indicate a ZH response was initiated. 
 In the current study, no differences were observed in heart and lung weights 
between treatment groups.  No difference was reported in combined heart and lung 
weights of beef steers fed ZH for 20 d (Holland et al., 2010).  However, the feeding of 
clenbuterol (β2-AA) in normal mice decreased heart weights by 8% when compared with 
control mice (Sharma et al., 1997).  Furthermore, May et al. (2014) reported a tendency 
for a decrease in heart weights of Holstein steers supplemented ZH for 20 d but no 
difference in lung weights between zilpaterol and control steers.  A decrease in kidney 
and liver mass of zilpaterol supplemented steers has been reported, when compared with 
control steers was observed (May et al., 2014).  In the current study, there was only a 
difference observed for right kidney weights, with ZIL supplemented heifers having 
lighter right kidney weights; however, overall kidney weights did not differ between 
treatment groups.  Furthermore, there was a tendency for liver weights to be greater in the 
CON heifers when compared with ZIL heifers in the current study.  The feeding of 
salbutamol (β2-AA) to pigs has been reported to decrease kidney and liver weights when 
compared with control pigs (Hansen et al., 1994).  The decreased in renal and liver mass 
could be a result of decreased gut fill.  The repartitioning of energy to skeletal muscle 
growth and a decrease in feed intake resulting in less gut fill could explain the decrease in 
renal and liver mass of ZIL supplemented cattle (Montgomery et al., 2009b).  
To our knowledge, data on the effect of β-AA’s on adrenal weights has not been 
reported in the literature.  The comparing of organ weight ratios to BW can result in 
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misleading data due to differences in animal adipose and muscle tissues (Joseph, 1908), 
as well as the previously reported effect of ZH on HCW (Montgomery et al., 2009a; 
Montgomery et al., 2009b).  Reported percent’s for bovine heart weight ratios to BW are 
0.26, 0.52, and 0.38% for steers, bulls, and female, respectively (Joseph, 1908).  In the 
current study, heifer heart weight ratios to BW were within this reported range for cattle. 
Minimum published anatomic data is available for measurements of the dissection 
of the bovine heart.  The total cardiac to BW ratios and the left ventricle and septum to 
right ventricle weight ratios were within the normal range (Leifsson, 2011). The 
expanded data and reference of a broader range of normal cardiac dimensional anatomy 
published here will be useful in evaluating finishing cattle affected by or at risk of 
pulmonary hypertension and chronic right heart failure which appears to be a growing 
problem (Neary et al., 2013). The gross lesions of liver fibrosis were only observed in 
CON heifers and the kidney lesion was in a heifer with a documented catheter infection 
and transient sepsis during the study. The mild chronic periportal hepatitis and chronic 
interstitial nephritis seen equally in both groups are common background lesions seen in 
cattle in standard production systems. Theses likely reflect residual inflammation of 
neonatal infections. The mild adventitial inflammation seen around the pulmonary artery 
in two ZIL and one CON heifers are of undetermined etiology but suspected to be 
residual scaring and inflammation due to past resolved pulmonary infection.  None of the 
histologic lesions were more prevalent in ZIL heifers and were typical of incidental 
changes seen in standard commercial cattle.  No pathologic changes were observed in 
these cattle associated with ZH treatment that might suggest a direct link between 
treatment and reported mortality risk in some production systems. Changes in feed 
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delivery and other production practices associated with implementing of supplement 
delivery and documentation of causes of mortality during the last 25 d of feeding need 
further prospective study.  
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Table 1.  Composition of finishing diets fed to control (CON) and zilpaterol (ZIL) heifers 
as a percent of DM basis during a corticotropin-releasing hormone (CRH; 0.3 µg / kg 
BW) and vasopressin (VP; 1.0 µg / kg BW) challenge in finishing heifers. 
  Treatment 
Item  Control ZIL
1 
Ingredient (%)    
High Moisture 
Corn 
 51.00 51.00 
Sweet Bran
2 
 40.00 40.00 
Wheat Straw    5.00   5.00 
Fine Ground Corn        1.8710       1.8710 
Limestone        1.6400       1.6400 
Salt        0.3000       0.3000 
Tallow        0.1000       0.1000 
Beef Trace Mineral        0.0500       0.0500 
Rumensin-90
3 
       0.0150       0.0150 
Vitamin A-D-E        0.0165       0.0165 
Tylan-40
3 
       0.0075       0.0075 
Supplement
4 
   
   Fine Ground Corn  5.0       4.9853 
   Zilpaterol Hydrochloride       -       0.0147 
1
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal 
2
Sweet Bran, (Cargill Corn Milling; Blair, NE) 
3
Elanco Animal Health; Greenfield, IN 
4
The control supplement contained fine ground corn only. Zilpaterol hydrochloride (ZH) 
supplement contained (DM basis) 0.0147% Zilmax® (Merck Animal Health) Type A medicated 
article and 4.9853% fine ground corn and supplied zilpaterol hydrochloride (ZH) supplementation 
(8.33 mg / kg on a DM basis).  Supplement was fed for 20 d. 
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Table 2.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a 
DM basis) on serum metabolites following 20 d ZH supplementation, 3 d withdrawal 
period, and a corticotropin-releasing hormone and vasopressin challenge administered on 
d 24. 
1
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal 
2
Total serum calcium 
3
Serum sodium-potassium ratio 
4
Calculated serum anion gap 
5
Serum creatine kinase 
6
Serum beta-hydroxybutyrate 
7
Serum lactate dehydrogenase 
8
Serum alkaline phosphatase 
9
Serum aspartate transaminase 
10
Serum gamma glutamyltransferase 
11
Serum sorbitol dehydrogenase  
Item                      CON        ZIL
1 
     SEM  Treatment      Time      Trt x Time 
Blood metabolite       
   Total Protein, g / dL       7.60     7.51       0.11  0.58  <0.001        0.001 
   Albumin, g / dL       3.64     3.45       0.05  0.02  <0.001        0.60 
   Globulin, g / dL       3.95     4.04       0.14  0.61  <0.001        0.001 
   Calcium, mmol / L
2
       9.75     9.49       0.07  0.01  <0.001        0.34 
   Phosphorus, mg / dL       5.67     5.80       0.19  0.60  <0.001        0.02 
   Potassium, mmol / L       3.90      3.82       0.02  0.02  <0.001        0.13 
   Sodium, mmol / L    138.3    138.3       0.24  0.95  <0.001        0.53 
   Na-K ratio
3 
   35.64   36.42       0.25  0.03  <0.001        0.06 
   Chloride, mmol / L    98.84   97.44       0.19  0.19  0.37        0.26 
   Bicarbonate, mmol / L    25.73   26.92       0.43  0.06  <0.001        0.88 
   Anion Gap
4 
   18.71  17.78       0.30  0.03  <0.001        0.66 
   Creatinine, mg / dL      1.13    1.40       0.06   0.003  0.02        0.06 
   CK, U / L
5 
131.8   227.1     49.0 0.17      0.55        0.40 
   BHB, ng / µL
6 
    89.13   83.73       2.35 0.11  <0.001        0.83 
   Lactate, ng / µL        22.94   20.52       1.02 0.09  <0.001        0.73 
   LDH, milliunits / mL
7 
  919.93    973.81     45.36 0.39  <0.001        0.41 
Liver enzymes       
   ALP, U / L
8 
111.6      88.5 8.02 0.05 <0.001        0.88 
   AST, U / L
9 
156.8    131.1     15.1 0.22 <0.001        1.0 
   GGT, U / L
10 
   48.66    39.00       6.41 0.28 <0.001        0.08 
   SDH, U / L
11 
   64.34    45.04       6.86 0.05 <0.001        0.64 
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1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal   
Table 3.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a DM basis) 
on live weights (kg), HCW (kg), and dressing percentage  following 20 d ZH supplementation, 3 
d withdrawal period, and a corticotropin-releasing hormone and vasopressin challenge 
administered on d 24.  
Item       CON     ZIL
1 
    SEM P-value 
Weights     
   Initial weight, kg     550     546      11.2 0.79 
   Final weight, kg     578     575      13.7 0.90 
   HCW, kg     359     378        9.2 0.17 
   Dressing percent, %     62.3          65.8        0.5 <0.001 
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1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal   
Table 4.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a DM basis) 
on major organ weights  following 20 d ZH supplementation, 3 d withdrawal period, and a 
corticotropin-releasing hormone and vasopressin challenge administered on d 24.  
Item           CON       ZIL
1 
   SEM P-value 
Organ     
   Heart, kg       2.64        2.51     0.10 0.36 
   Liver, kg       7.70        6.90     0.31 0.08 
   Lung, kg       3.76        3.52     0.17 0.30 
   Total Kidney, g  1197.24 1057.5 60.4 0.11 
   Right Kidney, g  595.3   504.8 28.9 0.03 
   Left Kidney, g  602.0   552.7 34.0 0.31 
   Total Adrenal, g    28.8     26.8     1.39 0.32 
   Right Adrenal, g    14.3     12.7     0.69 0.10 
   Left Adrenal, g    14.5     14.2     0.84 0.79 
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1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal   
Table 5.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a DM basis) 
on major organ weights as a percent of total BW  following 20 d ZH supplementation, 3 d 
withdrawal period, and a corticotropin-releasing hormone and vasopressin challenge 
administered on d 24. 
Item     CON     ZIL
1 
   SEM P-value 
Organ     
   Heart     0.46 0.44 0.02 0.45 
   Liver     1.33 1.19 0.05 0.06 
   Lung     0.65 0.61 0.03 0.41 
   Total Kidney         0.0021     0.0018       0.00009 0.08 
   Total Adrenal       0.005   0.005     0.0004 0.42 
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1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal 
2 
Aortic valve / left atrial ventricular valve diameter ratio 
3 
Aortic valve / pulmonary valve diameter ratio 
4 
Aortic valve circumference in cm 
5 
Aortic valve / right atrial ventricular valve diameter ratio 
6 
Interventricular septum thickness in cm 
7 
Left atrial ventricular valve circumference in cm 
8 
Left atrial ventricular valve / right atrial ventricular valve diameter ratio 
9 
Left ventricle free wall thickness in cm 
10 
Left ventricle + interventricular septum / right ventricle weight ratio 
11 
Left ventricle + interventricular septum / total heart weight 
12 
Left ventricle free wall thickness / right ventricle free wall thickness  
13
 Left ventricle thickness / septal thickness
 
14 
Left ventricle + septum weight kg. 
15 
Pulmonary valve / left atrial ventricular valve ratio 
16 
Pulmonary valve / right atrial ventricular valve ratio 
17 
Pulmonary valve circumference in cm 
18 
Right atrial ventricular valve circumference in cm 
19 
Right ventricle free wall thickness in cm 
20 
Right ventricle free wall weight in g 
21 
Right ventricle free wall / interventricular septal thickness ratio 
22 
Right ventricle / total heart weight ratio  
Table 6.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a DM basis) 
on heart measurements  following 20 d ZH supplementation, 3 d withdrawal period, and a 
corticotropin-releasing hormone and vasopressin challenge administered on d 24. 
Item               CON     ZIL
1 
    SEM P-value 
Heart parameter     
   A/LAV
2 
   0.71      0.73     0.03 0.64 
   A/P
3 
   0.98      1.04     0.03 0.16 
   Aorta, cm
4 
 11.61    11.60     0.38 0.98 
   AR/RAV
5 
   0.69      0.69     0.04 0.96 
   IVS, TH
6 
   4.12      4.29     0.12 0.30 
   LAV, cm
7 
 16.53    16.13     0.61 0.64 
   LAV/RAV
8 
   0.97      0.95     0.03 0.64 
   LVFW, TH
9 
   3.54      3.54     0.08 0.97 
   LV+S/RV
10 
   3.28      3.57     0.13 0.14 
   LV+S/THW
11 
   0.58      0.61     0.05 0.07 
   LVFWT/RVFWT
12 
   1.68      1.79     0.05 0.13 
   LVT/ST
13
    0.86      0.82     0.03 0.36 
   LVW+S
14 
   1.53      1.53     0.06 0.97 
   P/LAV
15 
   0.72      0.70     0.02 0.47 
   P/RAV
16 
   0.70      0.66     0.03 0.30 
   PUL, cm
17 
 11.89    11.20     0.30 0.11 
   RAV, cm
18 
 17.14    17.08     0.60 0.94 
   RVFW, TH
19 
   2.11      1.99     0.05 0.09 
   RVFW
20 
  467.60  436.60   22.40 0.33 
   RVFWT /IVST
21 
   0.51      0.47     0.02  0.04 
   RV/THW
22 
   0.18      0.17     0.06 0.72 
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1 
Heifers receiving zilpaterol hydrochloride for 20-d period with 3-d withdrawal
 1 
2 
Left ventricle + interventricular septum as percent of BW 
3 
Right ventricle as percent of BW 
  
Table 7.   Effect of zilpaterol hydrochloride (ZH) supplementation (8.33 mg / kg on a DM basis) 
on heart parameter weights as a percent of total BW following 20 d ZH supplementation  
Item     CON     ZIL
1 
    SEM P-value 
Heart parameters     
   LV+S BW
2 
    0.26     0.27    0.01 0.85 
   RV BW
3 
    0.08     0.08      0.003 0.30 
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CHAPTER V 
OVERALL SUMMARY, CONCLUSIONS, AND IMPLICATIONS FOR BEEF 
HEIFERS SUPPLEMENTED WITH ZILPATEROL HYDROCHLORIDE AND 
EXPOSED TO A DUAL CORTICOTROPIN-RELEASING HORMONE AND 
VASOPRESSIN STRESS CHALLENGE 
 
 
Performance 
Initial BW, final live weight, HCW, and dressing percentage are reported in.  
There was no difference in initial live BW (P = 0.79), final live BW (P = 0.90), or HCW 
P = 0.17) between treatment groups.  There was a difference (P < 0.001) in dressing 
percent with CON heifers having a decreased dressing percentage when compared to 
dressing percentage of ZIL heifers (62.3±0.5 vs 65.8±0.5 percent, respectively). 
In the current study, there was no difference in final BW or HCW potentially due 
to the number of animals on study; however, there was a numerical difference in HCW 
with ZIL supplemented heifers having a 19 kg increase when compared with CON 
heifers.  Montgomery et al., (2009a) reported an 11 kg increase in HCW with a 20 d 
supplementation of ZH in heifers.  In the current study, there was a positive increase in 
dressing percentage observed when ZH was supplemented.  Montgomery et al., (2009b) 
reported an increase in dressing percentage of 1.2% units when feeding ZH was utilized.  
The current study was not designed to evaluate the carcass effects of ZH but a more in-
depth analysis of organ parameters with the supplementation of ZH.  The increase in 
dressing percentage of ZIL heifers would indicate a ZH response was initiated.   
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Vaginal Temperature 
Vaginal temperature (VT) was decreased (P < 0.001) in ZIL compared with CON 
heifers, and varied over time.  Due to the treatment effect, with ZIL heifers entering the 
challenge with decreased VT, the VT data were further analyzed as the change from 
baseline values (average of values from -2 to 0 h; 0800 to 1000 h), with average baseline 
values included as a covariate in the analysis.  The change in VT relative to baseline 
values was affected by treatment (P < 0.001) and time (P = 0.02), but there was no 
treatment x time interaction (P = 0.99).  Heifers in the CON group had an overall positive 
change (increase; P < 0.001) in VT (0.068±0.005
o
C) while ZIL heifers had an overall 
negative (decrease) change in VT in response to CRH/VP challenge (-0.050±0.005
o
C).  
There is limited reported data regarding the effect of β-AA on body temperature in any 
species including cattle.  The feeding of ZH has been reported to decrease ruminal 
temperature when compared with control steers not fed ZH (Boyd et al., 2015).  As 
reported by Boyd et al (2015) the decreased body temperature may be attributed to 
increased respiration rates, allowing ZH supplemented steers the ability to dissipate 
excess body heat.  In this study, authors attributed decreased body temperature to 
increased respiration rates body heat, which has been published by others (Boyd et al., 
2015).  Another biological response typically observed following stimulation of the β-
adrenergic receptors is vasodilation of interior tissues (e.g. skeletal muscle, heart, lungs, 
liver, and gastrointestinal tract; (Dawes et al., 1997).  An increase in vasodilation would 
support the observed decrease in body temperature, as this would allow dissipation of 
heat from the body surface at a faster rate compared with CON heifers.  However, it 
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would be expected to see a decline in vasodilation with continued treatment of β-AA due 
to a possible down-regulation of the β-adrenergic receptors (Smith et al., 1994). 
Serum Metabolites  
There was no treatment effect observed for serum glucose and insulin 
concentrations.  Studies in cattle using other β-AAs (i.e., clenbuterol) have observed 
differences in glucose, lipid, and protein metabolism (Eisemann et al., 1988b); yet these 
metabolites were measured early in the supplementation process rather than following 
withdrawal as in the current study.  When glucose and insulin were measured on d 13 of 
cimaterol supplementation in steers, there were no differences in glucose or insulin 
concentrations compared with control steers (Chikhou et al., 1991b).  Additionally, 
results from a study in finishing steers revealed decreased glucose concentrations after 21 
d of supplementation with ZH (Van Bibber et al., 2010).  The observed difference in 
glucose concentrations reported by Van Bibber et al. (2010) differs from the current study 
where no treatment differences in circulating concentrations of glucose were observed in 
response to ZH supplementation in cattle.  The differences observed between the study by 
Van Bibber et al. (2010) and the current study could be due to sample frequency and the 
collection of samples following a 3 d withdrawal in the current study, which the previous 
studies did not include.  In the current study, samples were obtained through indwelling 
jugular catheters in 30 min increments whereas in the Van Bibber et al. (2010) study, 
blood samples were only collected once daily via restraining within working chute.  
Furthermore, the current study was conducted within an controled environment, thus a 
possible reduction in ME requirements (Hoffman and Self, 1970).   
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There was a treatment x time interaction (P < 0.001) for serum NEFA 
concentrations.  Concentrations of NEFA were greater in CON heifers, compared with 
ZIL heifers at 4 h (P = 0.04), at 6 h (P = 0.02) and from 7 to 8 h (P < 0.01) following the 
CRH/VP challenge.  Initial feeding of β-AAs has been reported to increase NEFA 
concentrations (Mersmann, 1998). During the initial stages of feeding, β-AAs exhibit 
more lipolytic effects, a biological effect that may be eventually down-regulated during 
extended feedings and as fat content decreases.  In a prior study, concentrations of NEFA 
measured weekly during ZH supplementation in finishing steers reported no difference in 
NEFA concentrations (Van Bibber et al., 2010), thus supporting data from the current 
study as baseline NEFA concentrations did not differ between treatments groups.  The 
decrease in NEFA concentrations in response to the CRH/VP challenge in the ZH-
supplemented heifers is not surprising considering the increase in lean tissue growth, and 
the decrease in lipogenesis that has been observed in β-AA fed cattle (Sillence, 2004).  
Feeding of β-AAs leads to decreased lipid deposition, and thus decreased NEFA 
concentrations when stimulated by a catabolic agent such as cortisol.  Studies reported in 
the literature have demonstrated that β-AAs have anti-lipogenic effects (Dunshea, 1993; 
Sillence, 2004), data that also supports the results in the current study.   
Serum BUN concentrations were affected by treatment (P < 0.001) and time (P < 
0.001).  Concentrations of BUN were greater in CON heifers when compared with ZIL 
heifers.  The major growth promoting effects of β-AAs are primarily observed in skeletal 
muscle (Sillence, 2004), which results in the catabolism of protein from other tissues to 
be used to build muscle, although only critical when provided inadequate nutrition 
(Sillence, 2004).  Furthermore, β-AA activate β-receptors in muscle and adipose tissue 
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resulting in decreased lipogenesis, and increased lipolysis and protein accretion 
(Mersmann, 1998).  Therefore, the decreased BUN concentrations in ZH supplemented 
heifers is likely due to increased anabolism of protein in skeletal muscle and decreased 
catabolism of protein in other tissues as these heifers were provided adequate nutrition to 
support additional lean tissue accretion during the study  (Bell et al., 1998a).  The 
decrease in BUN observed in the current study is supported by work with other β-AAs in 
which the authors observed similar decreases in BUN concentrations in cattle 
supplemented with cimaterol (Chikhou et al., 1991b).  The increase in BUN 
concentrations post-CRH/VP in both treatment groups is in concert with the increased 
concentrations of NEFA observed post-challenge, and suggests a greater energy demand 
during this period than was supplied by glucose alone.  Decreased BUN concentrations in 
ZH-supplemented cattle observed in the current study is supported by work in finishing 
steers in which the authors reported decreased BUN concentrations after 20 d and 21 d of 
ZH supplementation, (Parr et al., 2010; Van Bibber et al., 2010).   
Serum cortisol concentrations were affected by treatment (P = 0.002) and time (P 
< 0.001).  Cortisol concentrations were greater in CON when compared with ZIL heifers 
during the CRH/VP challenge.  Baseline cortisol concentrations were not different 
between treatments in the current study.  This is in agreement with a study utilizing 
cimaterol treatment in steers, where no difference in cortisol concentrations were 
observed 1 and 13 d following initiation of oral dosing (Chikhou et al., 1991b).  The 
temporal pattern associated with an acute increase in circulating concentrations of 
cortisol followed by a subsequent decline in the current study is similar to that observed 
in Brahman calves in response to a CRH challenge (Hulbert et al., 2013), albeit the 
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magnitude of the cortisol response was greater in the current study.  Control heifers 
produced a greater cortisol response to the CRH/VP challenge compared with ZIL 
heifers, thus suggesting a possible down-regulation of aspects associated with HPA axis 
regulation. 
Epinephrine and Norepinephrine Concentrations 
 Plasma epinephrine concentrations were affected by treatment (P = 0.003) and 
time (P < 0.001).  Due to the treatment effect, data were further analyzed within baseline 
and challenge periods.  Prior to the CRH/VP challenge, CON heifers had greater (P = 
0.005) baseline epinephrine concentrations (-2 to 0 h), when compared with ZIL heifers.  
Following the challenge, there was a treatment (P = 0.03) and time (P = 0.002) effect for 
epinephrine concentrations with CON heifers having greater epinephrine concentrations, 
when compared with ZIL heifers.  For plasma norepinephrine concentrations, there was 
only a time effect (P < 0.001) observed.  Norepinephrine concentrations decreased (P < 
0.001) 1 h following administration of CRH/VP. Concentrations remained decreased for 
the duration of the study (P < 0.001) for CON and ZIL heifers. 
 Differences observed in epinephrine concentrations but not norepinephrine 
concentrations would theoretically be expected when feeding ZH.  Naturally-occurring 
physiological β-adrenergic agonists consist of norepinephrine, a neurotransmitter, and 
epinephrine, an adrenal medullary hormone (Mersmann, 1998).  Both epinephrine and 
norepinephrine are capable of binding to the α1-, α2-, β1 and β2-adrenergic receptors 
(Robinson et al., 1989); however,  β2-adrengeric receptors have a greater affinity for 
epinephrine compared with norepinephrine.  Therefore, the lack of down-regulation of 
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the norepinephrine response may be due to the difference in receptor affinity.  With ZH 
being classified as a β2-adrenergic receptor agonist it should not affect the regulation of 
norepinephrine via actions on the α1-, α2-, and β1-adrengeric receptors.  Adenylate 
cyclase in the erythrocytes of frogs has been used to demonstrate a loss of β-adrenergic 
receptor binding sites in response to catecholamine induced sensitivity.  When injected 
with norepinephrine or isoproterenol (β1-adrenergic receptor agonist), cyclic adenosine 
monophosphate generated from frog erythrocyte membranes decreased compared with 
controls (Mukherjee et al., 1975).  I hypothesis  that the decrease in catecholamine 
responsiveness was due to a reduction in β-adrenergic receptors, or a conformational 
change resulting in inactive receptors (Mukherjee et al., 1975).  In the current study, 
decreased concentrations of epinephrine in ZIL heifers would further support a down-
regulation of the sympathomedulary axis via action on the β2-adrengeric receptors. 
Complete Blood Cell Counts 
 There were no main effect differences in total red blood cells (P = 0.82), 
hemoglobin (P = 0.14), or platelets (P = 0.70) between CON and ZIL heifers. There was 
a tendency (P ≥ 0.06) for both total red blood cells and hemoglobin to change over time 
regardless of treatment.  There was a time difference (P < 0.001) for platelets with 
platelet concentrations increasing relative to the CRH/VP challenge in both CON and ZIL 
heifers.  There was a treatment x time interaction (P = 0.03) for hematocrit.  Therefore, 
hematocrit concentrations were further analyzed as baseline and post-challenge.  There 
was a tendency (P = 0.06) for a treatment effect and a difference (P = 0.05) over time 
during the baseline period between treatments for hematocrit.  Therefore, change from 
baseline was calculated and analyzed as a percent change between treatments.  There was 
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no difference for treatment (P = 0.85) or treatment x time (P = 0.80) for percent change 
in hematocrit.  However, there was a time difference (P = 0.04) for percent change in 
hematocrit such that hematocrit concentrations decreased following administration of 
CRH/VP.  Total white blood cells, lymphocytes, and neutrophils were not affected by 
treatment (P ≥ 0.41); however, these variables were affected by time (P < 0.001).  White 
blood cells and lymphocytes increased (P < 0.001) 2 h following administration of 
CRH/VP, and remained increased for the duration of the study (P < 0.001, 8 h compared 
with 0 h). In contrast, neutrophils decreased (P < 0.001) 3 h following administration of 
CRH/VP, and remained decreased for the duration of the study (P < 0.001, 8 h compared 
with 0 h).  There was a treatment x time (P = 0.04) interaction for monocytes.  However, 
no time points were different between treatment groups during the trial.  The treatment x 
time interaction can primarily be contributed to a greater fluctuation of monocyte 
concentrations within the CON heifers.  There was a treatment effect (P =0.04) for 
eosinophils with greater concentrations for CON when compared with ZIL heifers.  There 
was a treatment x time (P = 0.04) interaction for basophil concentrations.  At 8 h post 
CRH/VP challenge, basophil concentrations were greater for ZIL heifers when compared 
with CON heifers during the CRH/VP challenge. 
Few studies have determined the effect of CRH or a combined CRH/VP challenge 
on immune cell populations, particularly in cattle; however, increased glucocorticoids 
results in an increase of neutrophils (Burton et al., 2005).  Immune cell populations are 
sensitive to CRH, as well as the intermediate stress hormone, adrenocorticotropic 
hormone (ACTH), and cortisol.  Hulbert et al. (2013) observed a decrease in total 
leukocytes at 1 h following a CRH challenge in Brahman calves.  This is in contrast to 
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the current study, in which an increase in total WBCs was observed 2 h following 
CRH/VP administration regardless of treatment.  Many factors may contribute to these 
opposing observations, including age of the cattle, breed of the cattle, and/or the 
combination of a CRH challenge with VP given simultaneously versus a solitary CRH 
challenge.  While there are limited studies utilizing CRH, the CRH/VP challenge in this 
study was utilized to mimic an acute stressor.  In mice exposed to acute restraint stress, 
an increase in natural killer (NK) cells, a subset of lymphocytes, was observed (Bauer et 
al., 2001).  Furthermore, the use of cyanoketone, an androstanol, in restraint-stressed rats 
resulted in less cortisol production during the time of stress (Dhabhar et al., 1996).  The 
blocking of cortisol production with cyanoketone also significantly reduced the stress-
induced decrease in leukocytes that has been reported in rats under acute stress (Dhabhar 
et al., 1996).   
The decrease in circulating neutrophils following CRH/VP challenge is indicative 
of movement of neutrophils out of the blood and into the tissues in preparation for 
immune activation (e.g. wounding).  In contrast, the increase in circulating total WBC 
and lymphocytes suggests a mobilization of these cells (Dhabhar et al., 2012).  This 
redistribution of immune cells suggests an activation of the immune response, as several 
factors, including chemoattractants, cell adhesion molecules, and cytokines are needed 
for this process to occur (Bauer et al., 2001).  Changes in expression of cell adhesion 
molecules, stimulated by stress hormones, may be responsible for the changes observed 
in immune cell populations not only in response to CRH/VP challenge, but in response to 
ZH supplementation. 
Blood Chemistry Profile 
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Serum calcium concentrations were affected by treatment (P = 0.001) and time (P 
< 0.001).  Overall, serum calcium concentrations were greater in CON heifers when 
compared with ZIL heifers.  For serum phosphorus concentrations, there was no 
treatment (P < 0.60) affect, but a time (P < 0.001) affect and treatment x time (P = 0.02) 
interaction was observed.  However, when individual time points were evaluated, no time 
points were different between treatment groups.  A treatment (P = 0.02) and a time (P < 
0.001) effect were observed for serum potassium.  Serum sodium concentrations were not 
affected by treatment (P = 0.95) or treatment x time (P = 0.53) interaction; however, 
there was a time (P < 0.001) effect for serum sodium concentrations.  Serum sodium-
potassium ratio was affected by treatment (P = 0.03) and time (P < 0.001).  Furthermore, 
there was a tendency (P = 0.06) for a treatment x time interaction for serum sodium-
potassium ratio.  There was no treatment (P = 0.19), time (P = 0.37), or treatment x time 
(P = 0.26) interaction for serum chloride concentrations.  There was a time (P < 0.001) 
effect and a tendency (P = 0.06) for a treatment difference for serum bicarbonate, but no 
treatment x time (P = 0.88) interaction.  There was a treatment (P = 0.03) and time (P < 
0.001) effect, but no treatment x time (P = 0.66) interaction for serum anion gap. 
 There was no treatment affect (P < 0.58) for serum total protein, but a time (P < 
0.001) affect and treatment x time interaction (P = 0.001) was observed between CON 
and ZIL heifers.  However, when individual time points were evaluated, no time points 
were different between treatment groups.  There was a treatment (P = 0.02) and time (P < 
0.001) effect for serum albumin but no treatment x time interaction (P = 0.60).  Serum 
albumin concentrations were increased in CON heifers when compared with ZIL heifers.  
There was no treatment affect (P < 0.61) for serum globulin concentrations, but a time (P 
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< 0.001) effect and a treatment x time (P = 0.001) interaction was observed between 
CON and ZIL heifers.  However, when individual time points were evaluated, no time 
points were different between treatment groups. 
To our knowledge, the evaluation of complete blood chemistry profiles of cattle 
supplemented with ZH for a 20 d period in a controlled environment has not been 
reported.  However, similar measurements have been reported in feedlot lambs 
supplemented with.  Lopez-Carlos et al. (2010) reported that ZH supplementation at 
either 0.10, 0.20, or 0.30 mg / kg of BW / d for the last 42 d of feeding had no impact on 
serum total protein (López-Carlos et al., 2010).  Serum total protein concentrations 
account for albumin and other globulin fractions and are indicators of overall serum 
protein status (Evans and Duncan, 2003).  Neither supplementation of ZH or ractopamine 
hydrochloride had an impact on overall serum protein status in feedlot lambs (López-
Carlos et al., 2010).  Furthermore, the feeding of clenbuterol to Hereford steers did not 
impact serum total protein (Ricks et al., 1984).  In the current study, ZH supplementation 
decreased serum total protein in heifers; however, the decrease was minimal.  
Furthermore, a decrease in total protein would be expected due to a decrease of albumin 
in ZIL supplemented heifers. 
 Blood pH affects blood calcium concentrations, with an increase in pH resulting 
in an increase in calcium concentrations (Russell and Roussel, 2007).  Furthermore, 
decreases in albumin can result in decreased calcium concentrations (Russell and 
Roussel, 2007).  In the current study, serum calcium concentrations were decreased in 
ZIL heifers which also had decreased albumin concentrations.  Ricks et al., (1984), 
reported no difference in blood calcium or phosphorus concentrations of Hereford steers 
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supplemented clenbuterol in samples collected immediately prior to harvest.  Due to 
approximately 99 percent of mineral storage in bone, serum circulating concentrations of 
minerals may be an unreliable measurement on total body mineral status of an animal 
(Russell and Roussel, 2007).  Potassium is the major intracellular cation which is 
extensively regulated due to organ interactions (Russell and Roussel, 2007).  In the 
current study, potassium concentrations were decreased in ZIL heifers when compared 
with CON.  The decrease in serum potassium concentrations in ZIL heifers could 
possibly be explained due to an increase in lean muscle deposition observed during the 
utilization of ZH (Vasconcelos et al., 2008).  Muscle has been reported to contain 
2.43±0.92 mg/g of potassium (Mariam et al., 2004).  Serum sodium concentrations reflect 
total body sodium due to the fact that sodium is a major extracellular cation which is the 
main contributor to osmotic force and is confined to extracellular fluid (Russell and 
Roussel, 2007).  No differences for serum sodium would be expected in the current study 
since all heifers had ab libitum access to water.  The treatment difference observed for 
Na:K ratio with ZIL heifers having greater concentrations when compared with CON 
heifers would be expected due to the observed differences between treatment groups for 
potassium.   
Chloride is the major anion in extracellular fluid and usually resembles sodium 
concentrations due to the reabsorption of sodium and chloride together in the kidneys 
(Russell and Roussel, 2007).  In the current study, serum chloride concentrations were 
not affected by treatment which would be expected when compared with serum sodium 
concentrations.  The reference range for bicarbonate in cattle is 17 – 29 mmol/L (Kaneko 
et al., 2008).  In the current study, both treatment groups had bicarbonate concentrations 
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within the reference range; however, bicarbonate tended to be decreased in CON heifers.  
Ramirez et al. (1992) reported a decrease in bicarbonate concentrations of Holstein cows 
reared at sea level when compared with Holstein cows reared at 3,000 m.  Cows reared in 
high altitude are exposed to ambient hypoxia resulting in the development of decreased 
bicarbonate concentrations to compensate abnormal acid-base concentrations (Ramirez et 
al., 1992).  Clenbuterol a β2-AA has been reported to increase blood flow and oxygen 
uptake in the hind-quarters of cattle during early supplementation (Eisemann and 
Huntington, 1987).  Due to an increase in oxygen uptake observed in β2-AA 
supplemented cattle, greater bicarbonate concentrations observed in ZIL heifers could 
suggest an increase in oxygen availability with ZH supplementation.  The reference range 
for anion gap in bovine is 13.9 – 20.2 mmol/L (Kaneko et al., 2008).  Alterations in the 
anion gap are commonly utilized to determine acid/base disorders with an increase in 
lactate or HB concentrations (Gabow et al., 1980). 
 Serum creatinine concentrations were affected by treatment (P = 0.003) and time 
(P = 0.02), but there was only a tendency (P = 0.06) for a treatment x time interaction. 
Overall, creatinine concentrations were less in CON heifers when compared with ZIL 
heifers.  Creatine kinase concentrations were not affect by treatment (P = 0.17), time (P = 
0.55), or treatment x time (P = 0.40).  Serum beta-hydroxybutyrate concentrations were 
not affected by treatment (P = 0.11) or treatment x time (P = 0.83), but there was a time 
(P < 0.001) effect.  For serum lactate concentrations, there was a time effect (P = 0.001) 
and a tendency (P = 0.09) for a treatment effect, but no treatment x time (P = 0.72) 
interaction observed.  There was no treatment (P = 0.39) or treatment x time (P = 0.41) 
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interaction for serum lactate dehydrogenase (LDH) but there was a time (P < 0.001) 
effect. 
In the current study both treatment groups were within the normal reference range 
for anion gap; however, CON heifers had a greater anion gap which could possibly be 
explained due to a tendency for CON heifers to have greater serum lactate.  Creatinine 
concentrations were greater in ZIL heifers but were within the normal reference range 
which is 1.2 -1.9 mg/dL (Kaneko et al., 2008); however, CON heifers had decreased 
creatinine concentrations when compared with normal reference ranges.  The increase in 
creatinine would be expected due to a numerical increase in HCW which was 19 kg for 
ZIL when compared with CON heifers.  During normal muscle metabolism, creatine is 
broken down into creatinine which can be utilized as an indicator of muscle mass in the 
serum (Russell and Roussel, 2007).  Furthermore, serum creatinine is positively 
correlated with carcass weight, dressing percentage, and proportion of lean meat in a 
carcass (Istasse et al., 1990).  Cimaterol, a β2-AA (Signorile et al., 1995), increased 
plasma creatinine concentrations in Friesian steers during long term supplementation 
(Chikhou et al., 1993).  Creatine kinase is a key enzyme for cellular energetics 
(Wallimann et al., 1992).  In the current study, there was no difference in creatine kinase 
between treatment groups.  Thomson et al., (2015) reported no increase in creatine kinase 
activity in steers under normal feedlot conditions supplemented ZH or ractopamine 
hydrochloride when compared with a control group.  Creatine kinase has been reported to 
increase when steers are transported (Warriss et al., 1995). 
-hydroxybutyrate  is a ketone body produced during the metabolism of NEFA in 
the liver and can indicate a negative energy balance (Ospina et al., 2010).  No difference 
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was observed between treatment groups for HB in the current study, which is similar to 
that reported in steers supplemented clenbuterol (Eisemann et al., 1988a).  Furthermore, 
there was also no difference observed for HB concentrations for steers supplemented 
ZH for a 23 d duration (Van Bibber-Krueger et al., 2015).  Van Bibber-Krueger et al. 
(2015) suggested that ZH supplementation in cattle did not alter the metabolization rate 
of BHB.  During anaerobic conditions, lactate is formed by the oxidation of NADH by 
pyruvate allowing glycolysis to continue (Reece et al., 2015).  In the current study, there 
was a tendency for lactate to be decreased in ZIL supplemented heifers.  Thomson et al. 
(2015) and Van Bibber-Krueger et al. (2015) reported no difference in lactate 
concentrations of steers supplemented ZH.  Differences observed between these studies 
could be explained by frequency of sampling, as the current study evaluated lactate 
concentrations during a 10 h CRH/VP challenge following a 3 d ZH withdrawal.  Van 
Bibber-Krueger et al. (2015) observed a numerical decrease in plasma lactate 
concentrations as days on ZH increased; however, no samples were obtained during the 
withdrawal period of ZH.  These findings are different than what have been observed 
with previous β-AA supplementation.  The inclusion of P-5369 and Q-2636 in milk 
replacer increased lactate concentrations in calves (Blum and Flueckiger, 1988).  
Eisemann et al. (1988) observed increased lactate concentrations with the inclusion of 
clenbuterol in steer diets.  Furthermore, arterial cimaterol infusion increased lactate 
concentrations as cimaterol infusion rates increased (Byrem et al., 1996).  Observed 
differences between the current study and these can possibly be explained with time of 
sampling as in the current study heifers had been withdrawn from ZH supplementation 
for a 3-d period.  The glycolytic enzyme LDH catalyzes the conversion of lactate to 
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pyruvic acid (Doornenbal et al., 1988).  The reference range for LDH in the cow is 692 – 
1445 U / liter (Kaneko et al., 2008).  In the current study, there was no difference in LDH 
concentrations between treatment groups.  When ZH was administered to horses, an 
increase in LDH was observed (Wagner et al., 2008).  Differences observed in these 
studies can possibly be explained by species differences as ZH is not approved for 
utilization in the horse. 
Liver Enzymes 
 There was a treatment (P = 0.05) and time (P < 0.001) effect for serum alkaline 
phosphatase (ALP) concentrations.  There was no treatment (P = 0.22) or treatment x 
time (P = 1.0) interaction, but there was a time (P < 0.001) effect for serum aspartate 
transaminase (AST).  There was no treatment (P = 0.28) effect for serum gamma 
glutamyltransferase (GT).  However, there was a tendency (P = 0.08) for a treatment x 
time interaction.  There was a treatment (P = 0.05) and time (P < 0.001) effect, but no 
treatment x time (P = 0.64) interaction for serum sorbitol dehydrogenase (SDH). 
   Alkaline phosphatase catalyzes the cleavage of Pi from phosphate esters with 
production of ALP originating in the liver of mature animals (Doornenbal et al., 1988).  
Ricks et al. (1984) reported no difference in ALP in Hereford steers supplemented 
clenbuterol.  In the current study, ALP concentrations were decreased in ZIL heifers 
when compared with CON.  One explanation to a decrease in ALP concentrations could 
be the decrease in liver weight observed in the current study.  Furthermore, in dogs with 
increased corticosteroid concentrations, ALP concentrations are increased due to the 
formation of a more heat stable isoenzyme of ALP (Teske et al., 1986).  The decrease in 
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cortisol in ZIL supplemented heifers which explain the increase in ALP observed in CON 
heifers.  Aspartate transaminase is an enzyme that catalyzes the transfer of an α-amino 
group from an amino acid to an α-keto acid (Doornenbal et al., 1988).  In the current 
study, no difference was observed in AST concentrations.  An increase in AST 
concentrations was observed in Friesian calves administered cimaterol (Chikhou et al., 
1993).  However, Chikhou et al. (1993) did not observe a difference in liver weights in 
cimaterol treated calves which could explain the differences between these studies.  
Gamma glutamyltransferase is a membrane bound enzyme that catalyzes the transfer of 
gamma glutamyl groups from gamma glutamylpeptides to other peptides or amino acids 
(Kaneko et al., 2008).  In the current study, there was no difference in GT between 
treatment groups; however, both treatment groups were above normal reference ranges.  
A potential cause of increased GT in the current study could be the CRH/VP challenge 
administered.  In canines, glucocorticoids have been associated with an increase in GT 
concentrations (Shull and Hornbuckle, 1979).  Lastly, SDH concentrations were 
increased in CON heifers in the current study; however, both treatment groups had 
elevated SDH concentrations compared with reference ranges for the cow which are 4.3 – 
15.3 U/L (Kaneko et al., 2008).  Feed restriction in llamas resulted in an increase in 
hepatic lipidosis which resulted in elevated SDH concentrations (Tornquist et al., 2001).  
Therefore, the increase in SDH in the current study could potentially be a result of 
increased lipolysis during the CRH/VP challenge allowing heifers to mount a stress 
challenge. 
Tissue samples 
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There were no differences (P = 0.49) in concentrations of glucose or lactate, and 
no difference in glycolytic potential for the liver samples between the CON and ZIL 
heifers.  Glucose concentrations within the LM were greater (P = 0.03) in CON heifers 
when compared with ZIL heifers.  Supplementation of ZH did not affect lactate 
concentrations (P = 0.39) or total glycolytic potential (P = 0.11) for LM samples.  
Glucose concentrations in the BF tissue samples were not affected (P = 0.22) by ZH 
supplementation.  Lactate concentrations in BF tissue samples were greater (P = 0.05) in 
CON heifers when compared with ZIL heifers.  Furthermore, there was a treatment effect 
for glycolytic potential in BF samples (P = 0.05) with CON heifers having greater 
concentrations when compared with ZH-supplemented heifers. 
Glycolytic potential (GP) is a measurement of glucose, lactate, glycogen, and 
glucose-6-phosphotase that is present in muscle that ultimately can be converted to lactic 
acid.  This index can be used as a measurement of the capacity for postmortem glycolysis 
in muscle resulting in a decrease of muscle pH in the conversion of muscle to meat 
(Monin and Sellier, 1985).  Glycolytic potential has been evaluated as a potential 
measurement of meat quality in beef and pork (Hamilton et al., 2003; Wulf et al., 2002).  
In cattle, GP has been reported to have a curvilinear response with ultimate LM pH after 
harvest.  Muscle samples with a GP less than 100 µmol/g are associated with a greater 
postmortem pH that results in decreased lactate production and can cause dark, firm, and 
dry beef (Wulf et al., 2002).  In the current study, GP in the LM was not different in CON 
and ZH supplemented heifers.  In the BF, ZH-supplemented heifers did have a decreased 
GP; however, this was associated with less available lactate resulting in a decreased 
calculated GP and was greater than the 100 µmol/g threshold that has been suggested for 
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optimal pH postmortem.  In previous ZH studies, Hilton et al. (2009) reported ZH 
supplementation increased beef color resulting in a brighter cherry red favorable beef 
color during a 5 d shelf-life study.  Furthermore, (Montgomery et al., 2009a) reported ZH 
supplementation increased LM cherry red color and resulted in a decrease of dark colored 
LM when compared with control carcasses.  The increase in bright cherry red color was 
attributed to an increase in myoglobin content that resulted in a favorable improvement in 
muscle color (Montgomery et al., 2009a).  In liver samples, there was no difference in 
glucose, lactate, or GP observed in CON and ZH supplemented heifers.  In the rat model, 
it has been reported protein kinases activity on glycogen synthase in skeletal muscle 
predominantly take place in the liver (Imazu et al., 1984).  Furthermore, the lack of 
differences in glucose and GP between treatment groups of liver samples would further 
support the fact that no differences in serum glucose were observed in the current study.  
If blood glucose concentrations decreased, glucagon would be released from the α-cells 
of the pancreas to raise blood glucose concentrations (Navarro et al., 1999).  These data 
suggest that ZH supplemented heifers do not have decreased available energy stores in 
muscle or liver samples that could cause muscle fatigue from lack of an energy source. 
Organ analysis 
In terms of select organ weights, there was no effect of treatment.  Weights for the 
heart (P = 0.36), lungs (P = 0.30), total kidneys (P = 0.11), left kidney (P = 0.31), and left 
adrenal gland (P = 0.79) were similar.  There was a tendency (P = 0.08) for liver weights 
to be greater in CON heifers when compared with ZIL heifers.  Also, there was a 
tendency (P = 0.10) for right adrenal gland weights to be greater in CON heifers when 
compared with ZIL heifers.  There was a treatment difference (P = 0.03) for right kidney 
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weights such that weights were greater in CON heifers when compared with ZIL heifers.  
As a percentage of BW, there was no treatment effect on heart (P = 0.45), lung (P = 
0.41), and total adrenal gland (P = 0.42) weights.  However, as a percentage of BW, there 
was a tendency (P = 0.06) for CON heifers to have greater liver and total kidney (P = 
0.08) weights than ZIL heifers. 
 Between CON and ZIL heifers, no treatment differences were observed between 
CON and ZIL heifers for aortic valve to left atrial ventricular valve diameter ratio (P = 
0.64), aortic valve to pulmonary valve diameter ratio (P = 0.16), aortic valve 
circumference (P = 0.98), or the aortic valve / right ventricular valve diameter ratio (P = 
0.96).  Also, there were no differences for interventricular septum thickness (P = 0.30), 
left atrial ventricular valve circumference (P = 0.64), left atrial ventricular valve / right 
atrial ventricular valve diameter ratio (P = 0.64), left ventricle free wall thickness (P = 
0.97), or for the left ventricle + interventricular septum / right ventricle weight ratio (P = 
0.14) between treatment groups.  There was a tendency (P = 0.07) for left ventricle + 
interventricular septum / total heart weight ratio to be less in CON, when compared with 
ZIL heifers.  There was no difference in left ventricle free wall thickness / right ventricle 
free wall thickness ratio (P = 0.13), left ventricle thickness / septal thickness ratio (P = 
0.36), or left ventricle + septum weight (P = 0.97).  Furthermore, there was no difference 
in pulmonary valve / left atrial ventricular valve ratio (P = 0.47), pulmonary valve / right 
atrial ventricular valve ratio (P = 0.30), or pulmonary valve circumference (P = 0.11).  
There was no difference (P = 0.94) for right atrial ventricular valve circumference.  There 
was a tendency (P = 0.09) for right ventricle free wall thickness to be thicker in CON vs 
ZIL heifers.  However, there was no difference (P = 0.33) in right ventricle free wall 
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weight between treatment groups.  There was a difference (P = 0.04) in right ventricle 
free wall / interventricular septal thickness ratio with CON having a greater ratio when 
compared with ZIL heifers.  However, there was no difference (P = 0.72) for right 
ventricle / total heart weight ratio between treatments.  Furthermore, there was no 
difference (P = 0.85) in left ventricle + interventricular septum as a percent of BW or 
right ventricle (P = 0.30) as a percent of BW. Gross lesions of hepatitis were seen in two 
CON heifers.  Gross nephritis was seen in one ZIL heifer that was noted to have a 
catheter infection during the study. Histologic evaluation of lungs demonstrated a very 
mild regional eosinophilic interstitial pneumonia in one CON heifer.  Pulmonary artery 
changes were adventitial and consisted of periarterial fibrosis and subacute inflammation 
and were noted in two CON and one ZIL heifer. Livers had mild periportal hepatitis in 6 
of 10 CON and 7 of 9 ZIL heifers. The two CON heifers with gross hepatitis had 
histologic fibrosis in addition to mild lymphocytic infiltrates. The hepatic lesions were 
typical mild periportal infiltrates and rare isolated small lymphocytic foci. Renal lesions 
were mild focal chronic interestital nephritis consisting of very small, sparse, scattered, 
interstitial aggregates of lymphocytes and plasma cells (6 CON and 6 ZIL heifers).  A 
single foci of lymphocytes was seen in the adrenal medulla of one CON heifer. Skeletal 
muscle and cardiac muscle was histologically normal in all heifers. 
Experiments that have evaluated and reported the effects of β-AA on major 
organs of feedlot cattle are limited.  In the current study, no differences were observed in 
heart and lung weights between treatment groups.  No difference was reported in 
combined heart and lung weights of beef steers fed ZH for 20 d (Holland et al., 2010).  
However, the feeding of clenbuterol (β2-AA) in normal mice decreased heart weights by 
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8% when compared with control mice (Sharma et al., 1997).  Furthermore, May et al. 
(2014) reported a tendency for a decrease in heart weights of Holstein steers 
supplemented ZH for 20 d but no difference in lung weights between zilpaterol and 
control steers.  Furthermore, a decrease in kidney and liver mass of zilpaterol 
supplemented steers when compared with control steers was observed (May et al., 2014).  
In the current study, there was only a difference observed for right kidney weights, with 
ZIL supplemented heifers having less right kidney weights; however, overall kidney 
weights did not differ between treatment groups.  Furthermore, there was a tendency for 
liver weights to be greater in the CON heifers when compared with ZIL heifers in the 
current study.  The feeding of salbutamol (β2-AA) to pigs has been reported to decrease 
kidney and liver weights when compared with control pigs (Hansen et al., 1994).  The 
decreased in renal and liver mass could be a result of decreased gut fill.  The 
repartitioning of energy to skeletal muscle growth and a decrease in feed intake resulting 
in less gut fill could explain the decrease in renal and liver mass of ZIL supplemented 
cattle (Montgomery et al., 2009b).  
To our knowledge, data on the effect of β-AA’s on adrenal weights has not been 
reported in the literature.  The comparing of organ weight ratios to BW can result in 
misleading data due to differences in animal adipose and muscle tissues (Joseph, 1908), 
as well as the previously reported effect of ZH on HCW (Montgomery et al., 2009a; 
Montgomery et al., 2009b).  Reported percent’s for bovine heart weight ratios to BW are 
0.26, 0.52, and 0.38% for steers, bulls, and female respectively (Joseph, 1908).  In the 
current study, heifer heart weight ratios to BW were within this range for cattle. 
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Minimum published anatomic data is available for measurements of the dissection 
of the bovine heart.  The total cardiac to BW ratios and the left ventricle and septum to 
right ventricle weight ratios were within the normal range (Leifsson, 2011). The 
expanded data and reference of a broader range of normal cardiac dimensional anatomy 
published here will be useful in evaluating finishing cattle affected by or at risk of 
pulmonary hypertension and chronic right heart failure which appears to be a growing 
problem (Neary et al., 2013). The gross lesions of liver fibrosis were seen only in CON 
heifers and the kidney lesion was in a heifer with a documented catheter infection and 
transient sepsis during the study. The mild chronic periportal hepatitis and chronic 
interstitial nephritis seen equally in both groups are common background lesions seen in 
cattle in standard production systems. Theses likely reflect residual inflammation of 
neonatal infections. The mild adventitial inflammation seen around the pulmonary artery 
in two ZIL and one CON heifers are of undetermined etiology but suspected to be 
residual scaring and inflammation due to past resolved pulmonary infection.  None of the 
histologic lesions were more prevalent in ZIL heifers and were typical of incidental 
changes seen in standard commercial cattle.  No pathologic changes were observed in 
these cattle associated with ZH treatment that might suggest a direct link between 
treatment and reported mortality risk in some production systems. Changes in feed 
delivery and other production practices associated with implementing of supplement 
delivery and documentation of causes of mortality during the last 25 d of feeding need 
further prospective study. 
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Conclusions and Implications 
Data from the current study would indicate that that activation of the 
hypothalamic-pituitary-adrenal (HPA) axis will increase both stress and metabolic 
variables in both CON and ZIL heifers respectively.  Activation of the HPA axis is a 
cascading response, regulated by the magnitude of the stressor (Tsigos and Chrousos, 
2002).  An acute response may result in brief down-regulation of systems not necessary 
for survival, such as digestion and reproduction, and stimulate catabolism of energy 
stores and body tissues to be used for energy (Sapolsky et al., 2000).  While there are data 
to suggest the initiation of a stress response during relocation events (Falkenberg et al., 
2013), there are few or no data available to describe how this event is altered due to 
supplementation of β-AAs.  Therefore, this data indicates the biological response of cattle 
supplemented β-AAs to a controlled endocrine stress.  Furthermore, these data 
demonstrate that a simulated stress induced by administration of CRH/VP in beef cattle 
elicits shifts in immune cell populations and metabolic variables; and stress hormones, 
metabolic variables, and immune cell responses are altered in beef heifers supplemented 
with ZH when cattle are exposed to a simulated stress challenge.  However, within the 
environment of this study, supplementation of ZH did not appear to hinder finishing 
heifer’s ability to mount a stress, immune, or metabolic response during a neurohomone-
induced stimulated stress challenge. 
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Appendix I 
β-Hydroxybutyrate Assay 
 
Reference: Sigma-Aldrich MAK041 Kit Bulletin, 2012 
 
 
Preparation of Reagents: 
 
Briefly centrifuge vials of each reagent before opening. Be sure to use 
ultrapure water for preparation. Avoid repeated freeze/thaw cycles to maintain 
integrity.  
 
1. β-Hydroxybutyrate Assay Buffer:  Allow to come to room temperature 
before use. 
 
2. β-Hydroxybutyrate Enzyme Mix:  Reconstitute with 220µl of β-
Hydroxybutyrate assay buffer. Mix well via pipette then aliquot and store, 
protected from light, at -20°C. Use within 2 months of reconstitution and 
keep cold while in use. 
 
 
3. β-Hydroxybutyrate Substrate Mix:  Reconstitute with 220µl of β-
Hydroxybutyrate assay buffer. Mix well via pipette then aliquot and store, 
protected from light, at -20°C. Use within 2 months of reconstitution and 
keep cold while in use. 
 
 
Preparation of Standards: 
 
1. β-Hydroxybutyrate Standards:  Reconstitute with 100µl of water to 
generate a 10mM solution. Mix well via pipetting, then aliquot and store, 
protected from light, at -20°C.  
 
2. Dilute 10µl of the 10mM β-Hydroxybutyrate Standard Solution with 90µl 
β-Hydroxybutyrate Assay Buffer to prepare a 1mM standard solution. 
 
 
3. For 2 plates mix 50µl of the 10mM β-Hydroxybutyrate Standard Solution 
with 450µl of the β-Hydroxybutyrate Assay Buffer. 
 
 
4. In 0.6 ml tubes make up the standards according to the following chart: 
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1mM Standard Solution (l) Beta-Hydroxybutyrate 
Assay Buffer (l) 
nmole / well Value 
0 400 0 
16 384 2 
32 368 4 
48 352 6 
64 336 8 
80 320 10 
96 304 12 
  
5. Once the standards are made up in the tubes, add 50 µl if the appropriate 
standard into duplicate wells on the plate.  
 
Preparation of Samples: 
 
     Add 8µl of each sample into duplicate wells on the plate. 
     Add 42µl of Assay Buffer to each well to get a final volume of 50 µl 
 
Assay Reaction: 
 
1. Set up the Reaction Mixes according to the scheme below. 50 µl of the 
appropriate Reaction Mix is required for each well in the plate.  
 
Reagent Samples and Standards Blank 
Beta-Hydroxybutyrate 
Assay Buffer 
46 l 48 l 
Beta-Hydroxybutyrate 
Enzyme Mix 
2 l - 
Beta-Hydroxybutyrate 
Substrate Mix 
2 l 2 l 
 
  For 1-96 well plate, mix:  
 4600 µl of β-Hydroxybutyrate Assay Buffer 
 200 µl of β-Hydroxybutyrate Enzyme Mix 
 200 µl of β-Hydroxybutyrate Substrate Mix 
  
2. Add 50 µl of the appropriate Reaction Mix to each of the wells. Mix well 
using a horizontal shaker and incubate the reaction for 20 minutes at room 
temperature. Protect the plate from light during the incubation.  
 
3. Measure the absorbance at 450 nm (A450) on the plate reader using the 
Beta Protocol. 
 
 
Results: 
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     Calculations:  
     The background for the assays is the value obtained for the 0 (blank) Standard.            
Correct for the background by subtracting the 0 (blank) value from all 
readings. 
Use the values obtained from the Standards to plot a Standard Curve (A 
new standard curve must be set up each time the assay is run).  Blank 
values must also be subtracted from the sample readings to obtain a 
corrected measurement. Use the corrected value in all calculations. 
 
    Concentration of Beta-Hydroxybutyrate: 
 
Sa/Sv = C 
Sa  = Amount of Beta-Hydroxybutyrate in unknown sample (nmole) from 
standard curve. 
Sv = Sample volume (l) added into the wells 
     C = Concentration of Beta-Hydroxybutyrate in sample 
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Appendix II 
Lactate Assay  
 
Reference: Sigma-Aldrich MAK064 Kit Bulletin, 2012 
 
Reagent Preparation: 
Lactate Assay Buffer:  Allow buffer to come to room temperature 
before use. 
 
Lactate Probe:  Warm to room temperature before use. Protect 
from the light. Mix well by pipetting, then aliquot and store at -
20°C. 
 
Lactate Enzyme Mix:  Reconstitute in 220 µl of Lactate Assay 
Buffer. Mix well via pipette, then aliquot and store at -20°C. Use 
within 2 months of reconstitution.  
 
Preparation of Lactate Standard:  
 
1. Take 10 µl Lactate Standard (100 nmole / µl) and dilute with 
990 µl of Assay Buffer to result in 1 ml of Diluted Standard (1 
nmole / µl). 
 
2. In 0.6 ml tubes make up the standards according to the 
following chart: 
 
Diluted Standard  Lactate Assay Buffer (l) Std. Value (nmole / well)  
0 250 0 
10 240 0.2 
20 230 0.4 
30 220 0.6 
40 210 0.8 
50 200 1.0 
 
3. Once standards are prepared in tubes, add 50 µl of the 
appropriate standard into duplicate wells on the plate.  
 
Preparation of Samples: 
         
1. Samples must be deproteinized using a 10 kDaMWCO spin 
filter. 
 
2. Add 500 µl of sample to filter. 
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3. Spin tube for 1.5 hours at 14,000g. 
 
4. Remove filter and store sample at -80°C until ready to use. 
 
Assay Reaction: 
1. Set up the Master Reaction Mix according to the following 
scheme: 
 
Reagent Master Reaction Mix (cell) Master Reaction Mix (plate) 
Lactate Assay Buffer 46 μL 4.600 ml 
Lactate Enzyme Mix 2 μL 200 μL 
Lactate Probe 2 μL 200 μL 
    
2. Add 50 µl of the Master Reaction Mix to each of the duplicate 
wells.  
 
3. Mix well using a horizontal shaker or by pipetting. 
 
4. Incubate the reaction for 30 minutes at room temperature. 
Protect the plate from light during the incubation 
 
5. Measure the absorbance at 570 nm (A570) 
 
Procedure: 
 
1. Allow Buffer to come to room temperature. Allow Lactate 
probe to come to room temperature (protect from light) 
 
2. Reconstitute Lactate Enzyme Mix in 220 µl of Lactate Assay 
Buffer, mix well 
 
3. Take 10 µl of Lactate Standard and reconstitute with 990 µl of 
Assay Buffer to get your 1 ml of Diluted Standard (1nmole / 
µl). 
 
4. Prepare standards according to the previous chart. (This should 
give enough standard for 2 plates) 
 
5. Place 50 µl of each standard into duplicate wells on the plate. 
(Do not dilute with assay buffer). 
 
6. Add 3 µl of sample to each duplicate well. 
 
7. Add 47 µl of Lactate Assay Buffer to each well that has a 
sample in it. (Do not add to the standards) 
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8. Make up the Master Reaction Mix according to assay chart in 
previous section (add probe last and use immediately.) 
 
9. Add 50 µl of the Master Reaction Mix to each well. 
 
10. Place plate on incubator/shaker and shake for 1 minute, then 
continue incubating for 29 more minutes. (Protect from light). 
 
11. Measure the absorbance using Lactate Procedure at 570 nm on 
plate reader.  
 
Results:  
 
The background for the assay is the value obtained for the 0 
(blank) lactate standard.  Correct for the background by subtracting 
the blank value from all readings.  Background values can be 
significant and must be subtracted from all readings. 
 
Use the values obtained from the appropriate lactate standards to 
plot a standard curve.  The amount of lactate present in the samples 
may be determined from the standard curve. 
(Note:  A new standard curve must be set up each time the assay is 
run.) 
 
Concentration of Lactate: 
 
   Sa/Sv = C 
C x 89.07 ng / nmole = ng / μL 
 
Sa = Amount of lactate acid in unknown sample (nmole) from 
standard curve 
Sv = Sample volume (μL) added into the wells. 
C = Concentration of lactate acid in sample 
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Appendix III 
Lactate Dehydrogenase Assay 
 
Reference:    Sigma-Aldrich MAK066 Kit Bulletin, 2013 
 
Preparation of Reagents:  
Briefly centrifuge vials before opening. Use ultrapure water 
for the preparation of reagents. To maintain reagent 
integrity, avoid repeated freeze/thaw cycles. 
 
1. LDH Assay Buffer:  Allow buffer to come to room 
temperature before use. 
 
2. LDH Substrate Mix:  Reconstitute in 1 mL of water. 
Mix well via pipette and keep cold while in use. 
(Substrate Mix is stable for one week at 4 ° C and 1 
month at -20°C. 
 
Preparation of NADH Standards:  
1. Reconstitute in 400 µL of water to generate 1.25 mM 
standard solution 
 
2. Mix well via pipette and keep cold while in use. The 
NADH Standard Solution is stable for one week at 4 ° 
C and 1 month at -20°C. 
 
3. In 0.6 mL tubes make up the standards according to the 
following chart: 
 
1.25mM Standard Solution 
(l) 
LDH Assay Buffer (l) nmole / well Value 
0 250 0 
10 240 2.5 
20 230 5 
30 220 7.5 
40 210 10 
50 200 12.5 
 
 
4. Once standards are made up in the tubes, add 50 µL of 
the appropriate standard into duplicate wells on the 
plate.  
 
Preparation of Samples: 
1. Dilute samples in tubes off of the plate : 
 2 µL of sample 
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 198 µL of LDH Assay Buffer (dilution factor 
100) 
 
2. Then add 50 µL of each diluted sample into duplicate 
wells on the plate (amount of sample going into plate 
0.5 µL). 
 
Assay Reaction: 
1. Set up Reaction Mixes according to the scheme below, 
50 µL of the appropriate Reaction Mix is required for 
each well. 
 
Reagent Master Reaction Mix 
LDH Assay Buffer 48 l 
LDH Substrate Mix 2 l 
 
2. Add 50 µL of the Master Reaction Mix to each of the 
wells. Protect the plate from light while incubating.  
 
3. Shake 1 minute while incubating.  Incubate an 
additional minute.  After these 2 minutes, take the 
initial measurement (Tinitial).  Measure the absorbance at 
450 nm at the initial time (A450) initial.  Note:  It is 
essential (A450)initial) is in the linear range of the 
standard curve. 
 
4. Incubate the plate at 37°C taking measurements (A450) 
every 5 minutes.  Protect the plate from light during the 
incubation. 
 
5. Continue taking measurements until the value of the 
most active sample is greater than the value of the 
highest standard (12.5 nmole / well).  At this time the 
most active sample is near or exceeds the end of the 
linear range of the standard curve. 
 
6. The final measurement [(A450) final} for calculating the 
enzyme activity would be penultimate reading or trhe 
value before the most active sample is near or exceeds 
the end of the linear range of the standard curve.  The 
time of the penultimate reading is Tfinal. 
Note:  It is essential the final measurement falls within the linear range of the standard 
curve. 
 
